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Abstract 
 
 
Over the past 15-20 years, there has been growing interest and concern from the scientific and 
regulatory communities over the potential risks of emerging environmental contaminants (ECs). 
State-of-the-art techniques used for monitoring ECs do not provide the high spatial and temporal 
resolution measurements required to better understand and mitigate the risks. Immunoassays, 
which use antibodies to detect a target compound with high affinity, specificity and selectivity, 
partly address these limitations. However, the use of antibodies for the detection of small-sized, 
non-immunogenic environmental contaminants, presents a number of challenges. Recent advances 
in protein engineering have led to the emergence of antibody mimetics that offer the high affinity 
and specificity associated with antibodies, but with reduced batch-to-batch variability, increased 
stability, and in vitro selection to ensure rapid discovery of binders against a wide range of targets. 
This study explores the potential of Affimers, a recent example of antibody mimetics, as suitable 
bioreceptors for the detection of small organic molecules. Methylene blue (MB), a redox-active 
molecule used as a fabric dye and diclofenac (DCF), an important environmental contaminant, 
were selected as the target compounds and Affimers against MB and DCF were developed by the 
BioScreening Technology Group, University of Leeds. The objectives of this project were to a) 
demonstrate that the developed Affimers can bind to the selected targets with very high affinity, b) 
assess their performance in the complexity of environmental water samples (selectivity), and c) 
investigate the potential of an Affimer-based assay for small molecule detection.  
  
Target immobilisation for Affimer characterisation was achieved using long-chained alkanethiol 
linkers coupled with oligoethylene glycol (LCAT–OEG) and the immobilisation approach was 
evaluated through electrochemical measurements and infrared spectroscopy. Subsequently, binding 
between the immobilised targets and target-specific Affimers was quantified using quartz crystal 
microbalance with dissipation monitoring (QCM-D). Affimer affinity studies revealed Affimer 
dissociation constants (KD=13.7 nM and 73 nm for MB and DCF Affimers respectively) was 
comparable to that of high affinity antibodies. Furthermore, the high selectivity of MB-Affimers 
was demonstrated using limnetic water samples. Finally, an Affimer-based competition ELISA was 
demonstrated (LOD=75 nM), illustrating the potential of Affimers as bioreceptors in 
immunoassays for the detection of small-sized, non-immunogenic compounds. These findings are 
very promising, encouraging further research into Affimer-based assays and biosensors in order to 
introduce a novel, alternative path for rapid, on-site monitoring of contaminants in the 
environment.   
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Chapter 1 
 
Overview  
 
1.1 Emerging Environmental Contaminants  
 
The exponentially growing world population and the subsequent urbanisation has led to the 
development of large and densely populated cities, which, social and economic impacts aside, have 
a number of detrimental impacts on public health and the ecosystem [1]. Rapid technological and 
social advances (e.g. transportation, industrialization, health care, communication) have improved 
life quality, but have also induced a major shift in the urban lifestyle that results in an increased 
concentration of energy use and product consumption which consequently lead to increased waste 
production. Additionally, diseases associated with the modern urban way of life such as obesity, 
diabetes and mental illnesses along with an increasingly aging population have led to a huge 
increase in the use of pharmaceuticals [2] [3].  Therefore, in addition to the pollution caused by 
industrial activity in the city outskirts, urban dwellers contribute to a heightened discharge of 
compounds, such as personal care products (PCPs), cleaning agents, pharmaceuticals, microplastics 
and engineered nanoparticles (ENPs). All of the above contribute to the complex lattice of urban 
pollution sources that threaten human and ecosystem health. For example, ethinyl estradiol, 
typically administered with contraceptive pills, is not fully metabolised by the human body and the 
greatest part of it (~60%) is excreted and released to the environment in wastewater discharges [4]. 
Many studies have linked this xenostrogen with endocrine disruption or other adverse effects to 
aquatic organisms, most notably the feminisation of several species of fish in surface waters [5].  
 
Just like ethinyl estradiol, the plethora of newly introduced compounds found in PCPs, 
pharmaceuticals, microplastics and ENPs are not well characterised regarding their environmental 
fate and effects [6]. However, through a number of pathways, these compounds are discharged to a 
variety of environmental compartments potentially causing harm to the ecosystem. A characteristic 
example of the complexity of exposure to these recently identified environmental contaminants is 
diclofenac (DCF) and its fatal effects on vulture populations of the Indian subcontinent. 
Diclofenac, or 2-(2, 6-dichloranilino) phenylacetic acid, is a widely consumed, over-the-counter 
nonsteroidal anti-inflammatory drug (NSAID), used to treat inflammatory diseases or as an 
analgesic. Although a number of studies have reported potential adverse effects of diclofenac on 
2 
 
aquatic organisms [7], its disastrous ecological impact was identified in South Asia in what came to 
be known as the Indian vulture crisis. Diclofenac was extensively used in this area as a veterinary 
drug to treat inflammation or other symptoms of disease in cattle. The vultures scavenging on 
livestock carcasses would be exposed to diclofenac, which was extremely toxic to these birds, 
particularly those of the Gyps genus, causing extensive visceral gout, kidney failure and death. This 
resulted in a critical decline of their population bringing them to the brink of extinction. The 
eradication of vultures across the Indian continent caused additional ecological consequences that 
threatened human health, such as the rapid increase in the number of feral dogs that benefited from 
the absence of scavenging birds, and the subsequent rise in cases of rabies in humans [8] [9].  
 
Such case-studies demonstrate that these classes of compounds, collectively called emerging 
contaminants (ECs), pose a complex challenge, not only due to the generally limited knowledge 
base, but also due to their usually very low concentrations in the environment which may render 
them difficult to detect [10]. The concern and awareness of ECs was raised due to recent 
technological advances in analytical methods, which allowed detection of these compounds in very 
low concentrations. These methods, however, are often time-consuming, specialist, complex and 
expensive and thus can limit the spatial and temporal resolution with which the presence of ECs 
can be mapped. These challenges need to be properly addressed by the scientific community and 
the regulatory authorities; it is imperative to understand the factors and processes affecting urban 
pollution as well as the effects and potential threats to human health and the ecosystem. This 
knowledge is necessary in order to support well-informed decision making for developing 
improved and effective approaches to mitigate current pollution, and proactively address potential 
future urban environmental problems. The introduction of novel, cost- and time-effective tools for 
assessing pollution is essential for reaching these objectives. Aiming to contribute to such efforts, 
an approach using novel biomolecular technologies is presented in this work.  
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1.2 Current Methods for Detection of ECs in Water   
 
Currently, the major approach for monitoring water quality involves the periodic collection of 
aquatic samples (grab or composite samples), followed by extraction and purification steps and 
analysis using laboratory-based instruments. The state of the art techniques for analysing ECs in 
aquatic samples are primarily based on liquid (LC) or gas (GC) chromatography coupled with mass 
spectrometry (MS). In general, chromatographic techniques are used to separate mixtures ahead of 
infusing them into the mass spectrometer for analysis. GC or LC use a separation column 
containing material, called the stationary phase, and the sample is carried through the column by an 
appropriate solvent or gas, called the mobile phase. Depending on their different interactions with 
the stationary phase, each of the substances in a sample may be eluted by the mobile phase at a 
different rate from the others and so exit the column at different times, before reaching the mass 
spectrometer [11]. Mass spectrometry is a technique to identify compounds in a sample. The 
molecules of the analyte are ionised and the resulting ions are separated by a mass analyser and 
detected according to their mass-to-charge ratio. This technique measures the molecular weight of 
the compounds present in the mixture while fragmentation of the molecular species provides 
structural information. Mass spectrometry coupled with gas or liquid chromatography is a powerful 
analytical approach; its high selectivity and exceptional detection limits rank it as what is 
considered the “gold standard” in sample analysis and is routinely used in research, diagnostics, 
forensics and many other fields and applications [12]. 
 
In regard to emerging contaminants, the US-EPA standard analytical method for determining 
pharmaceuticals and personal care products is based on high performance liquid chromatography 
combined with tandem mass spectrometry (HPLC/MS/MS) in a multiple reaction monitoring 
(MRM) acquisition mode, which is a highly sensitive and selective technique. Steroids and 
hormones, which belong to another subclass of ECs, are routinely analysed by high resolution gas 
chromatography combined with high resolution mass spectrometry (HRGC/HRMS). Both 
techniques are highly sensitive and the limits of detection (LOD) can reach levels of ng/L and in 
some cases even pg/L [13] [14]. For example, the standard methods for analysing diclofenac in 
aquatic samples involves solid phase extraction (SPE) followed by LC-MS methods, such as LC-
ion-trap-MS-MS and the LODs of these techniques range from 1-7 ng/L [15]. In addition, the US 
Geological Survey recently introduced a novel method for the detection of 110 pharmaceuticals by 
injection of the water sample without prior SPE (solid phase extraction) onto HPLC-MRM, where 
detection limits ranged from 0.45 to 94.1 ng/L [16].  
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These techniques are powerful and their excellent LODs have allowed the detection of previously 
unnoticed substances in environmental samples. They are, however, bound by a certain number of 
limitations. Firstly, since measurements cannot be taken in situ, they mainly rely on grab samples, 
which provide only a ‘snapshot’ of the presence of specific compounds at the point and time of 
sampling. Additionally, as with most analytical techniques, these approaches do not give further 
information about bioavailability. Increasing the temporal and spatial resolution of spot sampling 
would be impractical, since these methods are labour-intensive and can be expensive (including 
transport and analytical costs). Composite samples using automatic samplers set at a high sampling 
rate can generate samples that are more representative than grab samples, but are still limited by 
costs, time and manual effort. Moreover, there are many cases, such as in drinking water quality 
monitoring, where analytical results are required rapidly, but the overall spot sampling, transport 
and laboratory based analysis process is time-consuming and often does not meet that need [17].   
 
Apart from spot samples and automated samplers, passive samplers are often used, which 
sequester, accumulate and retain the pollutants until collection and analysis, providing time-
weighted average (TWA) concentrations of the analyte(s). Notable examples include Chemcatcher, 
used for organic compounds and heavy metals, and Polar Organic Chemical Integrative Sampler 
(POCIS), which is able to mimic bioaccumulation of pollutants in organisms. These approaches 
have been shown to be very reliable and sensitive, however, they still rely on laboratory-based 
analytical methods, such as those introduced earlier. The analytical instruments used for such 
methods are usually large, complex and expensive, and involve labour-intensive techniques to 
handle, purify and analyse environmental samples, and require highly skilled and trained operators, 
factors that greatly impede the development of a rapid, cost-efficient environmental monitoring 
scheme [17-20]. 
 
Alternative approaches to assess contaminant levels and exposure include the use of biomarkers or 
whole-organism bioassays which are based on the biological response or reaction of organisms to 
the presence of specific substances, providing acute toxicity indicators. Similarly, biological early 
warning systems (BEWS) can provide real-time measurements of health levels of organisms (such 
as fish, daphnia, algae or microorganisms) based on physiological or behavioural changes in the 
environment. These approaches are very useful as preliminary screening methods and allow the 
early detection of the environmental impact of contaminants, but have limitations (e.g., being time-
consuming, labour-intensive) and often require validation from standard analytical techniques [17].  
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target compound. Immunoassays are bioassays that use antibodies as biorecognition elements. 
Critically, antibodies offer very high specificity and affinity for their respective antigen, which can 
be exploited in immnoassays.  Such assays are fast, simple and fairly inexpensive if employed 
broadly following antibody development. Antibodies are highly selective and can recognise the 
target antigen even in complex matrices, such as blood or urine, and thus require little to no sample 
pre-treatment. Moreover, depending on the assay format, immunoassays do not usually require 
large, laboratory-bound instruments, thus allowing operation in the field and reducing the time 
delays and expenses associated with sample transport. There are several EU projects, such as the 
River ANAlyser (RIANA) and the Automated Water Analyser Computer Supported System 
(AWACSS), that employ immunosensors for the multiplexed detection of organic contaminants 
such as pesticides, polycyclic aromatic hydrocarbons (PAHs), or endocrine disruptors (EDCs). 
These approaches provide a rapid, cost-effective, multiplexed screening of pollutants in water 
samples that can substantially enhance pollution monitoring [22].  
 
However, the biorecognition mechanism of antibody-antigen binding can be sensitive to the 
surrounding environmental parameters, such as temperature, pH or ionic strength, since antibodies 
are biomolecules that naturally function within the narrow range of conditions inside organisms 
[23]. In environmental samples, these parameters can vary significantly from these conditions, 
which can consequently affect the binding abilities or stability of antibodies. It is possible to 
optimise experimental design in order to improve the performance of the assay, but this can be a 
challenging and time-consuming procedure which, in the complexity of environmental matrices, 
may still not always guarantee reliability [23]. Another important limitation of antibodies for 
environmental applications is development, since raising antibodies against a target compound 
requires the immunisation of animals. Most environmental contaminants are small-sized molecules 
that are potentially toxic or non-immunogenic. Therefore, the development of antibodies against 
such targets can prove to be a challenging, expensive and time-consuming process, if not unfeasible 
[25]. As a result, despite their numerous advantages, antibody-based assays often fail to meet the 
demand of regulatory and routine environmental monitoring for cheaper, faster, reliable and robust 
methods.  
 
Recent advances in protein engineering technologies and synthetic chemistry have enabled the 
development of alternative affinity receptors with improved characteristics, in order to address the 
limitations of antibodies. Notable examples of such reagents include antibody fragments (Fabs), 
DNA or RNA aptamers, molecularly imprinted polymers (MIPs) and antibody mimetics [26]. This 
study is focused on antibody mimetics, which are synthetic binders that can mimic the highly 
specific binding of antibodies, but with increased stability, whilst addressing the limitations of in 
vivo development, exhibiting high versatility and reduced costs and time of development,. Affimers 
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(previously described as Adhirons) are a recent example of antibody mimetics [27]. The 
development of Affimers against a specific target is achieved by in vitro selection instead of in 
vivo, which enables the production of Affimers against a wide range of conventional and 
unconventional targets, including small, organic compounds such as environmental contaminants. 
Moreover, the size of the Affimer protein scaffold is ~12-15 kDa, which is almost ten times smaller 
than that of a typical antibody (~150 kDa), and is significantly more stable, exhibiting very high 
thermostability (melting temperature is over 100 °C).  
 
The increased stability of the scaffold permits surface immobilisation free of conformational 
changes, and thus integration of the receptors with biosensors. The scaffold is also largely pH 
resistant, therefore (in contrast to conventional antibodies) allowing for Affimer development 
against a target in a wider range of conditions.  
 
Several recent studies have demonstrated the selection of Affimers against over 350 different 
proteins, as well as peptides, cells, organic molecules and even inorganic metallic nanoparticles, 
illustrating the versatility of this technology. However, the main aim of these studies, including 
Affimer characterisation and assay development, has been primarily focused towards applications 
in clinical diagnostics and therapeutics, where, in most cases, the target antigens are proteins. 
Proteins are large and complex molecules, with several epitopes, which permit the use of a variety 
of approaches for the development of Affimer-based bioassays, based on conventional 
immunoassay methods. However, assay development for small-sized organic compounds, such as 
environmental contaminants, can be more challenging. In addition, the complexity of 
environmental matrices, such as surface water, can significantly impede the sensitivity of the assay. 
These are critical issues for the future development of assays for monitoring emerging 
contaminants in the environment or even for quantifying the concentration of pharmaceuticals in a 
patient sample [27-31].  
 
Considering the improved characteristics of synthetic binders over conventional antibodies and the 
versatility of Affimer technology, it is worth exploring the potential of these protein-engineered 
antibody mimetics as alternative bioreceptors in bioassays for the detection of contaminants in the 
environment. This project aims to investigate the ability of Affimers to bind to small organic 
compounds in surface water samples, aspiring to provide the groundwork for novel, sensitive and 
reliable bioanalytical tools that would contribute to the increasing efforts to optimise pollution 
monitoring.  
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1.4 Project Description and Summary of Thesis 
 
Methylene blue (MB) and diclofenac (DCF) were selected as the target compounds for this study 
and Affimers against these two targets were developed by the BioScreening Technology Group 
(BSTG group, Biomedical and Health Research Centre, University of Leeds), and named MB-
Affimers and DCF-Affimers respectively, in this study. The main aims of this project were to a) 
demonstrate that the developed Affimers can bind to the selected targets with very high affinity, b) 
assess their performance in the complexity of environmental water samples (selectivity), and c) 
investigate the potential to develop an Affimer-based assay for small molecule detection.  
  
 
Figure 1.2: Chemical structure of a) methylene blue and b) diclofenac 
 
MB (Figure 1.2a) is a water-soluble dye belonging to the phenothiazine class of heterocyclic 
compounds and is the most commonly used substance for dying cotton, wood and silk [32]. In 
addition, it is widely used as a therapeutic agent, most notably for the treatment of 
methemoglobinemia and malaria, and is also a common stain used in biochemical research [33]. 
MB has a size comparable to that of many classes of environmental contaminants, and although not 
highly toxic, its widespread release in the aquatic environment renders it an important 
environmental contaminant [32]. However, the reason to select MB as a target contaminant in this 
study was its well-characterised redox properties [34]. Considering the small molecular mass of 
most environmental contaminants, such as MB, immunosensors for environmental monitoring are 
typically operated in a competition assay format, which requires the immobilisation of the target 
molecule on the sensing surface. Therefore, it is of key importance that the properties of the target 
compound are not altered by the immobilisation process. Here, the small-molecule target was 
immobilised using a self-assembled monolayer (SAM) of long-chained alkanethiols (LCAT) 
containing an MB-labelled oligoethylene glycol component (OEG) and by using MB, it is possible 
to monitor its redox behaviour when immobilised on the surface. For these reasons, MB was 
selected as the proof-of-principle target for the purposes of this study.  
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Electrochemical (cyclic voltammetry, electrochemical impedance spectroscopy) and spectroscopic 
(polarisation modulation-infrared reflection-absorption spectroscopy or PM-IRRAS) techniques 
were employed for the assessment of MB immobilisation protocols and the characterisation of the 
MB-terminated molecular layer on the gold surface of sensors. Next, quartz crystal microbalance 
with dissipation monitoring (QCM-D) was used to monitor the interactions between MB-Affimers 
and the surface-immobilised MB in order to estimate affinity. QCM-D was also used to evaluate 
the performance of MB-Affimers in surface water samples, here a limnetic
1
 sample. Finally, the 
potential for Affimer-based assays in a competition format was investigated by QCM-D. 
 
Given its well-reported adverse ecotoxicological impacts and the increasing need to monitor its 
presence in the environment, diclofenac (DCF) was selected as the second target compound for this 
study (Figure 1.2b). Using the knowledge and information acquired by studying MB-Affimers, the 
same approaches (QCM-D; target-derivatised LCAT-OEG SAMs) were applied to assess the 
performance of DCF-Affimers. Finally, considering its widespread use as a monitoring tool, 
enzyme-linked immunosorbent assays (ELISA) were used to further assess DCF-Affimer binding 
affinity and demonstrate a competition assay. The ELISA protocol was developed and adapted for 
DCF by the BioScreening Technology Group and was replicated at the University of York.  
 
This thesis is divided into two main segments, namely, the introduction (Chapters 1-3) and the 
experimental section (Chapters 4 and 5). Chapter 2 provides an overview of immunoassays, 
antibodies and the main principles of antibody binding, as well as a literature review of alternative 
affinity receptors, including Affimers, and a brief description of the Affimer selection process.  
 
Chapter 3 provides a background to the techniques used in this work for the assessment of Affimer 
affinity selectivity and assay development.  
 
Chapter 4 is focused on MB-Affimers and presents the experimental results of: 
a) Assessing and characterising the protocol used for immobilisation of MB on gold surfaces 
through MB-terminated LCAT-OEG SAMs using cyclic voltammetry (CV), electrochemical 
impedance spectroscopy (EIS), PM-IRRAS and QCM-D. 
b) Investigating the binding interaction between MB-Affimers and surface immobilised MB using 
QCM-D, estimating Affimer affinity through saturation binding and kinetics studies, demonstrating 
its selectivity for MB in limnetic samples and presenting an Affimer-based competition assay with 
QCM-D.  
                                                          
1
 Limnetic: ‘pertaining to or living in the open water of a freshwater pond or lake down to the depth of light 
penetration’ [35]. Here, limnetic refers to limnetic water samples.   
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Chapter 5 explores the binding interactions of DCF-Affimers with DCF, building on the experience 
obtained by studying MB-Affimers. Similarly to MB, DCF was immobilised on gold surfaces using 
DCF-terminated LCAT-OEG SAMs and the molecular film was characterised using EIS and PM-
IRRAS. Next, QCM-D sensors functionalised with LCAT-OEG-DCF SAMs were used to 
investigate the interactions with DCF-Affimers. The affinity of DCF-Affimers was estimated 
through saturation binding measurements using ELISA. Finally, preliminary work on the 
development of an Affimer-based competition ELISA is presented.  
 
Lastly, in Chapter 6, the findings of this study are summarised and discussed, as well as the 
potential future directions of this research and the focus of the corresponding further work.  
  
11 
 
Chapter 2 
 
Alternative Receptors for Immunoassays  
 
2.1 Overview 
 
Conventional immunoassays rely on the use of antibodies as biorecognition elements, which are 
typically developed through the immunogenic response of infected mammals. This approach not 
only involves significant effort, time and costs but also poses a number of challenges and 
limitations, particularly where antibodies are required against non-immunogenic targets. Advances 
in recombinant technologies and protein engineering have enabled the development of artificial 
binding agents that are selected in vitro. The relative simplicity of selection coupled with the 
robustness of these synthetic biorecognition elements have led to significant interest in their use in 
bioassays. This chapter presents an overview of immunoassays, antibodies and the underlying 
principles behind antigen-antibody interactions, as well as an introduction to synthetic affinity 
receptors, including Affimers, which are the main focus in this project. 
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2.2 Immunoassays 
 
Immunochemical analytical methods are bioassays that rely on the specific interaction between an 
antibody and its antigen. Immunoassays have found widespread use in several areas, such as 
clinical diagnostics, food safety and environmental monitoring. The immunoassay depends on two 
key processes: i) biorecognition of the antigen which is provided by the selectivity of the antigen-
antibody binding reaction, and ii)  the signal transfer process, where the biorecognition event is 
translated into a quantifiable signal through a change in the electrochemical, optical, mechanical or 
thermal properties of the system. In general, immunoassays can be divided into two broad 
categories, label-based or label-free, depending whether the detection is dependent on use of 
signalling labels [20].  
 
2.2.1 Labelled immunoassays; enzyme-linked immunosorbent assay 
(ELISA) 
 
In labelled immunoassay formats, a label is used to quantify the amount of bound target analyte. 
Widely used labels are enzymatic, fluorescent, chemiluminescent, redox probes or radioactive 
isotopes (radioimmunoassay). The most extensively used and established immunoassay in medical 
diagnostics, food and environmental analysis is the enzyme-linked immunosorbent assay (ELISA), 
where enzymatic labels, typically horseradish peroxidase (HRP), alkaline phosphatase, β-
galactoxidase or glucose oxidase are used to enable transduction of the biorecognition event. In the 
presence of its substrate, the enzyme label produces a measurable signal, such as colour change, 
fluorescence or chemiluminescence and the intensity of the optical signal is measured to quantify 
the amount of analyte. A source generates a light beam of known characteristics (wavelength, 
intensity) which passes through the sample and, following Beer’s law, the intensity of the absorbed 
light is proportional to the amount of the analyte solution [36]. For example, in colourimetric 
assays that use horseradish peroxidase, the enzyme reacts with the substrate 3,3',5,5'-
tetramethylbenzidine (TMB) in the presence of hydrogen peroxide which results in a blue colour, 
and the intensity of the colour is measured by a spectrophotometer at ~650 nm [37]. In a similar 
manner, immunoassays based on fluorescent or chemiluminescent labels quantify the amount of 
bound analyte by measuring the light emitted by the label [38]. Most colourimetric, 
chemiluminescent or fluorescent assays are highly sensitive and have found numerous applications 
as diagnostic tools.  
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Figure 2.1: Schematic of the most common ELISA formats: direct, indirect, competition and sandwich. The 
sandwich ELISA is shown in two configurations: direct (left) or indirect (right) detection (adapted from [39]).  
 
There are four principal ELISA formats: direct, indirect, sandwich and competitive (Figure 2.1). 
Sandwich ELISAs consist of two steps where a primary and secondary antibody are used. The 
primary antibody (Ab1) is immobilised on a surface and is used to capture the target analyte. Then, 
the enzyme-labelled, secondary antibody (labellledAb2) is introduced into the system and binds to a 
different region of the captured analyte, forming an immunocomplex (Ab1-analyte-labelledAb2). 
The intensity of the enzymatically-generated signal is then proportional to the amount of the target 
analyte. This format involves the development of at least two antibodies against different regions of 
the target, and is consequently more suitable for large antigens, such as proteins. Perhaps the most 
well-known example of a sandwich ELISAs is associated with the pregnancy test, where 
monoclonal antibodies are used to detect the presence of the established pregnancy biomarker, 
human chorionic gonadotropin (hCG). It is a rapid (1-3 min) test where hCG detection is 
determined by visual evaluation of the colour change at the test lines of a lateral flow strip or by 
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measuring the reflectance or transmittance of light. Here, hCG is captured by immobilised anti-
hCG antibodies and detected by secondary, anti-hCG antibodies labelled with enzymes (or directly 
with blue-coloured latex particles for detection via reflectance). Today, a vast array of technologies 
for over-the-counter home pregnancy tests have been developed with the latest advance being the 
digital, “one-step” home pregnancy test, launched by Clearblue [37].  
 
ELISAs can be further characterised as ‘direct’ or ‘indirect’ depending on the detection approach. 
In direct assays, the target antigen is adsorbed on a solid support, such as polystyrene well plates, 
and an enzyme-labelled antibody is used for the direct detection of the target. In indirect detection, 
the signal is transduced by a secondary, labelled antibody that binds to the primary antibody 
(Figure 2.1). 
 
In competition (or inhibition) ELISAs, a sample containing the antigen is first incubated with 
antibodies before the mixture is added to antigen-coated wells. Sample and immobilised antigens 
compete for a limited number of antibody binding sites, so after washing, the amount of the analyte 
in the sample is inversely proportional to the signal generated by the antibodies bound to 
immobilised antigens (through direct or indirect detection; Figure 2.1 shows direct detection). This 
format is commonly used for small sized antigens that usually have limited epitopes [40] [41].   
 
The main advantages of ELISA compared to instrumental analytical techniques are the low cost 
and shorter analysis time and its simplicity of use. 96-well plate formats are ordinarily used, and 
coupled with the rapid analysis provided by an absorbance microplate photometer (also known as 
plate reader), it is possible to screen more than 100 samples a day. The use of 384- and 1356- well 
plates can increase assay productivity ten-fold, if not higher, without significantly increasing the 
costs or man power. The throughput can be further increased with automation of several steps of 
the process. An additional advantage of ELISA is that very small volumes of reagents are required 
for each assay. Finally, depending on the assay development and optimisation, ELISAs can analyse 
samples from complex matrices with minimum (or no) purification requirements, such as gravity 
filtration, solid-phase extraction or ultrasonic extraction [40].  
 
Although ELISAs were developed for basic and applied biological and clinical research, 
immunoassays have been used increasingly for the detection of environmental contaminants, 
primarily pesticides or endocrine disruptors. ELISA test kits that package all the required reagents 
and sample preparation equipment are available commercially in various formats, enabling the 
acquisition of field measurements [42]. For example, ELISA tests for atrazine, a widely used and 
highly toxic pesticide, have been available for many years and demonstrate detection limits in the 
range 0.01-0.3 μg/L and show good correlation with GC-MS comparisons [43-45]. Most field 
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immunoassays use colourimetric analysis, because even though fluorescent and radioactive assays 
are more sensitive, the portability of associated measurement systems is difficult to achieve. 
 
ELISA assays have also been developed for detecting pharmaceuticals, such as diclofenac [9] [46]. 
Deng et al. [46] demonstrated an indirect competitive ELISA for detection of diclofenac in surface, 
drinking and waste water, using HRP-labelled antibodies and a plate reader to measure absorbance. 
The LOD was found to be 6 ng/L in pure water, while the analytical working range was about 20 to 
400 ng/L and showed a good correlation with data from LC-MS. To note, the European Quality 
Standards for diclofenac in surface waters have been defined as 100 ng/L [47]. In a further study, 
the same research group modified the ELISA for analysis of diclofenac in animal tissue extracts, 
again with a good correlation with ESI-LC-MS data [9]. In 2015, an ELISA using of monoclonal 
antibodies for the detection of diclofenac in freshwater and wastewater samples was demonstrated. 
The LOD was 7.8 ng/L, while the antibody used in the assay remained stable over a wide pH range 
(5.2 – 9.2 pH), increased levels of salinity or humic acids and showed minimum cross-reactivity for 
major diclofenac metabolites or structurally similar NSAIDs [48].  
 
Although diclofenac ELISA test kits are not yet available commercially, anti-diclofenac antibodies 
for use in ELISAs are sold by several companies [49].  In view of the urgent need for constant 
monitoring of diclofenac levels, ELISAs offer a reliable and sensitive yet cost effective alternative 
to conventional instrumental techniques, especially considering the limited availability of the latter 
in countries like India or Nepal, where the ecotoxicological impact of diclofenac has been 
significant [9].  
 
Immunoassays provide a rapid, low-cost, simple-to-use alternative to standard instrumental 
analysis such as LC- or GC-MS. While most ELISAs do not offer as low detection limits as these 
analytical techniques, they remain a useful tool for routine screening of contaminants in the field 
[20]. However, conventional ELISAs present a number of technological and analytical challenges. 
ELISAs consist of several stages, including multiple incubation and washing steps, which can 
increase time, costs and the complexity of the assay. Moreover, it can often be difficult to develop a 
pair of antibodies (primary and secondary) that bind to different epitopes of the antigen, and the 
development of monoclonal antibodies, which are usually required for sandwich assays, need 
greater development time and so incur increased costs over polyclonal antibodies. Finally, ELISAs 
do not permit real-time monitoring of the antigen-antibody interactions, thus little information is 
provided regarding the kinetics of the process, if that is desirable in an assay. These limitations 
have led to the development of label-free immunoassays, where the biochemical interaction 
between the antibody and antigen is measured directly (i.e. label-free) by an underlying transducer 
that generates a signal proportional to the amount of antigen [20, 50].  
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2.2.2 Label-free immunoassays 
 
There are two basic types of label-free immunoassays, direct and indirect. In direct assays, the 
signal is directly proportional to the amount of target analyte captured by antibodies immobilised 
on a sensor surface. Indirect assays function similarly to competitive assays, and are essentially a 
binding inhibition test. Here, the target compound is immobilised on the transducer surface, while a 
mixture of the sample, containing the target analyte, and antibodies are preincubated in solution 
and introduced onto the sensor. The presence of the target analyte inhibits the binding of antibodies 
to the immobilised target. The signal due to bound antibodies is thus inversely proportional to the 
amount of the sample analyte [20].  
 
In general, there are three main elements that constitute a label-free immunoassay or 
immunosensor: a bioreceptor, a transducer and a signal processing and amplification system 
(Figure 1.1) [50]. The transducer is a device capable of translating a physical, chemical or 
biological signal into an electric response, which enables the generation of a readable, electronic 
signal. Ideally, this conversion is performed with minimum disruption to the biological complex in 
the measured system [51]. Essentially, the sensitivity and LOD of the biosensor is highly dependent 
on the transducer and the affinity of the bioreceptor, whereas the selectivity and specificity is 
mainly determined by the bioreceptor [52]. Several transduction mechanisms have been 
investigated, notably transducers that are sensitive to changes in electrochemical, optical or 
mechanical properties, that can easily be developed into portable devices for field measurements.  
 
Electrochemical transduction is perhaps the most widely used method in immunosensors. Here, the 
biochemical reaction occurs at the surface of an electrode that measures the local changes in the 
electrochemical properties of the analytical system. The resulting electrical signal is associated 
with the number of biorecognition events and is thus directly related to the amount of the target 
analyte. The main advantages identified with electrochemical biosensors are their speed, high 
sensitivity and low LODs, low cost, ease of use, the simplicity of the system and their potential for 
miniaturisation which can allow in situ analysis [20] [38] [50].  
 
There are several types of electrochemical transduction, depending on the nature of the 
electrochemical changes to be detected during a biorecognition event. Electrical impedance 
spectroscopy (EIS) has been increasingly gaining ground as an approach for biosensing. In EIS, 
changes in the capacitance or conductance of the system following formation of the antigen-
antibody complex are detected through the impedimetric response. EIS is a powerful tool 
demonstrating high sensitivity and can provide real-time, label-free monitoring of molecular 
interactions [50]. For instance, a label-free impedimetric immunosensor for the detection of 
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bisphenol A in human serum has been reported with a detection limit of 0.3 ng/mL [20]. A second 
type of electrochemical sensor relies on amperometric methods, where the measured property is the 
change in current when an electroactive species is either reduced or oxidised as a result of the 
antigen-antibody interaction [20]. As an example, Deng and Yang [53] reported the detection of the 
herbicide 2, 4-dichlorophenoxyacetic acid through an amperometric ELISA, which reached a 
detection limit of 0.072 ng/mL, with high stability
2
 and sample throughput.  
 
Label-free sensors based on optical transduction of a molecular binding event have also been 
established in many areas including medicine, security, food safety and environmental health. 
Optical immunosensors measure changes in the optical properties (including absorption, 
luminescence and refractive index) of the sample or the transducer’s surface when biochemical 
reactions occur. As with electrochemical sensors, optical approaches are able to provide rapid and 
real-time detection, require small amounts of reagents and, in some cases, miniaturisation is 
possible to achieve. Several types of optical transducers have been demonstrated, such as Mach-
Zehnder interferometry (MZI) and reflectometric interference spectroscopy (RIfS), with surface 
plasmon resonance (SPR) being the most established [20].  
 
Surface plasmon resonance (SPR) is a highly sensitive, versatile and powerful technique capable of 
real-time, label-free detection of biomolecular interactions. Briefly, in SPR, the bioreceptors are 
immobilised on a thin gold film deposited on a glass prism. A polarised beam of light hits the metal 
film and upon reaching a certain angle, the incident light resonates with the surface plasmons of the 
metal, resulting in absorbance, which appears as a dark line in the spectrum of the reflected beam 
(Figure 2.2). The adsorption or desorption of mass due to biomolecular interactions changes the 
refractive index local to the sensor surface, resulting in a shift of the incident angle where surface 
plasmon resonance occurs. Thus, the observed shifts are directly related to the amount of the 
analyte [54]. SPR has been used extensively in health science research and has demonstrated a 
great miniaturisation, portability and automation potential. These attributes render it an excellent 
tool in immunosensing and has found numerous applications in drug discovery, clinical trials and 
environmental monitoring [55]. For example, Mauriz et al. demonstrated a portable SPR 
immunosensor for the detection of the pesticide chlorpyrifos in aquatic samples through a 
competitive assay [56].  
 
                                                          
2
 In this report, stability was referred to the number of precise and accurate measurements without cleaning 
and recalibration of electrodes [53].  
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Figure 2.2: Schematic of surface plasmon resonance. The polarised light beam hits the metal film, and at a certain 
angle the surface plasmons resonate and absorb light which appears as a dark line in the reflected spectrum. 
Changes to the refractive index of the sensor surface due to biomolecular interactions causes an angular shift. The 
angular shift is monitored over time to study binding kinetics (adapted from [57] [58]). 
 
Although optical and electrochemical approaches have found widespread applications in 
biosensors, the potential of acoustic wave sensors has also been increasingly investigated for 
immunosensing. The principle is based on the use of piezoelectric materials, such as quartz 
crystals. The application of an external, alternating electric field to the crystal incurs deformation, 
resulting in a mechanical wave that propagates through or along the surface of the sensor 
(depending on the shape and size of the crystal or the electric field). The wave is subsequently 
transduced back to an output electrical signal. The acoustic wave is sensitive to changes in the 
properties of the crystal (such as thickness, mass, viscosity) due to physical, chemical or biological 
phenomena occurring at its surface. Therefore, the differences between the input and output 
electrical signal provide a measure of the interactions on the sensor surface [59]. 
 
A widely used acoustic wave sensing technique is the quartz crystal microbalance (QCM). A quartz 
crystal is sandwiched between two electrodes, and a surface coating (such as gold) is used to 
immobilise the molecular components, such as antibodies or antigens. The application of an 
external alternating electric field forces the crystal to oscillate at its resonant frequency (in a shear 
vibrational mode). The adsorption of molecules on the surface increases the mass loading on the 
sensor, resulting in a decrease in the measured resonant frequency. The resonant frequency is 
measured over time, and thus, QCM provides real-time monitoring of molecular interactions 
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without the need for hazardous (e.g radioactive) or expensive labels. More recently, dissipation 
monitoring has been incorporated in QCM (called QCM-D), where the dissipation of the energy of 
the oscillation is monitored simultaneously with the frequency. This approach enables the 
viscoelastic properties of molecular films to be studied, and thus the detection of conformational 
changes occurring during biomolecular interactions [60] [61]. Label-free immunosensors based on 
QCM have been employed for a number of environmental applications. For example, QCM in both 
a competitive and a direct assay format has been used to detect atrazine with very low LODs (25 
pg/mL and 1.5 ng/mL, respectively) [62]. As with SPR, QCM enables label-free detection and real-
time monitoring, allowing the study of the kinetics of biomolecular interactions. 
 
Acoustic sensors offer high versatility, since a wide choice of materials can be used for surface 
coating of the piezoelectric crystals, whilst a wide range of targets can be analysed, such as 
proteins, nucleic acids, whole cells, nanoparticles or small molecules, making them excellent tools 
for biosensing [63]. QCM (or QCM-D) is a bulk acoustic wave (BAW) sensor, since the acoustic 
wave propagates through the bulk of the crystal. However, besides BAW sensors, another type of 
acoustic wave sensors is surface acoustic wave (SAW) sensors, where the acoustic wave travels 
across the surface of the piezoelectric material. SAW sensors, notably Love wave type sensors, 
have been used in numerous bioanalytical and diagnostic applications. SAW biosensors can be 
integrated with microfluidics systems and miniaturised to produce lab-on-chip devices. For 
instance, SAW biochips for diagnostic applications have been reported, demonstrating label-free, 
sensitive detection of protein and DNA biomarkers [64] [65]. 
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carboxyl group, while the N-terminal amino acid, conventionally considered to be the beginning of 
the polypeptide chain, is not linked to any further amino acids through its α-amino group.  
 
Hydrogen bonds between amine and carboxyl groups of adjacent amino acids in the backbone 
cause the polypeptide to fold into its secondary structure, which consists mainly of β-sheets and α-
helices (Figures 2.3b and 2.3c), while the remaining sections of the chain adopt simpler structures, 
such as β-turns or ω-loops. The tertiary structure is the three-dimensional conformation of the 
entire polypeptide chain, as the secondary structural elements fold together governed by covalent 
(disulfide bonds) and non-covalent (hydrophobic, Van der Waals and ionic) interactions (Figure 
2.3d). For multimeric proteins, two or more polypeptides (subunits) are combined through the same 
forces so that the protein attains its quaternary structure (Figure 2.3e) [66]. 
 
Antibodies belong in a class of proteins called immunoglobulins, which are soluble glycoproteins 
produced in the B-lymphocytes (B-cells), a type of white blood cells of vertebrates and are one of 
the many elements of an organism’s immune system. Immunoglobulins are present in the serum 
and tissue fluids as soluble proteins or as membrane-bound receptors on the surface of B-cells, and 
are responsible for recognising and specifically binding to a certain epitope (the antigenic 
determinant) of an antigen in order to either mark the antigen and activate other mechanisms of the 
immune system or neutralise the antigen by blocking a functional moiety. In humans, antibodies 
are divided into five different classes of immunoglobulins, IgG, IgA, IgM, IgD and IgE, which 
differ in size, amino acid sequence and carbohydrate content. IgG, weighing around 150-170 kDa, 
is the predominant immunoglobulin protein (~80%) in human serum and is the type of antibody 
principally used in immunoassays [67]. 
 
An IgG molecule consists of four polypeptide chains, two light chains (L), ~25 kDa each, and two 
heavy chains, (H), ~55 kDa each. Each heavy chain forms a dimer with a light chain (H-L) through 
disulfide bonds and multiple non-covalent interactions, and the two H-L dimers are similarly bound 
to form the complete immunoglobulin molecule (Figure 2.4). Both the heavy and light chains 
consist of variable and constant regions. The variable regions are located at the N-terminus domain 
of each chain and the amino acid sequence of these regions vary greatly among different 
antibodies, while the remaining region is constant and characteristic of each antibody. VH and VL 
refer to the variable domains of the heavy and light chains respectively, while CH and CL are used 
for the constant domains of the immunoglobulin, which have very limited variations between 
different IgG antibodies. Enzymatic proteolytic cleavage of IgG produces three fragments: two 
identical Fab fragments that demonstrate antigen binding activity and one Fc fragment that is not 
involved with antigen binding and consists of heavy chain components (Figure 2.4). The 
oligosaccharides of the antibody are attached to the Fc fragment, and although they play no role in 
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antigen binding, they affect interaction with Fc-receptors that are present on the B-cell surface and 
recognition of the antibody by the immune system [68]. 
 
 
 
Figure 2.4: a) Schematic of the main elements of an IgG antibody, consisting of two heavy (H) and two light (L) 
chains; enzymatic cleavage separates the molecule into Fab and Fc regions. In the Fab fragments, the antigen 
binding site is formed by the combination of the variable domains, VL and VH, of the light and heavy chain 
respectively.  The Fc fragment consists of only constant regions of the heavy chains and contains carbohydrates 
(CHO) that interact with Fc-receptors of B-cells (adapted from [69]), b) 3-D representation of IgG protein 
structure (PDB ID: 1IGT; visualised using Chimera). 
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Both heavy and light chains in a Fab fragment consist of a variable domain (~110 amino acids in 
the N-terminal region) and a constant domain (~110 residues in the C-terminal region), called VH, 
VL, CH1 and CL respectively. Constant and variable domains in both heavy and light chain consist 
of a similar double β-sheet structure, called the immunoglobulin fold, (Figure 2.5) which comprises 
antiparallel β-strands connected by peptide loops of varying length. The two β-sheets are folded 
and held together mainly by hydrophobic interactions and a disulfide bond [67] [68] [70].  
 
The antigen-binding site is formed by six peptide loops, three from the VL domain and three from 
the VH domain, which are called hypervariable regions or complementarity determining regions 
(CDRs) while the double β-sheet regions, called the framework regions (FRs) exhibit much less 
variation and serve as a scaffold where the antigen-binding site is presented. An IgG molecule has 
two identical binding regions, one from each pair of H-L chains, which enables bivalent binding 
[23]. Other immunoglobulin molecules, such as IgM, that have several binding sites, exhibit 
multivalent binding [68].  
 
 
Figure 2.5: Front and side view of the 3D structure of the immunoglobulin fold. Antiparallel β-sheets are held 
together by hydrophobic interactions and a disulfide bond, while three hypervariable loops are presented at one 
end of the structure (adapted from [66]; PDB ID: 7FAB, visualised using Chimera). 
  
Since most antigens consist of multiple epitopes, B-cells produce a variety of antibodies against an 
antigen, each binding to a different epitope. The antiserum, i.e. the serum of an immunised 
organism, thus contains a heterogeneous mixture of antibodies, called polyclonal antibodies. This 
heterogeneity increases the effectiveness of the immune response in vivo. However, it can be 
24 
 
disadvantageous for in vitro applications that require consistency in the antibodies developed for 
the recognition or caption of antigens through specific epitopes. This batch-to-batch variability can 
be overcome using monoclonal antibodies. Monoclonal antibodies are derived from a single B-cell 
clone hybridised with a myeloma cell, to form hybridoma. All antibodies produced by the same 
hybridoma are specific to the same epitope of the antigen. In addition, the clones of the hybridoma 
cells can be cultured indefinitely and produce monoclonal antibodies with consistent specificity for 
research, diagnostic and therapeutic purposes [68].  
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2.4 Antibody-Antigen Interactions 
 
The antigen-antibody complex is formed through the bimolecular association between the antigen’s 
epitope and the binding site (CDR regions) of the antibody. The antigen-antibody binding depends 
on a range of non-covalent interactions which include:  
 
 Hydrogen bonds between electronegative atoms of the amino acid residues. 
 Ionic bonds (salt bridges) between oppositely charged groups. 
 Hydrophobic interactions between non-polar residues. 
 van der Waals interactions [68]. 
 
Hydrophobic interactions force the non-polar groups of the amino acids to aggregate so as to avoid 
contact with water molecules and they play a key role in the stability of the antigen-antibody 
complex. The hydrogen bonds and the salt bridges contribute largely to the specificity of the 
interaction. Compared to a covalent bond, each type of the above interactions is individually weak, 
so a large number is necessary for high affinity binding. These interactions only occur over very 
short distances, so the formation of the antigen-antibody complex depends on their proximity [71].  
 
The association between a single epitope of an antigen and the binding site of an antibody is based 
on the complementarity of the interacting sites, a characteristic that defines the specificity of the 
antigen-antibody interactions. A measure of the strength of this non-covalent interaction is the 
binding affinity, and high affinity antibodies bind strongly to the antigen’s epitope to form a stable 
complex. Equation 2.1 describes the association between one of the binding sites of the antibody 
(Ab) and the epitope of a monovalent antigen (Ag) in order to form the antigen-antibody complex 
(Ag-Ab): 
 
           
 
   
Here, kon refers to the second order association rate constant and is expressed in units of M
-1
s
-1
, 
while koff is the first order dissociation rate constant expressed in s
-1
 [71].  
 
The affinity constant, KA, (with unit M
-1
) is the ratio of the rate constants,  
 
𝐾A =
𝑘on
𝑘off
=
[𝐴𝑔−𝐴𝑏]
[𝐴𝑔][𝐴𝑏]
 (2.2) 
Ag + Ab  Ag-Ab 
kon 
koff 
(2.1) 
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and is a measure of the antibody’s affinity for the specific antigen at equilibrium, where [Ag-Ab] is 
the concentration of the bound Ag-Ab complex and [Ag], [Ab] are the concentrations of free 
antigen and antibody, respectively. While KA is used to quantify the affinity of the antibody, the 
dissociation constant, KD, is used to express the stability of the Ag-Ab complex (in M). It is based 
on the reverse reaction of Equation 2.1 and is the reciprocal of KA so that, 
 
𝐾D =
1
𝐾𝐴
=
𝑘off
𝑘on
=
[𝐴𝑔][𝐴𝑏]
[𝐴𝑔−𝐴𝑏]
 
 
Stable complexes thus have low values of KD. For immunoassays, high affinity is required for a 
low limit of detection, but the stability of antigen-antibody complex is also crucial to the 
performance of the assay, since dissociation during washing steps is undesirable. Using biosensor 
technology, such as SPR or QCM, it is possible to study the antigen-antibody binding kinetics in 
real time. Here, an antibody is immobilised on the sensor surface and as the analyte is introduced 
into the system, the interaction between the antibody and antigen is monitored in real time. The 
more analyte that is bound to the surface immobilised antibody, the greater the response signal until 
it reaches a plateau, which corresponds to saturation. The resulting association part of the response 
curve (Figure 2.6) can be used to calculate the association rate, kon. In a typical experiment, the 
analyte solution is then replaced by running buffer, which shifts the equilibrium conditions ([Ag] is 
now reduced), leading to dissociation of antigen from the surface-immobilised antibodies. The 
dissociation phase is again monitored in real time in order to estimate the dissociation rate, koff.  
 
Figure 2.6 illustrates three hypothetical assays for three different antibodies against the same 
antigen. An antibody with high association and high dissociation rates forms the antigen-antibody 
complex rapidly but also dissociates quickly in a washing step (Ab3), while little dissociation is 
observed for an antibody with a low dissociation rate (Ab1). Thus, the lower the koff is, the more 
suitable the antibody will be for most immunoassay formats. For this reason, the affinity of 
bioreceptors is typically expressed using the dissociation constant, KD, and high affinity antibodies 
are expected to have KD values between 10
-12
 and 10
-8
 M [37].  
 
The experimental determination of affinity is based on a number of assumptions. 1) The antibodies 
are assumed to be homogeneous (e.g. monoclonal antibody) and only one species of the 
analyte/antigen is present in the solution. 2) The reaction is assumed to proceed to equilibrium and 
the separation of bound and unbound antigen is complete. 3) There is no non-specific binding or 
allosteric effects [37]. In practice, it is not possible to meet all of these conditions, but the above 
(2.3) 
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above equations provide a theoretical framework for studying the antigen-antibody interactions and 
understanding the underlying processes. 
 
 
Figure 2.6: Example of responses curves (using real-time monitoring techniques such as SPR or QCM) of antigen 
binding with three different antibodies. Ab1 and Ab3 both have a high rate of association (kon) but the dissociation 
rate (koff) for Ab3 is faster than that of Ab1. Ab2 represents the response curve for a typical antibody (adapted 
from [37]) 
 
Since most antigens have more than one epitope, and antibodies can have multiple binding sites, 
there can be several interactions that affect the strength of the overall antigen-antibody binding. 
The overall strength of the interactions between a multivalent antibody and the epitopes of a 
multivalent antigen is called avidity. Therefore, even if an interaction at a single site has low 
affinity, higher valence can result in high avidity and thus stronger antigen-antibody binding [68]. 
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2.5 Parameters Affecting Antigen-Antibody Interactions 
 
Several types of molecular interactions are responsible for the antigen-antibody interactions, and 
these interactions are dependent on the local conditions and may thus influence protein stability and 
antigen binding. 
 
The main parameters that can affect the stability of the proteins or the antigen-antibody complex 
are the temperature, pH and ionic strength of the solution. One of the main non-covalent 
interactions that drive protein folding and protein interactions is hydrogen bonding. The thermal 
energy provided by increasing temperature can break these hydrogen bonds leading to antigen 
dissociation and protein unfolding (denaturation). In contrast, decreasing the temperature can affect 
hydrophobic interactions in aqueous solutions, as a result of change in the interactions between 
water molecules around non-polar residues, which consequently weakens the hydrophobic effect 
that drives the folding of the protein (cold denaturation) [72].  
 
The pH of the solution can also affect protein structure and function, by changing the charge of 
residues that participate in hydrogen bonding or salt bridges. At neutral pH, acidic side chains are 
negatively charged, but will become neutral in a pH lower than their pKa. In contrast, basic residues 
are positively charged at neutral pH, becoming neutral at a pH greater than their pKa [67]. 
Additionally, changes in the ionic strength of the solution, that is the concentrations of anions and 
cations, may also affect electrostatic interactions between charged residues.  
 
The change in the overall charge of a protein or the screening of charge interactions that occurs at 
high ionic strength not only affects the structure and function of a protein, but also the way it 
interacts with the surrounding environment. For example, when the pH of the solution reaches the 
isoelectric point, the protein becomes neutral and thus less soluble in water and may form 
aggregates. Furthermore, changes in the net charge can influence interaction of a protein with 
surfaces, depending on the properties of the solid material, either by increasing its affinity for the 
material to the point of denaturation or changing its orientation so that the binding site becomes 
inaccessible [37].   
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2.6 Challenges and Limitations of Antibodies for Environmental 
Applications 
 
The dependence of antigen-antibody binding on local environmental conditions has the potential to 
compromise the specificity or reliability of an immunoassay. Antibodies are a product of the 
immune response system and have evolved to function within the well-defined conditions 
maintained in an organism [23]. The use of antibodies in environments where the pH, temperature 
or ionic strength differ from physiological conditions can affect their binding abilities and stability. 
This presents a significant challenge for the application of immunosensors for use with 
environmental samples, where samples with a wide range of matrix properties (including pH and 
ionic strength) have to be analysed.  Moreover, antibodies are large proteins with multiple domains, 
thus surface immobilisation, as is required for application in immunosensors, can often be 
challenging as it may lead to conformational changes that affect the antigen-antibody interaction, 
induce variations in antibody orientation or lead to steric hindrance between proteins [30].  
 
Furthermore, monoclonal antibodies are preferred over polyclonal as they not only reduce batch-to-
batch variability but are also homogeneous, ensuring the antibodies bind to only one epitope in an 
assay. However, the time, efforts and costs of hybridoma development are significantly higher than 
for polyclonal antibodies [68]. In addition, in vivo development of antibodies can be challenging or 
impossible when the targets are small-sized molecules, non-immunogenic or potentially toxic, 
which can be the case for environmental contaminants [73]. As a result, antibody-based assays for 
small molecule environmental contaminants often fail to meet the demands of regulatory and 
routine environmental monitoring for cheaper, faster, reliable and robust methods.  
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2.7 Alternative Affinity Receptors  
 
Recent advances in protein engineering and materials chemistry, have led to the emergence of 
synthetic affinity receptors as replacements for antibodies in immunoassays. For example, 
recombinant technologies enable the production of large libraries of potential bioreceptor 
molecules containing randomly generated sequences from which bioreceptors with the highest 
affinity for the target compound are selected. These biological approaches, as well as bio-inspired 
chemical synthesis approaches, have led to a variety of receptors with improved characteristics 
compared to antibodies, such as increased specificity and selectivity, higher stability and reduced 
costs and time of development [40].   
 
Antibody fragments 
 
Antibody fragments, which only contain those regions of an antibody associated with antigen 
binding, have been introduced as alternative bioreceptors that are easier and less expensive to 
manufacture. The most common types include Fab fragments and single chain variable fragments 
(scFv), which are both significantly smaller than antibodies. This enables optimisation of surface 
coverage in biosensors and reduction of steric hindrance. Their reduced size also allows tissue 
penetration, which is an important property for therapeutic applications. However, antibody 
fragments tend to degrade more quickly than antibodies, and although methods to extend their half-
life have been developed, these can significantly increase the production costs [74]. In addition, 
their tendency to aggregate makes purification challenging, while immobilisation on solid surfaces 
can often cause conformational changes and, as a result, reduction in affinity or specificity [30].   
 
Molecularly imprinted polymers 
 
A non-biological approach to generate affinity receptors is template-directed chemical synthesis for 
the production of molecularly imprinted polymers (MIPs). Inspired by the lock-key mechanism of 
enzyme activity, MIPs are polymers containing cavities that are complementary to a target 
compound. The molecular imprinting process involves the co-polymerisation of functional 
monomers and a cross-linker in the presence of a template molecule that resembles the target 
(Figure 2.7). The monomers form a complex with the template and their functional groups are held 
in position by the cross-linked polymer. Although a wide range of materials can be employed, the 
most common functional monomers used in molecular imprinting are vinyl and acrylic monomers, 
such as methacrylic acid or vinylpyridine. Following polymerisation, the template molecule is 
removed leaving complementary cavities behind that serve as binding sites for molecular 
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recognition [38] [75]. This approach enables the development of artificial, non-biological receptors 
that can mimic the molecular recognition properties of biological receptors, such as antibodies and 
enzymes. In comparison to bioreceptors, MIP production can be much faster and more cost-
effective. Due to their synthetic nature, MIPs are also very stable and robust, with high thermal and 
pH resistance and very long shelf-life [26]. MIPs can function as excellent receptors for small 
molecules, which has led to their increasing use in sample purification techniques, such as solid-
phase extraction (SPE). A vast array of MIPs targeting toxins, pesticides, antibiotics and 
pharmaceuticals have been developed over the years and have become available commercially as 
highly selective SPE phases [26] [76].  
 
 
Figure 2.7 Schematic of the molecular imprinting process (adapted from [26]).  
 
Other uses of MIPs have been focused on molecularly imprinted bioassays (analogous to 
immunoassays) and, to a lesser extent, in vivo applications. Notable examples include the 
development of MIP-based immunoassays for the detection of the pharmaceuticals theophylline 
and diazepam [77] and the antibiotic vancomycin [78]. Furthermore, melittin, a small, toxic peptide 
was successfully removed from mice using MIPs [79]. However, despite their advantages, MIPs 
exhibit much lower affinities than antibodies, slow binding kinetics, poor reproducibility and quite 
often poor site accessibility. [38] [79]. In addition, MIPs for protein capture and recognition are 
severely limited; typically organic solvents are used for the molecular imprinting process and MIPs 
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are thus more effective in non-aqueous environments. Moreover, the synthetic nature of MIPs 
poses increased risks of immunogenicity or toxicity in live organisms, which greatly restricts their 
use in therapeutics and in vivo diagnostics [26]. Although efforts to overcome such challenges are 
increasing, including development of water-compatible MIPs or the use of molecularly imprinted 
polymer nanoparticles (MIP NPs) [75] [79], these limitations need to be comprehensively 
addressed in order to fully exploit the potential of MIPs as alternative receptors. 
 
Aptamers 
  
A class of non-protein biorecognition elements that has received significant interest is nucleic acid 
affinity probes, called aptamers. Aptamers, which is a portmanteau word derived from the Latin 
aptus (to ‘fit’) and the Greek meros (‘part’) [81] , are artificial, in vitro selected, single stranded 
DNA or RNA sequences that bind to a target compound with very high affinity and specificity. The 
concept of this technology relies on that of natural selection; here, from a large pool of binders, a 
binder’s ‘fitness’ over that of others is determined by its ability to bind strongly to a target 
molecule [82]. Aptamers that bind to a specific target are developed using systematic evolution of 
ligands by exponential enrichment (SELEX), a method firstly presented in 1990 that enabled the 
selection of high affinity, non-antibody binders in vitro (Figure 2.8). 
 
 
Figure 2.8: Brief schematic of the SELEX process for aptamer development. The library of oligonucleotides is 
incubated with the target, washed to remove unbound sequences and eluted to select the target-binding sequences. 
The eluted oligonucleotides are amplified and can be either subjected to subsequent screening rounds or isolated 
for sequencing (adapted from [80]).  
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SELEX starts with a large library of oligonucleotides (10
14
 – 1015 distinct sequences). The first 
selection round begins by mixing this library with the target antigen. Following incubation, low-
affinity molecules are washed away, after which strong binders are eluted and amplified by 
polymerase chain reaction (PCR). The reduced oligonucleotide pool is then used in the following 
round of selection. This selection process is repeated several times, resulting in high affinity probes 
that are then isolated, sequenced and characterised. Aptamers are smaller and more stable than 
antibodies, have longer shelf-life and can demonstrate high binding affinity. An interesting trait of 
aptamers is that they often undergo a conformational change upon binding to the target. This is a 
very useful feature for biosensing, where, by adding fluorescent or redox labels on specific regions 
of the aptamer, target binding can be detected by the shifts in the electrochemical or optical signal 
due to such conformational changes.  
 
These advantages, along with the versatile, cost- and time-efficient in vitro development, has 
encouraged researchers to intensify their efforts in producing aptamers, and numerous sequences 
have found use in basic and applied research, diagnostics or even therapeutics [26] [50]. However, 
while aptamers are more stable than antibodies, they can be easily degraded in complex matrices, 
such as blood serum or cell environments. More importantly for application in environmental 
monitoring, they can become unstable over a range of pHs or temperatures, and are sensitive to 
cation concentration and nuclease digestion. DNA aptamers are more stable than RNA, but are still 
not fully resistant to degradation. In addition, the charged backbone of the oligonucleotides is self-
repelling which can lead to conformational instability or unfolding during surface immobilisation. 
Efforts to overcome such challenges have been focused on chemical modifications to increase their 
stability and functionality. Still, aptamers are limited to the types of chemical bonds they can form 
for target capture due to their short range of building blocks, which consequently narrows their 
range of targets [83-85].   
 
Antibody mimetics 
 
A promising alternative to aptamers are protein-based synthetic binders called protein scaffolds or 
non-IgG scaffolds (or peptide aptamers, due to their similarities in function and development with 
DNA or RNA aptamers). Protein scaffolds mimic the high binding affinity and specificity of 
antibodies, and for this reason they are also termed antibody mimetics [73] [86]. Although not 
based on immunoglobulins, they mimic many of the features associated with antibodies: a constant 
protein backbone and variable antigen-binding domains, similar to the complementarity 
determining regions (CDRs) of antibodies. However, antibody mimetics are considerably smaller 
than antibodies (between 6-20 kDa compared to 150 kDa), and highly stable and robust against 
local environmental conditions. The selection of protein scaffolds proceeds through a process 
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similar to SELEX in the sense that they both follow a repetitive cycle of selection and amplification 
until the strongest binders are identified.  The majority of selection methods employ phage display 
technologies, although several other approaches have been used, such as cell, yeast or ribosomal 
display [87]. 
 
A number of different protein scaffolds derived from a range of organisms (including viruses, 
bacteria, fungi, plants, animals and humans) have been selected for antibody mimetics 
development, and modified by inserting variable peptide sequences at specific sites using 
recombinant technologies. In addition, similar to aptamers, their small size allows tissue 
penetration, an important trait for therapeutic applications. Furthermore, due to their synthetic 
nature, they can readily be modified chemically, depending on the desired properties. For example, 
cysteine residues can be engineered at specific sites either for orientation-specific surface 
immobilisation or for conjugation of functional molecules, such as biotin, radionuclides, 
fluorescent labels or polyethylene glycol. This allows the properties of the binders to be engineered 
for the intended application, such as tailoring their pharmacokinetic characteristics, e.g. extended 
half-life for therapeutics or rapid clearance for diagnostics such as medical imaging [88] [89].  
 
The flexibility of antibody mimetics is not limited to their enhanced physicochemical properties. 
The in vitro nature of their selection entirely bypasses the use of animal immunisation, which 
permits the selection of binders against a vast range of targets, including those which would 
normally be challenging or impossible for conventional antibodies, due to their small size, toxicity 
or low immunogenicity. The variable domains which form the binding sites of antibody mimetics, 
are typically peptide loops anchored at both ends within the protein scaffold. This enables the 
peptide loop to adopt different conformations and recognise targets of different shape, charge or 
hydrophobicity while being embedded in a rigid and biologically inert protein scaffold [73]. The 
peptide sequences of the variable loops are randomised in order to construct large pools (libraries) 
of different variants of the binding protein. A gene encoding each antibody mimetic is inserted into 
the DNA of a microorganism or an expression vector, so that when the gene is expressed the 
binding protein is displayed on the outer surface or compartment of the carrier. This approach 
enables the creation of large and diverse libraries of carriers, each displaying a different variant of 
the protein scaffold.  
 
The display library is screened for the selection of high affinity target-binding proteins, using a 
process similar to SELEX screening, called biopanning (Section 2.8; Figure 2.13) [87] [90]. This 
process has been shown to enable the selection of antibody mimetics against a wide range of 
conventional or unconventional targets, and that exhibit very high affinities, comparable to that of 
antibodies. Furthermore, while the development of antibodies against new targets is time-
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Monobodies (Adnectins) 
 
Monobodies are an antibody mimetic that has been used extensively in clinical studies. The 
scaffold is based on the tenth domain of human fibronectin, a small (~10 kDa) protein consisting of 
a stable backbone of seven β-sheets and three accessible loops with randomised sequences that 
serve as binding sites (Figure 2.9e). Several approaches have been reported for library screening, 
including phage display, mRNA display and yeast-two hybrid. Monobodies demonstrate high 
thermal and chemical stability as well as remarkable KD values reaching picomolar levels. A wide 
variety of proteins have been targeted by monobodies, including SARS viral proteins, rabbit and 
goat IgG, yeast small-ubiquitin-like modifier (SUMO), green fluorescent protein (GFP) and various 
cytokines, growth factors, enzymes and signalling proteins. Monobodies are available 
commercially as Adnectins
TM
 from Adnexus Therapeutics (currently owned by Bristol-Myers 
Squibb) [26] [89] .  
 
Anticalins 
 
Anticalins are based on lipocalins, which are extracellular proteins found in both prokaryotes and 
eukaryotes and are responsible for storage or transport of hydrophobic molecules such as vitamins, 
lipids or various secondary metabolites. Anticalins consist of eight anti-parallel β-strands that form 
a barrel like structure (a β-barrel), four connecting variable loops and an α-helix at the C-terminus. 
The variable loops and the adjacent residues of the β-barrel form a ligand pocket that binds tightly 
to small molecules or peptides (Figure 2.9b). Anticalins are small (160-180 residues) proteins, that 
lack disulfide bonds and exhibit high thermal stability, while demonstrating very high binding 
affinities of nano and picomolar levels [26] [89] [92]. The Anticalin technology has been 
commercialised by Pieris Pharmaceuticals and is focused on therapeutic applications, focusing to 
date on anemia, respiratory and cardiovascular diseases, and immuno-oncology applications, some 
of which have advanced to human Phase I clinical trials. An Anticalin for anemia treatment has 
already moved to Phase II trials [93].   
  
Kunitz domains 
 
Kunitz domains are based on serine protease inhibitors, usually of human origin. They are small 
(~60 residue), stable proteins, consisting of disulfide-cross-linked α-helices and β-sheets and one or 
two  (Figure 2.9a) variable loops that can be randomised to yield high affinity binders via phage 
display library screening. Kunitz domain scaffolds have been primarily used for the development of 
therapeutic agents [26]. The most notable example is the FDA-approved drug Kalbitor (ecallantide) 
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for the treatment of hereditary angioedema or blood loss prevention during cardiothoracic surgery 
and functions as an inhibitor to plasma protease kallikrein [94].  
 
Affibodies 
 
Affibodies are derived from the artificially mutated B-domain of the immunoglobulin-binding 
region of staphylococcal protein-A, called the Z-domain. These are small (6.5 kDa; 58 residues), 
single domain proteins containing only three α- helices and no disulfide bridges (Figure 2.9c). The 
target-binding regions are developed by randomisation of 13 residues in two of the protein’s helices 
and selection is achieved using phage display [95]. The applications of Affibody technology have 
been explored for diagnostic, therapeutic and research purposes, such as molecular imaging, 
targeted therapy, protein purification or biosensors. For instance, Affibodies targeting HER2 
proteins have been tested in clinical trials for in vivo imaging of malignant tumours on breast 
cancer patients, while Affibodies against Taq DNA polymerase and human IgA have been used as 
capture agents in microarrays [89].   
 
DARPins 
 
Designed ankyrin repeat proteins (DARPins) are based on ankyrin repeat (AR) proteins, which are 
binding proteins ubiquitous in eukaryotic organisms. AR proteins are assemblies of repeated 
motifs, each motif containing 33 residues shaped into two α-helices linked by a short β-turn. 
DARPins (14-22 kDa) are consensus designed AR proteins with 7-8 randomised residues in each 
repeat and usually consist of four, five or six AR repeats (Figure 2.9d). Selection of DARPins 
through ribosomal display yields high affinity binders with KDs in the picomolar range. DARPins 
demonstrate very high stability owing to a hydrophobic interface in the interior, while the N-
terminal and C-terminal repeats are hydrophilic, and thus can be readily expressed in E. coli as 
soluble proteins. DARPins can be designed to exhibit avidity since their repeat structure enables 
the insertion of different binding sites on a single DARPin molecule, so that it can target multiple 
epitopes on the same antigen or capture several targets [26]. The DARPin approach was further 
extended to synthesise LoopDARPins, where elongated loops (19 residues) were inserted in the β-
turn position of each repeat, aiming to increase the interaction surface on the proteins [96]. 
DARPins are currently a registered trademark of Molecular Partners AG. The main focus of 
research has been on their use as therapeutic agents in immuno-oncology, where DARPins 
targeting cancer-related proteins have currently entered phase I and II clinical trials, as well as 
ophthalmology, where phase III trials on treatment of retinal diseases have already been initiated 
[97]. DARPins have also been used in biosensors for the detection of MalE, a maltose binding 
protein, demonstrating nanomolar range affinities and 0.3 nM LOD [98].  
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The range of unique and novel antibody mimetics is growing constantly and these are steadily 
gaining ground as useful tools in therapeutics, diagnostics and basic or applied research. Other 
noteworthy antibody mimetics include Affilins, Avimers, Fynomers, Knottins, Atrimers, 
Alphabodies, Repebodies, Centyrins, Pronectins and Obodies. For a more detailed discussion on 
established antibody mimetics see recent review articles [26] [86-89] [92].  
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A similar cystatin scaffold, but based on plant-derived cystatins (phytocystatins) and called 
Adhiron (Figure 2.11), was designed and presented by the BioScreening Technology Group 
(BSTG) at the University of Leeds [27]. Here, 57 phytocystatin sequences were aligned in order to 
derive a consensus phytocystatin sequence by identifying the most common residues at each site of 
the aligned sequences. Consensus protein design is based on the hypothesis that regions in the 
protein sequence that are most instrumental for protein stability and functionality are expected to 
show a high degree of conservation among homologous proteins in different organisms [110]. The 
consensus sequence derived from the sequence alignment consists of a four-stranded antiparallel β-
sheet and one α-helix. The scaffold was further modified by replacing the two peptide loops 
responsible for protease inhibitor activity with randomised peptide sequences of nine amino acid 
residues at each loop (excluding cysteine) to create antigen-binding peptides. This randomisation 
yielded a large (~10
10
) and highly diverse library of Adhiron variants that, through phage display, 
can be screened for the selection of high affinity binders against a particular target. The Adhiron 
scaffold is a small (92 residues, 12-14 kDa), monomeric, single-domain protein, that lacks disulfide 
bridges and glycosylation sites, demonstrates high stability (melting temperature up to 101 °C) and 
high solubility, while it is readily expressed in microbial hosts. These features satisfy the criteria 
proposed for protein engineered therapeutic proteins [111] as well as the requirements defined by 
the designers of the STM Affimer scaffold [112]. The scaffold is also largely pH resistant, thus, 
allowing target selection in alkaline or acidic conditions. Moreover, as with the STM scaffold, the 
insertion of a cysteine residue enables covalent and oriented immobilisation of Adhirons on gold 
surfaces [105]. These traits (high scaffold stability, site-directed immobilisation free of 
conformation changes) make Adhirons ideal for integration in biosensors.  
 
 
Figure 2.12: Schematic of the basic structure of an M13 filamentous bacteriophage. The ssDNA is encapsulated by 
a cylindrical protein coat, which consists of about 2700 copies of the major coat protein (pVII) and five copies of 
each of the minor coat proteins (pIII, pVI, pVII and pIX). The Adhiron protein is displayed at one of the pIII coat 
proteins (adapted from [114]).  
 
The selection of Adhiron molecules is achieved using phage display libraries and an affinity 
selection process called biopanning. Phage display relies on the use of bacteriophages (or simply 
phages), which are DNA-containing viruses that infect bacteria (typically Escherichia coli) and use 
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the host machinery to replicate. Phages are valuable tools in biotechnology and are extensively 
used in protein engineering processes [82]. Different types of bacteriophage (such as M13, f1, fd, 
T7, T4 and λ) are used depending on the application; for Adhiron development, the M13 
filamentous phage is employed. These are long (900 nm), rod-shaped viruses that encapsulate a 
closed, circular single-stranded DNA molecule (ssDNA) inside a cylindrical protein coat, that 
consists of about 2700 copies of a major coat protein and five copies of four different minor coat 
proteins (Figure 2.12) [112]. To create phage display libraries, the gene that encodes the phage coat 
major (pVIII) or minor (pIII) protein is modified in order to carry a foreign sequence, which is 
expressed as a ‘fusion’ (hybrid) coat protein. [113].  
 
 
Figure 2.13: Brief schematic of phage display construction. Here, the coding region of an Adhiron protein is 
inserted into the pIII minor coat protein gene and the recombinant phage DNA is incorporated into a phagemid3.  
The recombinant phagemid is inserted into E. coli and replicated using the host machinery. Phage assembly is 
initiated by superinfection of the host bacteria with helper phages, followed by excretion of phage particles that 
display the Adhiron protein as a fusion pIII coat protein.  
 
 
                                                          
3
 A phagemid is a plasmid that carries a plasmid origin of replication (so as to normally replicate in bacterial 
host cells), an antibiotic resistance gene (for selection of plasmid-bearing host cells) and a filamentous phage 
origin of replication. A plasmid is a small, circular, double-stranded DNA molecule, typically of bacterial 
origin. Plasmids (or phagemids) containing foreign DNA (recombinant DNA) are extensively used in protein 
engineering as cloning vectors to carry the recombinant DNA into host cells for replication and expression; 
phagemids  can also be packaged into viral particles as ssDNA [82]. 
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In order to construct the Adhiron phage display library, the coding region of the Adhiron protein 
was inserted into the pIII minor coat protein gene and the recombinant phage DNA was 
incorporated into a phagemid vector (called pBSTG1) that was subsequently introduced into E. coli 
through electroporation (Figure 2.13). In the Adhiron coding region, the scaffold sequence remains 
constant, whereas the antigen-binding peptide sequences are randomised, resulting in a large pool 
of sequence variants of the Adhiron coding region, each incorporated into pBSTG1 phagemids 
(called pBSTG1-Adh). Following electroporation, each E. coli cell carries a phagemid with a 
different sequence variant. The ssDNA of each phagemid is replicated inside the host but its phage 
assembly mechanism is inactive. Virion assembly is initiated by infection of the phagemid-rich 
bacteria with helper phage particles (here M13KO7) that carry all necessary phage assembly genes. 
The secreted phage particles are hybrids (or mosaics) of the phagemid and helper phage, which 
contain both the recombinant (fusion) and wild-type of the pIII coat proteins. Therefore, inside the 
protein coat, the DNA of the virion carries the Adhiron protein coding region, whilst the Adhiron 
protein is exposed to the environment where it can interact with other proteins or molecules. As a 
result, the pool of pBSTG1-Adh phagemids is now a large library of phage particles (phage display 
library), each displaying a different Adhiron variant as a pIII fusion coat protein [27] [82] [113]. 
 
 
Figure 2.14: Schematic of the affinity-based protein selection process (biopanning) from phage display  libraries. 
In the first screening round, the phage library is incubated with the target and then washed to remove non-
specifically bound phages. The specifically bound phages are eluted and amplified by infecting bacteria. The 
amplified phages are subjected to additional selection rounds or are isolated and sequenced for further 
characterisation (adapted from [26]). 
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The biopanning process starts with the immobilisation of the target on a solid substrate and the 
incubation with the Adhiron library (Figure 2.14). Typically, the immobilisation method is based 
on the remarkably high binding affinity between biotin and streptavidin. Initially, the target 
molecule is labelled with a biotin linker. Then, the biotin-labelled target is immobilised onto 
streptavidin-coated substrates through the biotin. Notably, to reduce binding of non-specific 
Adhirons, prior to the first selection round (incubation with target), the Adhiron phage library is 
pre-panned against wells containing only the biotin linker (no target). This pre-panning step helps 
removing phages that bind to the biotin linker and streptavidin-coated surfaces. The unbound 
phages are then used for the first selection round, where following incubation with immobilised 
target, those that did not bind to the target are washed away, so that only target-interacting phages 
remain. The specifically bound phages are eluted, usually by low or high pH buffers. Unlike the 
antigen-binding peptides, the Adhiron scaffold and the M13 phage are resistant to extreme pH 
values, enabling them to withstand these harsh conditions and remain stable, whilst the Adhiron 
binding site is destabilised and dissociates from the target. Here, elution was achieved by adding 
glycine-HCl (pH 2.2) followed by Tris-HCl (pH 9.1) for neutralisation and further eluting with 
triethylamine (neutralised with Tris-HCl pH 7). The eluted phages are then amplified by infecting 
bacterial cells, facilitated by M13KO7 helper phages. The enriched and amplified phage library 
aliquot is used for the second screening round, where the biotinylated target is now immobilised on 
streptavidin-coated magnetic beads. The phage library aliquot is incubated with target, washed to 
remove unbound phages, whilst bound phages are eluted and amplified as in the first round. In the 
final round, the phage pool is now incubated with immobilised target on NeutrAvidin-coated plates 
(so as to further reduce non-specific binding). For selection of Adhirons against small targets, such 
as short peptides or small molecules, additional screening rounds are required [27] [82]. Following 
amplification of the phages selected in the final round, the ability of the displayed Adhirons to bind 
the target is typically demonstrated by phage ELISA. In this assay, the phages are incubated with 
biotinylated target on streptavidin-coated wells and, following washing, bound phages are detected 
by an HRP-labelled, anti-phage antibody with TMB as substrate [27]. The phages that demonstrate 
binding to the target are then isolated and sequenced to identify and compare the antigen-binding 
peptide sequences of each Adhiron protein in order to reveal common occurring binding motifs (i.e. 
clones of the same Adhiron variant). Adhirons with unique binding motifs are then selected for 
further characterisation, such as thermal stability, structure determination or binding affinity [113]. 
Adhiron binders against yeast SUMO have been demonstrated with nanomolar range affinities for 
their target protein, whilst showing minimum cross-reactivity with the closely related human 
SUMO proteins [27]. High affinity Adhiron binders have since been selected against numerous 
molecules, including fibroblast growth factor (FGF1), cell adhesion molecule CD31, SH2 domains 
as well as a 12-amino acid peptide. The latter, as a small-sized target, required additional screening 
rounds to ensure high affinity and specificity. More recently, Adhirons have been selected against 
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fibrinogen, hypoxia-inducible factor 1 (HIF-1) and even magnetite nanoparticles [28] [29] [115] 
and today Affimers targeting over 350 different targets have been reported, illustrating the 
versatility of this technology. 
 
Adhirons have also been demonstrated as important binding agents for use in immunoassays. For 
example, an Adhiron-based impedimetric biosensor for the detection of anti-myc tag antibodies 
was shown to have picomolar sensitivity [30]. More recently, an impedance biosensor with 90 
fg/mL LOD has been demonstrated for the detection of interleukin-8, an important biomarker of 
acute inflammation [31]. The Affimer (human stefin A) and Adhiron (phytocystatin) scaffolds have 
been commercialised by Avacta and both are currently marketed under the Affimer brand (as Type 
I and Type II Affimer corresponding to the STM and the Adhiron scaffold, respectively). Recently, 
Avacta announced the selection of high affinity and specific Affimers against the NS1 protein of 
the Zika virus and the development of three independent assays for rapid diagnostics of Zika 
infection; notably, selection, characterisation and immunoassay development together required 
approximately 16 weeks, a very short period compared to conventional antibody development 
[116].   
 
The main focus of Affimer research has been orientated towards clinical diagnostic and therapeutic 
applications that are largely involved with targeting specific proteins. Proteins are large, complex 
molecules with several epitopes. This increases the probability of selecting Affimers with high 
affinity. However, detection of small-sized molecules by bioreceptors, including Affimers, is 
significantly more challenging and has received far less attention. Indeed, to date, only the single 
use of Affimers in competitive ELISAs for the detection of a small molecule (the antifungal drug 
posaconazole), has been reported. Critically, the posaconazole Affimers exhibited high specificity 
and insignificant cross-reactivity with the closely related drug voriconazole, illustrating the 
potential for Affimers for small-molecule detection [117].  
  
Considering the versatility of Affimers and their enhanced properties and benefits compared to 
conventional antibodies, it is worth exploring their potential as alternative bioreceptors in bioassays 
for the detection of contaminants in the environment. This project aimed to evaluate Affimers as 
synthetic binders of small organic compounds, focusing on the environmental contaminants 
methylene blue and diclofenac. Affimers based on the Adhiron scaffold were selected against the 
two targets (Appendix A) and their affinity was evaluated using a variety of techniques. For 
methylene blue, the performance of Affimers in the complexity of surface water samples was also 
assessed. Finally, Affimer-based assays in competition format were developed for both targets, in 
order to demonstrate the potential for environmental applications (Chapters 4 and 5). It should be 
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noted that, hereinafter, the term Affimer will be used to refer to the Adhiron scaffold and the 
Adhirons selected against the targets of this study.  
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Chapter 3  
 
Description of Techniques for Studying 
Affimer-Target Interactions 
 
3.1 Overview 
 
Immobilisation of the target analyte is critical for Affimer selection; for streptavidin-coated 
surfaces this was achieved by coupling the target to a long-chained biotinylated linker (Appendix 
A). In this work, however, the analytical techniques used to study Affimer-target interactions 
involved the use of gold-coated sensors (with the exception of ELISAs), and the most widely used 
approach for target immobilisation on gold surfaces is through self-assembled monolayers (SAMs) 
of alkanethiols. Both diclofenac (DCF) and methylene blue (MB) were thus attached to long-chain 
alkanethiols (LCAT) coupled with oligoethyleneglycol components (OEG). The LCAT component 
ensured the formation of dense and well-ordered molecular monolayers assembled on gold, 
whereas the OEG region enhanced the protein resistance of the molecular film [118]. The synthesis 
of target-derivatised LCAT-OEGs for this study is an adaptation of the synthetic protocol reported 
in Murray et al. [119], which makes use of the versatility of solid-phase chemistry to synthesise 
functionalised LCAT-OEGs. The MB- or DCF-derivatised LCAT-OEGs (referred to as LCAT-
OEG-MB and LCAT-OEG-DCF respectively) were synthesised following this approach and were 
then used to form SAMs on the gold surfaces of sensors, in order to study the interaction of the 
immobilised target with Affimers (synthesis of LCAT-OEG-MB and LCAT-OEG-DCF are 
described in Chapters 4 and 5, respectively). 
 
Biomolecular interactions between the target-derivatised SAMs and Affimers were studied through 
quartz-crystal microbalance with dissipation monitoring (QCM-D), where the target was 
immobilised on the gold surface of QCM-D sensors. However, before using LCAT-OEG-DCF and 
LCAT-OEG-MB to study the Affimer-target interactions, it was important to ensure that the SAM 
has assembled correctly and that surface immobilisation did not affect the properties of the target. 
This was achieved using cyclic voltammetry (CV), to study the redox properties of the methylene 
blue in the LCAT-OEG-MB SAMs. In addition, the conformation and structure of both the LCAT-
OEG-DCF and LCAT-OEG-MB SAMs was characterised through electrochemical impedance 
spectroscopy (EIS) and infrared-spectroscopy (polarisation modulated – reflection absorption 
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infrared spectroscopy, PM-IRRAS), to determine whether through this immobilisation approach the 
target was efficiently presented on the surface for studying Affimer-target interactions.   
 
The LCAT-OEG SAM characterisation and Affimer binding studies are reported in Chapters 4 and 
5. This chapter provides a brief overview of SAMs and the above mentioned analytical techniques.  
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3.2 Self-assembled Monolayers 
 
In general, the term SAM refers to the well-structured molecular assemblies that form 
spontaneously when organic molecules chemisorb onto the surface of solids (and sometimes 
liquids, such as mercury).  The organic adsorbates contain a ‘headgroup’ (Figure 3.1), which has a 
high affinity for the substrate’s surface and is responsible for the spontaneous adsorption of the 
molecules, which in effect lowers the free energy of the substrate [120]. Inter-molecular 
interactions between neighbouring organic backbones drives ordering of the SAM, leading to the 
formation of a well-structured 2D monolayer which alters the interfacial properties of the substrate, 
as determined by the nature of the ‘tailgroup’. SAMs thus offer a highly versatile approach to tailor 
the physical and chemical properties of a material’s surface according to the intended use, such as 
conductivity, wettability, chemical functionality or thermostability. As a result, macroscopic or 
microscopic phenomena occurring at the interface can be studied through SAMs, which enable 
coupling the external conditions to the electronic and optical properties of the substrate. An 
additional advantage of SAMs is that they are easily prepared in ambient atmospheric conditions 
and can assemble on objects of any size or shape [120] [121].   
 
 
Figure 3.1: Schematic of self-assembled monolayers main components. The head groups (such as thiol groups) are 
chemisorbed to the metal substrate (e.g. gold) and separated by a spacer (alkane chain); the terminal (tail) groups 
interact with the species in the solution (adapted from [120]). 
 
The solid substrates used for preparing SAMs are usually metals, and preferably noble metals such 
as Au, Ag, Pt, Pd or Hg. Other materials, such as silicon, carbonaceous materials and metal 
nanoparticles, have also been used for assembling SAMs. The most commonly used material, and 
of particular interest to this project, is gold. As a fairly inert metal, gold does not react with most 
chemicals and is resistant to oxidation, which makes it ideal to handle and use under atmospheric 
conditions and in combination with complex biological matrices. Additionally, thin gold films can 
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easily be deposited onto silicon wafers, glass slides or other silicon-based materials, and 
subsequently patterned through various lithographic and etching methods. Gold nanoparticles can 
be also used as SAM substrates. Moreover, the inert and robust nature of gold allows the removal 
of deposited impurities or residues through UV-ozonation critical for the assembly of well-
structured SAMs; in fact, gold can withstand even more aggressive cleaning methods such as 
piranha cleaning. Another important characteristic is gold’s biocompatibility, which enables the 
adhesion of cells or viruses to its surface without toxic effects, thus enabling analysis of whole cell 
systems or bacteriophages. Finally, thin gold planar surfaces are compatible with a number of 
established analytical and characterisation methods such as SPR, QCM-D, PM-IRRAS or 
electrochemical techniques [120] [121]. 
 
The first reported SAMs were based on alkylsilanes, but today a wide variety of monolayers and 
substrates have been introduced and investigated. The most widely studied and extensively used 
class of monolayers are those based on organosulfur compounds on gold, which depend on a stable 
bond formed between the thiolic groups and the substrate’s surface [122]. More specifically, n-
alkanethiols on gold are of particular interest to this study, since they form a strong S-Au bond, 
enabling the formation of densely packed and highly ordered SAMs [123]. This bond (which is 
considered a type of covalent or semi-covalent bond [120]) is energetically favourable and 
displaces other adventitiously adsorbed organic materials.  
 
 RSH + Au(0)𝑛
         
→  RS − Au(I) ∙ Au(0)𝑛−1 + 
1
2
H2   (3.1)  
 
It is worth noting that this mechanism of alkanethiol-SAM formation on gold can be also applied 
for site-directed immobilisation of bioreceptors (antibodies, peptide aptamers, etc.), where the self-
assembly is enabled through cysteine residues [122]. Figure 3.1 illustrates the typical structure of a 
thiol-based SAM on a gold substrate. Each alkane chain (spacer) has a thiol head group that is 
chemically linked to the gold surface. A terminal (or “tail”) group is on the opposite end of the 
alkane chain, and consists of a functional group. Alkanethiols have been synthesized with a wide 
variety of terminal groups (including amine, carboxylic acid, hydroxyl, methyl and redox-active 
groups) which can alter the interfacial properties of the substrate, for example hydrophobicity and 
surface charge, and provide chemical functionality such as electron transfer or chemical reactivity. 
The composition of the SAM determines its functionality which can vary depending on the 
application [122].  
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Figure 3.2: Scheme of the different phases of self-assembly of alkanethiols on gold: a) physisorption, b) ‘lying-
down’ phase, c) gradual formation of the ‘standing-up’ phase, d) completion of the final, ‘standing-up’ phase 
(adapted from [124]) 
 
The mechanism of alkanethiol-SAM assembly consists of separate, progressive phases. Initially, 
more than 90% of the alkanethiols that make up the fully assembled SAM, assemble rapidly 
(within minutes) on the surface (Figure 3.2a). In the second phase, a more dense and well-ordered 
monolayer is formed at a slower rate (over hours). It is presumed that in the initial stage, the 
alkanethiols instantaneously interact with the gold substrate, primarily through physisorption rather 
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than chemisorption and are mainly in a ‘lying-down’ position (or ‘striped’). Gradually, 
chemisorption starts taking place so that more alkanethiols become alkanethiolates as time passes 
(Figure 3.2b). The resulting monolayer in this initial phase, although ordered to a certain degree, 
has a low coverage and contains defects. However, chemisorption (in this case, the formation of 
Au-S bonds) is more energetically favoured than physisorption, so, over the course of hours, the 
alkanethiols undergo reorganisation that increases the number of chemisorbed molecules (Figure 
3.2c). Specifically, the alkanethiols slowly adopt a more upright position (‘standing-up’ phase) so 
as to attain the highest possible number of S-Au bonds and thus maximise density while the defects 
are filled with alkanethiols from the solution. Finally, the SAM adopts its final structure (Figure 
3.2d), as the alkanethiols reorganise and orientate through chain-chain interactions in order to 
become a well-packed, dense and highly crystalline monolayer [121] [122]. Figures 3.1 and 3.2d 
depict the SAM as composed of uniformly aligned molecules; in reality however, the monolayer 
exhibits a variety of defects such as pinholes, islands, domains or collapsed sites. The metallic 
surface of the substrate is not flat and free of defects, but contains several features in its 
polycrystalline structure, such as terraces, steps or impurities, that can affect the uniform packing 
of the monolayer. In addition, variations in the tilt angles or molecular vacancies from alkanethiols 
that have remained in the ‘lying-down’ phase will influence the homogeneity of the SAM packing.  
 
SAMs modified with redox molecules have drawn increasing interest, since they can be used to 
study electron transfer kinetics on functionalised electrodes or provide label-free platforms for 
electrochemical sensing of biomolecular interactions. The most widely studied redox species on 
SAMs are metal complexes such as Fe, Ru or Os complexes [122]. For example, ferrocene-
terminated SAMs have been used to probe molecular interactions [125]. Here, label-free detection 
of biotin–streptavidin interactions was demonstrated using mixed-SAMs of hydroxyl-, ferrocene- 
and biotin-terminated alkanethiols (the hydroxyl chains were used as dilutants). The ferrocene 
complexes showed sensitivity to the changes in the local electrostatic environment caused by the 
binding of streptavidin to biotin. This type of interaction, which affects the electron transfer, can be 
detected by simple electrochemical methods, such as cyclic voltammetry. It should be noted that 
for such applications, the redox potential of the electroactive species should be within a certain 
potential range, which is limited by the stability of the SAM and the characteristics of both the 
electrolyte and the analyte [126].  The electrochemical desorption potential for alkanethiolates on 
gold (Equation 3.2) is typically around -1.0 V (vs Ag/AgCl reference electrode), although this 
value can vary depending on the electrolyte, SAM chain length, the degree of order or the number 
of intermolecular interactions (such as hydrogen bonding) [120].  
 
RS − Au + 𝑒−
         
→  RS− + Au0    (3.2) 
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There are two main approaches for modifying SAMs with redox groups, either via attachment of 
ligand after SAM formation (post-assembly) or, as used in this work, through synthesis of 
alkanethiols modified before SAM formation (pre-assembly) [119]. In many cases, the bulky, 
charged redox species result in steric hindrance or interactions between the redox centres that can 
affect the ordered packing of the monolayer and often cause defects in the SAM. The most 
common solution to such issues is using mixed-SAMs where a dilutant alkanethiol with inert tail 
groups is incorporated in the SAM in order to separate the redox molecules (Figure 3.3) [126].  
 
 
Figure 3.3: Schematic of alkanethiol SAMs on gold illustrating a) the SAM disorder caused by steric hindrance of 
bulky terminal groups and b) the increased order by separating the terminal groups with a dilutant to form mixed 
SAMs.  
 
For the purposes of this study, long-chained alkanethiols (LCAT) were combined with 
oligoethyleneglycol units (OEG) and were then crosslinked with the target molecules (MB or 
DCF). This approach enables the formation of dense and well-packed SAMs where the presence of 
the OEG region increases the hydrophilicity of the monolayer and enhances its resistance to non-
specific adsorption of proteins or other organic material [120]. Water molecules bind to the oxygen 
atoms of the oligomer through hydrogen bonding and form a stable solvation shell, so the proteins 
cannot easily displace the bound water to adsorb on the surface [127].  
 
  
54 
 
3.3 Brief Description of Electrochemical Techniques 
 
Electrochemistry is the area of chemistry that studies the interrelation of electrical and chemical 
processes in a system. Specifically, it is interested in the transport of charge (electrons or ions) 
across the interface between two chemical phases, such as an ionic conductor (the electrolyte) and 
an electronic conductor (the electrode). The main focus in this study is the interactions and events 
that occur at the electrode/electrolyte interface when a potential difference is applied and a current 
flow occurs by the movement of electrons to/from a redox-active group attached to the electrode.  
 
The simplest form of an electrochemical system consists of two electrodes separated by at least one 
electrolyte phase. This system is called an electrochemical cell, and the potential difference 
between the two electrodes, the cell potential, corresponds to the relative energies of the charge 
carriers in the two different phases of the interface, and controls the direction and rate of electron 
transfer. The electrode where electrons are released to the electrolyte phase, and is thus oxidised, is 
called the anode, whereas the electrode where reduction is occurring by the gain of electrons is 
called the cathode. This movement of electrons allows the flow of current through the system, 
which functions as an electrical circuit [128].  
 
 
Figure 3.4: Diagram depicting a three-electrode system, where the electrochemical cell is connected to an external 
power supply. Current flows between the working and counter electrodes while the potential of the working 
electrode is measured with respect to the reference electrode (which has a fixed potential); adapted from [128]. 
 
According to Faraday’s laws for electrochemical systems, the current passing through an electrode 
is directly proportional to the amount of a substance reduced or oxidised at the electrode’s surface. 
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Voltammetric techniques, such as cyclic voltammetry, are used to study the chemical reactions 
occurring in the cell by measuring the flow of electrons moving across the interface (i.e. the rate of 
electron transfer). These methods use a three-electrode system (Figure 3.4), since it is necessary to 
control the potential on one of the electrodes, which is not possible using a two-electrode cell. A 
three-electrode system consists of the working (or indicator) electrode, the reference electrode and 
the counter (or auxiliary electrode). One is usually interested in studying only one of the redox 
reactions occurring in the cell; the electrode where this reaction takes place is the working 
electrode, and it is usually made of an inert material such as gold, platinum or carbon. The potential 
of the working electrode is always measured and reported with respect to that of the reference 
electrode. The composition of the reference electrode is such that its potential remains essentially 
constant and is not affected by changes in the cell. The standard (or normal) hydrogen electrode, 
SHE (or NHE) is the internationally accepted reference electrode and all other potentials are 
reported with respect to the NHE. Another very commonly used reference electrode, as used in this 
study, is the silver-silver chloride electrode (Ag/AgCl/KCl) which has a potential of +0.197 vs. 
NHE. Finally, the counter electrode, which is typically made of graphite or platinum, is responsible 
for facilitating the current flow and completing the circuit, so that current is not run through the 
reference electrode, which would alter its potential [128].  
 
In this work, the working electrode is a planar gold surface deposited on a silicon wafer, while a 
platinum electrode functions as the counter electrode. At the electrode surface, the array of charged 
species and oriented dipoles at the metal-solution interface form a double layer (Figure 3.5), which, 
within a certain potential range, can approach the behaviour of an ideal polarised electrode (IPE), 
where no charge transfer is occurring across the interface, so only non-faradaic
4
 processes are 
happening (accumulation of charges on both sides of the interface, also called charging current). 
This structure, where charge cannot cross the interface, is analogous to a capacitor, and the 
structure of the double-layer will affect the rate of charge transfer processes occurring at the 
electrode. 
 
The inner layer of the solution side of the double layer is called the compact Helmholtz or Stern 
layer and is the one closest to the electrode (Figure 3.5). The compact layer includes solvent 
molecules and other species (ions or molecules) that are specifically adsorbed (through short range, 
non-coulombic interactions) on the electrode and, as described by IUPAC [129], “the locus of the 
electrical centres of the specifically adsorbed ions” is called the inner Helmholtz plane (IHP). The 
                                                          
4
 Faradaic processes involve charge (e.g. electrons) transfer across the electrolyte/electrode interface, causing 
oxidation or reduction to occur. In contrast, no charge transfer takes place during non-faradaic process and 
the observed current flow occurs due to accumulation (or removal) of charges on the electrode owing to 
changes in the potential of the electrode [128]. 

57 
 
enables tunnelling of electrons through the molecular film. The electroactive terminated molecules 
are often diluted with non-electroactive molecular chains within the film to form mixed SAMs 
(Figure 3.3), so that the bulky redox groups are kept apart [121] [126] [128].  
  
58 
 
3.3.1 Cyclic Voltammetry (CV) 
 
Cyclic voltammetry is a widely used amperometric method for interrogating interfacial electron 
transfer processes. In general, voltammetry is a potential sweep method, where the potential of the 
working electrode is varied linearly over time and the current is observed as a function of the 
applied potential; such a plot is called a voltammogram. In CV, the potential is applied within a 
specified range, and upon reaching one of the extremes, it is reversed so that it moves in the 
opposite direction, until it reaches the initial potential, thus completing a full cycle (Figure 3.6a).  
 
 
Figure 3.6: a) Working electrode potential (Ewe Ag/AgCl reference electrode) as a function of time during a CV 
cycle, b) cyclic voltammogram (current vs. Ewe of an LCAT-OEG-MB SAM in McIlvaine buffer pH 7 at 100 mV/s 
scan rate. The main parameters shown in a CV plot are the peak current (ipa for oxidation and ipc for reduction), 
the peak potential (Epa and Epc), the full-width at half of the peak maximum height (FWHM) and the charging or 
capacitive current ich. [126] 
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Initially, only non-faradaic current flows in the cell. As the potential becomes more positive and 
approaches the formal potential of the redox groups, a gradually increasing electron flow towards 
the electrode occurs, causing a faradaic current which corresponds to the oxidation of the redox 
species (Figure 3.6b) [128]. For an ideal, surface-immobilised reversible redox reaction, the peak 
potentials, Epa and Epc, are independent of the scan rate (the rate at which the applied voltage is 
scanned, 𝑣 in mV/s) and concentration of redox moieties, and the peak separation ΔEp = Epa - Epc 
equals zero at low scan rates. The formal potential, E
0
, is centred between the two peak potentials 
so that E
0
= Epa+Epc/2. For an ideal reversible system, where there are no other processes that 
affect the charge transfer reaction, the peak oxidation, ipa, and peak reduction current, ipc, are equal 
such that ipa / ipc ≈ 1, and both exhibit a linear relationship with scan rate [126] [128]. This linear 
relationship between the faradaic current, 𝑖𝑝, and the scan rate, 𝑣, can be used to calculate the 
surface coverage, Γ (mol/cm2), of redox-immobilised moieties using Equation 3.3 [126]. 
 
𝑖𝑝 = 
𝑛2𝐹2
4𝑅𝑇
 𝑣𝐴Γ      (3.3)  
 
Here, n is the number of electrons involved in the reaction and F the Faraday constant 
(96,485.3365 s A/mol), R is the universal gas constant (8.314472 J/K 
 
mol), T is the absolute 
temperature (K) and A the surface area of the substrate (cm2). 
 
At low scan rates, redox SAM-functionalised electrodes, such as the LCAT-OEG-MB SAM used 
in the following experiments, behave like a reversible system, with symmetrical peaks and the peak 
current is directly proportional to the scan rate. Increasing the scan rate can cause peak separation 
so that ΔEp ≠ 0, and the higher the rate the more the peaks separate. Here, the potential is swept 
faster than species involved in the redox reaction (such as protons) can diffuse to the layer, so that 
electron transfer appears sluggish and thus, larger potentials are required to motivate charge 
transfer. By plotting the peak potential vs. log(𝑣) it is possible to calculate the rate of electron 
transfer (𝑘𝐸𝑇) of the species absorbed to the electrode by following the Laviron method (Figure 
3.7) [126].  To determine 𝑘𝐸𝑇, one must first find the transfer coefficient, α, which ideally 
should be 0.5 for all overpotentials
5
, but very often deviates from this value. To calculate α, the 
peak potentials, Epa and Epc, are plotted separately against the logarithm of the scan rate, so that 
                                                          
5
 The overpotential (η) is the difference between the applied potential, Ep, and the formal potential, E
0
, and 
can be determined by the difference in the peak and formal potential (𝜂 = 𝐸𝑝 − 𝐸
0) [126].  
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they give two branches (Figure 3.7). As the scan rate increases the data form a straight line where 
the gradient of this line is given by Equation 3.4,  
 
slope =  −
2.3𝑅𝑇
𝛼𝑛𝐹
      (3.4) 
 
The electron transfer rate, 𝑘𝐸𝑇, can be calculated from Equation 3.5 [126] which assumes that η=0. 
Here, νa and νc are determined from the x-intercepts of the lines fit to Epa and Epc, respectively.  
 
𝑘ET =
𝛼𝑛𝐹𝜈𝑐
𝑅𝑇
= (1 − 𝛼)
𝑛𝐹𝜈𝑎
𝑅𝑇
     (3.5)  
 
  
Figure 3.7: Laviron (trumpet) plot of an LCAT-OEG-MB SAM in 100 mM phosphate buffer at pH 7. Peak 
potentials, Epa and Epc are plotted against the logarithm of the scan rate. The linear regions at higher scan rates 
have been fitted to calculate the rate of electron transfer,  𝒌𝑬𝑻. 
 
Finally, a cyclic voltammogram can provide additional information about the characteristics of the 
monolayer. The background current (ich), also called the charging or capacitive current, can be 
used to calculate the capacitance of the SAM, as shown in Equation 3.6.  
 
𝑖𝑐ℎ = 𝐶DL𝑣      (3.6)  
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Here, CDL is the capacitance of the SAM in Farad (1 F = 1 s
4
 A
2
/m
2
 kg) and v is the scan rate 
(mV/s). Subsequently, the capacitance can be used to calculate the thickness of the monolayer, d 
(nm),   
 
𝐶𝐷𝐿 = 𝜀0𝜀r
𝐴
𝑑
      (3.7)  
 
where ε0 is the permittivity of the vacuum (8.85419 × 10
−12
 F/m), εr the relative permittivity 
(dimensionless) and A the surface area of the substrate (cm
2
) [123] [130].   
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Here, Et is the potential
6
 at time t, E0 is the amplitude of the excitation signal and ω is the radial 
frequency (where ω=2πf). The resulting AC current signal, It, is given by Equation 3.9 where ϕ is 
the phase difference (Figure 3.8): 
 
𝐼t = 𝐼0sin (𝜔t + 𝜙)     (3.9)  
 
As defined by Ohm’s law, the resistance (R) of a resistor is the ratio of voltage and current 
(Equation 3.10).  
 
𝑅 = 𝐸/𝐼      (3.10)  
 
Analogously, the impedance, Z, of the system is calculated as a ratio of Et and It (Equation 3.11). 
However, this is only true in a linear system, where the AC current response to the sinusoidal AC 
excitation potential is also a sinusoid function over time at the same frequency (but out-of-phase). 
Therefore, in EIS, the applied AC excitation signals are very small (1-10 mV), so as to approach a 
pseudo-linear system so that, 
 
Z = 𝐸t/𝐼t      (3.11)  
 
Through Equations 3.9-3.11, the impedance can thus be expressed as: 
 
Z =  
𝐸0 sin(𝜔t)
𝐼0sin (𝜔t+𝜙)
= 𝑍0
sin(𝜔t)
sin (𝜔t+𝜙)
    (3.12)  
 
The relationship between frequency, phase and impedance can be visualised using a Bode plot, 
where the logarithm of the magnitude of the impedance, log(|Z|), and the phase, ϕ, are plotted as a 
function of frequency, log(ω), as shown in Figure 3.9a. Considering that the impedance of a SAM-
functionalised electrode is dependent on the structural characteristics of the organic coating, 
valuable information regarding the properties of the monolayer can be obtained by studying its 
capacitive and resistive behaviour through EIS. The Randles circuit shown in Figure 3.9b is often 
used as a simple model of the impedance of an electrode coated with a SAM. Here, RSOL refers to 
the solution resistance, CDL is the double-layer capacitance formed at the electrode-electrolyte 
interface, RCT the charge-transfer resistance and CAD the capacitance of the adsorbed layer [126] 
[131] [132].  
                                                          
6
 The symbol V is used extensively in the literature for voltage or potential, but here (and in section 3.3.1), in 
order to avoid confusion with the symbol for volume, V, the symbol E is used instead, following the 
nomenclature often used in electrochemistry [128] 
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In order to study the impedance of a redox-active SAM, the applied potential is selected to be far 
from the redox potential of the electroactive species, so that no electron transfer occurs. In this 
case, electron transfer associated with the redox reaction need not be considered and only RSOL and 
CDL contribute to the impedance.  
 
 
Figure 3.9: a) Example of a Bode plot, where the impedance magnitude (log(Z)) and the phase angle, ϕ, are 
plotted as a function of frequency; b) Randles circuit model for a redox-species coupled to a monolayer [132].  
 
The magnitude of the impedance of a capacitor reduces with frequency, thus at high frequencies the 
resistive components of the Randles circuit (RCT and RSOL) dominate and the current and potential 
are thus in phase. As the frequency decreases, the impedance of the capacitive components 
increases, thus the overall impedance of the system also increases and the current and potential are 
no longer in phase. If the capacitive component of the impedance is dominant, then the phase shift 
will approach -90º, characteristic of a pure, ideal capacitor. When studying SAMs, this capacitive 
behaviour is associated with the insulating properties of the organic film, which in turn is related to 
the order and packing density of the monolayer. A dense, well-packed SAM with few pinholes and 
defects is expected to approach the behaviour of an ideal capacitor, which is translated as a phase 
value close to -90º in a Bode plot [126] [131]. 
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3.4 Quartz Crystal Microbalance with Dissipation Monitoring 
(QCM-D) 
 
QCM is an interfacial acoustic sensing technique that enables real-time monitoring of molecular 
interactions. The working principle of QCM relies on the piezoelectric property of quartz. In 1880, 
Pierre and Jacques Curie observed that the application of external pressure to a quartz crystal 
induced an electrical potential across the deformed crystal, generating an electric field; this is the 
piezoelectric effect [133]. One year later, the converse piezoelectric effect was predicted 
mathematically by Gabriel Lippmann and demonstrated by the Curie brothers, who showed that the 
application of an external electric field caused mechanical deformation of a quartz crystal 
[59][134]. The mode of deformation depends on the cut of the crystal with respect to its 
crystallographic axes, whilst the direction and extent of deformation depends on the direction and 
amplitude of the applied electric field. At equilibrium, all dipoles in the quartz crystal are randomly 
orientated and thus have zero net dipole moment. Upon the application of an electric field, the 
dipoles are orientated parallel to the field, causing a lattice strain and an overall deformation of the 
crystal (Figure 3.10a). By applying an alternating electric field, the direction of the crystal 
deformation alternates at the frequency of the field (Figure 3.10b) [135] [136].  
 
Figure 3.10: a) Converse piezoelectric effect: Upon application of an electric field, the randomly orientated dipoles 
(SiO2) in a quartz crystal (left) align their direction with that of the applied field (right), resulting in b) a lattice 
strain and a deformation of the crystal (here, a shear strain), where the direction of applied field affects the 
direction of the shear stress (adapted from [135-137]).  
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A QCM sensor consists of a very thin quartz crystal sandwiched between two electrodes, so that 
upon application of AC voltage, the oscillation of the crystal deformation occurs in a thickness-
shear mode, where a transverse wave propagates through the crystal (Figure 3.11a). When the 
frequency of the applied voltage reaches the resonant frequency of the crystal, the amplitude of 
vibration reaches its maximum [133]. Resonance occurs when a system oscillates at its natural 
frequency driven by an external force (such as an alternating electric field). An oscillating system 
can vibrate in a series of distinct modes, called normal modes. For each mode (here, the shear 
vibrational mode), the lowest frequency is called the fundamental frequency (f0). For instance, the 
quartz crystals used in commercial QCM devices have a fundamental frequency between 5-10 
MHz [138]. Any frequency higher than the fundamental frequency is called an overtone, and 
integer multiples of the fundamental frequency are called harmonics (n) [139]. Here, the quartz 
crystal plate oscillates at its fundamental frequency (in the thickness-shear mode) when its 
thickness, tQ, is half the wavelength of the acoustic wave, λQ, so that tQ=λQ/2, which creates a 
standing wave that propagates across the crystal and reflects back into the crystal at the surface 
[133].  
 
 
Figure 3.11: a) shear deformation of the QCM sensor due to the applied AC voltage; b) schematic of a typical 
QCM sensor (adapted from [61], [133] and [140])  
 
A typical QCM sensor consists of a thin-cut quartz wafer, where two gold electrodes are plated on 
each side (typically through vapour deposition), whilst one side is covered with a surface coating, 
usually gold (Figure 3.11b). Adsorption processes, such as the formation of self-assembled 
monolayers of alkanethiols, occur on this coated surface. Depending on the application, other 
surface coatings can be used, such as Ti, Pt, Cr, Co, SiO2, polystyrene, graphene oxide, etc. [140]. 
In a typical experimental set-up, the QCM sensor chip is loaded into a flow cell, as seen in Figure 
3.12. The sensor is connected to an oscillator through the gold electrodes from both sides. Once the 
circuit is closed, the oscillator drives the sensor to shear vibrational mode at its resonant frequency, 
by applying an AC voltage. A frequency counter is used to measure the frequency output of the 
oscillator, and is recorded and processed by a computer [61] [133] [141]. The resonant frequency 
of the quartz plate is temperature-dependent, so a temperature-controlled chamber is often used.  
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Figure 3.12: Schematic of the basic experimental set-up of a quartz crystal microbalance (here, using liquid 
samples); adapted from [142-144].  
 
Critically, the resonant frequency of the crystal depends on its structure, thickness, shape and mass 
[144]. In 1959, Günter Sauerbrey showed that shifts in the resonance frequency of the sensor in 
vacuum are related to changes in the mass of the crystal. Mass deposited on the sensor due to 
adsorption or desorption processes on the surface results in a proportional shift in the resonant 
frequency. This relationship between frequency and mass is described by the Sauerbrey model, 
which states that under vacuum and for a thin, rigid and homogeneous surface film, the measured 
frequency shift is linearly related to the adsorbed or desorbed mass, as described in Equation 3.13,  
 
   𝛥𝑓 = −𝐶𝑓𝛥𝑚     (3.13)  
 
where Δm is the deposited mass (in ng/cm2), Δf=ff  – fi (ff is the frequency measured after mass 
deposition and fi is the initial frequency), while Cf is the mass sensitivity constant:  
 
𝐶𝑓 =
𝜌𝑄𝑣𝑄
2𝑓0
 or 
𝜌𝑄𝑑𝑄
𝑓0
         (since  𝑣𝑄 = 𝑑𝑄𝑓0)  (3.14)  
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Here, ρQ and dQ refer to the density and thickness
7
 of the quartz crystal, respectively, whilst vQ is 
the shear wave velocity. For a quartz crystal with fo=5 MHz (such as the one used in this study), 
vQ=3340 m/s, 330 μm thickness and 2650 kg /m
3
 density, the mass sensitivity constant is 5.65 
MHz·m
2
/kg. Consequently, a frequency shift of 1 Hz, corresponds to a shift in mass of 17.7 
ng/cm
2
. Thus, when using Equation 3.13 to estimate the deposited mass from the measured 
frequency shift, Cf is often expressed as C (1/ Cf ; 17.7 ng/cm
2∙Hz), and the Sauerbrey equation  
takes the following form: 
 
  𝛥𝑚 = −𝐶
𝛥𝑓
𝑛
      (3.15)  
 
where n (n = 1, 3, 5, 7…) refers to each harmonic [60 ] [61] [133]. The calculated mass may be 
used to determine the surface coverage (Γ, molecules/cm2) and the deposited film thickness (df, nm) 
through Equations 3.16 and 3.17 respectively.  
 
𝛤 =
𝛥𝑚 𝑁𝐴
𝑀𝑊
      (3.16)  
 
  𝑑𝑓 =
𝛥𝑚
𝜌𝑓
      (3.17)  
 
 Here, NA is Avogadro’s constant (6.02214 × 10
23
 molecules/mol), while MW refers to the 
average molecular weight of the deposited compounds. ρf refers to the density of the film, which, 
for hydrated biomolecules, is considered to be close to that of water (1 g/cm
3
) [145].  
 
 
Figure 3.13: Propagation of the shear wave from the quartz crystal into the liquid above (adapted from [146]). 
                                                          
7
 The symbol t is often also used for thickness; here, to avoid confusion with the time symbol, t, thickness is 
symbolised by d.  
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and elastic contributions are often added to the frequency shift. Dissipation monitoring within the 
QCM (QCM-D) provides an approach to account for such contributions, and Q-sense was the first 
to commercialise this technology, in 1996 [60] [61]. In QCM-D, the applied AC voltage is 
momentarily shut off (~20 ms every second), and the decay of the oscillation of the quartz crystal is 
recorded [61] [141] [142]. The oscillation decay over time depends on the properties of the sensor, 
the surface coating and the liquid in contact, thus changes in the viscoelastic properties of the 
sensor surface are reflected as changes in the decay rate of the oscillation, which is related to the 
dissipation of the oscillating energy (Figure 3.14). The amplitude of oscillation, A, decays as an 
exponentially damped sinusoidal: 
 
𝐴(𝑡) = 𝐴0𝑒
−𝑡
𝜏⁄ sin (2𝜋𝑓 +𝜙), 𝑡 ≥ 0     (3.19)  
 
where, A0 is the amplitude at t=0, τ is the decay time constant and ϕ is the phase. Thus, f and τ can 
be calculated through this equation by recording the amplitude of oscillation over time. The 
dissipation factor, D, which is dimensionless and calculated using Equation 3.20, reflects the 
viscoelastic characteristics of the sensor surface and changes in viscoelasticity are expressed by a 
shift in energy dissipation, ΔD, (in 10-6).Simultaneous monitoring of frequency and dissipation thus 
enables the mechanical nature of the deposited film, i.e. rigid or soft to be determined, as well 
revealing structural changes of an adsorbed layer, for example, as a result of conformational shifts 
of absorbed antibodies, enzymes or DNA due to molecular binding or changes in the pH of the 
buffer. 
 
𝐷 =
1
𝜋𝑓𝜏
     (3.20)  
 
A thin, rigid film couples to the oscillation of the sensor and the shear wave exhibits low energy 
dissipation, whereas a softer, more elastic film will not completely follow the oscillation of the 
crystal, but experiences further deformation, resulting in increased dissipation (Figures 3.14 and 
3.15) [61]. Consequently, considering that the Sauerbrey model does not account for viscoelasticity 
or adsorbed water, when ΔD > 0 the measured frequency shift is not directly proportional to the 
change in mass, leading to misestimates of the deposited mass [148]. Several investigators have 
presented models to quantify mass changes with respect to the viscoelastic properties of soft and 
thick layers [149]. However, for very small dissipation shifts (ΔD<1-2×10-6), the molecular film 
can still be considered a hard, non-elastic layer, and a D/f ratio greater than 1/30 is commonly used 
as practical rule of thumb for deciding when the Sauerbrey model is suitable for estimating the 
adsorbed mass [145] [150].  
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potentiostat and using a specially designed electrochemical flow cell, where the gold surface of the 
electrode facing the solution is used as the working electrode [154]. The combination of these 
techniques enables several parameters in the same molecular system to be studied in one 
instrument, such as mass and structure of deposited films by QCM-D and interfacial charge transfer 
and electrostatic interactions between adsorbed molecules by electrochemical measurements, such 
as cyclic voltammetry.  
 
QCM-D has been used in a wide range of applications in several areas, such as food, environmental 
and clinical analysis, and for a broad spectrum of analytes, from large biomolecules (e.g. DNA, 
antibodies, enzymes) to smaller molecules (such as pharmaceuticals or contaminants), lipids or 
even whole cells [142]. Critically, it is a valuable tool for immunosensing as it provides real-time, 
label-free, in situ monitoring of biomolecular interactions, thus allowing kinetics analysis of 
binding reactions. It has also been used widely to characterise and optimise antibody 
immobilisation approaches, which is a key element to the development of immunosensors [144]. 
However, QCM-D’s accuracy and application for analytical purposes is limited by a few factors. 
Firstly, as the resonant frequency depends on density and viscosity, it can be significantly affected 
by temperature variations. While a temperature-controlled QCM-D measurement chamber is 
simple to implement in a laboratory instrument, the temperature sensitivity can be challenging for 
portable QCM-D based biosensors for environmental monitoring in the field. Other limiting factors 
are mounting stresses on the sensor or pressure waves caused by the fluidic pumps. These, 
however, can be overcome by careful handling and selection of an appropriate pump and tubing 
[145]. Moreover, the application of this technology in routine analysis is faced with cost 
limitations, since instrument, accessories and sensors are expensive, whilst the re-usability of 
sensors is limited and usually decreases the accuracy of the measurement [144]. Finally, the 
accuracy in mass determination can be affected by the model used to convert frequency changes to 
mass [133]. Further research on instrument design and materials can potentially improve 
performance and overcome most limitations, so as to incorporate this technique in biosensor 
technology for faster, rapid and on site monitoring. Nonetheless, QCM-D is a very useful tool for 
immunosensing and studying antigen-antibody binding reactions and is thus increasingly used by 
researchers.    
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3.5 Introduction to FT-IR Spectroscopy (PM-IRRAS ) 
 
IR spectroscopy is used widely for structural determination of compounds by measuring the 
absorption of light in the infrared region. A beam of IR light passing through a sample causes 
vibrational excitations of covalently bonded atoms in a molecule (Figure 3.16). Each type of bond 
in the molecule vibrates at different frequencies and will thus absorb electromagnetic energy at this 
specific frequency, resulting in an absorbance spectrum that is characteristic of the studied 
molecule [155].  
 
 
Figure 3.16: Examples of vibrational modes for linear and non-linear molecules (adapted from [11] [155] [156]. 
 
FT-IR spectrometers are used routinely for compound identification and are preferred over the 
conventional, double-beam dispersive IR spectrometers, due to their higher speed and signal-to-
noise ratio. The main feature of an FT-IR instrument is the interferometer, typically in the 
Michelson configuration, which consists of a beamsplitter, a fixed mirror and a moving mirror 
(Figure 3.17). The energy generated by an IR source (usually a SiC element heated above 1000 K) 
reaches the beamsplitter and is split into two beams. One beam is reflected towards the fixed mirror 
and the other one is transmitted to the moving mirror. The latter moves back and forth with a 
constant velocity, so that the reflected light has a variable path length. The two beams reflected 
from each mirror are recombined at the beamsplitter, where they interfere either constructively or 
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destructively with each other due to the difference in path length, creating an interferogram. The 
recombined beam passes through the sample, where a portion of energy is absorbed while the 
transmitted light is sent to the detector. A computer connected to the detector transforms the 
interferogram to an IR spectrum by applying a mathematical function called a Fourier transform. 
The sample spectrum is ratioed to a background spectrum by measuring a reference sample in order 
to produce a transmittance spectrum (%T) as a function of frequency in wavenumbers (cm
-1
). An 
absorbance spectrum can be also obtained by taking the log10 of the reciprocal of transmittance 
[157]. Typically, FT-IR measurements are performed under vacuum, so as to eliminate spectral 
contributions from atmospheric background, such as water vapour or carbon dioxide.  
 
 
 
Figure 3.17: Layout of the Michelson interferomeneter (adapted from [36] [158] and [159]). 
 
Infrared Reflection-Absorption Spectroscopy (IRRAS) is an application of FT-IR to characterise 
the chemical composition and conformation of molecular layers adsorbed onto metallic surfaces. In 
IRRAS, the light beam impinges onto the surface at a grazing angle of incidence and the reflected 
light is detected at the same angle. At this angle, the incident light interacts with the adsorbed 
molecules on the surface causing vibrational excitations that absorb energy at certain, characteristic 
frequencies. The transmitted beam is then reflected by the metal substrate and directed into the 
detector and, following Fourier transformation, presented as reflectance vs frequency. The main 
advantages of this approach are that measurements can be made at ambient pressure, instead of 
under vacuum, and also, a wide variety of substrates can be used. However, the thin-layered sample 
has significantly fewer molecules compared to a sample in a conventional FT-IR transmittance 
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measurement, which can severely affect the signal-to-noise ratio. In addition, the weak signal can 
be often suppressed by the vibrational bands of atmospheric water vapour, resulting in a poor 
signal-to-noise ratio. Moreover, a background spectrum requires an absolutely clean substrate, but 
the purity of the surface can be often compromised by interaction with the ambient atmosphere. 
Furthermore, alignment sensitivity and instrument drift can make it challenging to obtain a sample 
spectrum free of baseline artefacts [160].  
 
 
Figure 3.18: Schematic illustration of s- and p- polarised light on a reflective surface, where the electric field is 
wave is perpendicular or parallel to the plane of incidence, respectively. IR active vibrational modes are only those 
that produce electric dipole shifts parallel to the surface normal, so that only p-polarised light is effectively 
interacting with the surface molecules, in contrast to the s-polarised light (adapted from [159] and [161]).  
 
Polarisation modulation-infrared reflection-absorption spectroscopy (PM-IRRAS) is an alternative 
approach that can overcome these challenges. This method relies on the selective interaction of 
different polarisation states of light with the thin film on the metal surface (Figure 3.18). The IR 
beam generated by an FT-IR spectrometer is passed through a polariser and a photoelastic 
modulator (PEM) that generates alternating states of s- and p-polarised light. At a high grazing 
incidence angle (~80º), the intensity of the electric field of p-polarised IR light is enhanced, due to 
constructive interference of the waves of the incident and reflected rays at the interface. 
Consequently, the interaction with the thin film is enhanced, and so is the IR absorption by the 
molecular layer on the surface, which allows the p-polarised IR reflectance spectrum of very thin 
layers of adsorbed species to be observed. In contrast, the electric field of s-polarised light at this 
incident angle is practically cancelled so that the interaction with the sample is negligible and 
essentially no absorption occurs. Thus, the reflected s-polarised light can provide the IR reflectance 
spectrum of the metal surface. By exploiting this simple selection rule for absorption of IR 
radiation at the surface (p-polarised light is enhanced, s-polarised light is cancelled) and switching 
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from one polarisation state to another, the spectrum of the molecular layer and the background can 
be obtained in a single measurement of the same sample. Hence, the issues concerning signal 
intensity and suppression by atmospheric interferences can be easily overcome and the sensitivity 
is significantly increased [159] [160]. 
 
 
Figure 3.19: PM-IRRAS optical setup (adapted from [160] and [162]).  
 
For a PM-IRRAS measurement, an IR beam is generated by an FT-IR spectrometer and, as shown 
in Figure 3.19 is focused by a parabolic mirror so that it impinges on the sample surface at a high 
incidence angle (~75º-80º). Before reaching the sample, the beam is polarised by a mid-infrared 
(MIR) wire grid polariser which consists of a closely spaced grid of metal wires on a ZnSe 
substrate. Next, the polarised light reaches the PEM, which is tilted at an angle of 45° to the 
transmission axis of the polariser. The PEM consists of a ZnSe crystal attached to a piezoelectric 
transducer (PZET) which is forced to oscillate at its resonant frequency (usually at 37 or 50 KHz) 
by an applied voltage. The oscillation of the piezoelectric transducer alternately stretches or 
compresses the ZnSe crystal, which induces birefringence shifts of the material. The alternating 
birefringence of the crystal refracts the incoming polarised light at different speeds so that during 
each PEM cycle the refracted light alternates polarisation states from parallel to perpendicular to 
the transmission axis. These polarisation states shift at a frequency twice that of the PEM 
oscillation. Finally, the polarisation modulated IR beam reaches the metallic surface of the sample, 
where the s- and p-polarised light interact with the surface and adsorbed molecules, and the 
reflected light is focused onto the detector by an MIR lens (usually a ZnSe lens). The detector is a 
mercury-cadmium-telluride (MCT) type detector, that is typically used for detection in the mid-IR 
region [160-163].  
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Chapter 4  
 
Investigating Affimer Interactions with Small 
Molecules: Methylene Blue Exemplar 
 
4.1 Overview 
 
Affimer selection required the target to be immobilised by crosslinking the target with a long 
oligoethyleneglycol-biotin linker (Appendix A). Similarly, the study of Affimer-target interactions 
and the development of a competition binding assay required the immobilisation of the target on a 
sensor surface. This was achieved through self-assembled monolayers (SAMs) of long-chained 
alkanethiols (LCAT) containing an analyte-labelled oligoethylene glycol component (OEG). 
Methylene blue (Figure 4.1a) was selected as a proof-of-principle analyte for this study and the 
solid-phase synthesis of LCAT−OEG−MB, also referred to as MB SAM (Figure 4.1b), was 
performed following the protocol described by Murray et al. [119].  
 
Prior to proceeding with Affimer-target binding studies, it is essential to 1) demonstrate that the 
LCAT−OEG−MB assembles into a stable, well-ordered molecular monolayer and 2) assess 
whether the attachment of a long-chained linker and the subsequent surface immobilisation affects 
the properties and behaviour of the target. The redox properties of MB were exploited in order to 
answer these questions. For this purpose, gold electrodes were functionalised with MB SAM and 
the redox activity characterised using cyclic voltammetry as a function of pH (the redox activity of 
MB is dependent on local proton concentration).  
 
Furthermore, electrochemical measurements (both CV and EIS) were used to provide insight into 
the structure of the MB SAM. This was complemented by spectroscopic characterisation (PM-
IRRAS) which revealed details of molecular structuring within the MB SAM. Critically, the bulky 
MB terminal groups of the MB SAM were found to influence the structure of the SAM. Additional 
monolayers formed by co-immobilisation of LCAT−OEG−MB with a dilutant were thus also 
investigated. Here, an OH-terminated LCAT-OEG (also referred to as OH SAM) was used to form 
mixed SAMs of LCAT-OEG-MB and LCAT-OEG-OH (also referred to as MB:OH SAM). Both 
mixed and pure MB SAMs were compared and characterised through CV, EIS and PM-IRRAS.  
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Finally, interactions between MB-Affimers and surface immobilised MB were studied using QCM-
D. The use of QCM-D also enabled the effect of Affimer binding on the redox activity of MB to be 
investigated in situ through electrochemical QCM-D (EQCM-D). The affinity constant, KD, of MB-
Affimers was measured through both saturation binding and kinetics measurements in the QCM-D, 
while the selectivity of the Affimers for its target in complex matrixes was demonstrated using 
limnetic samples. Finally, the potential of Affimers as bioreceptors in immunoassays for the 
detection of small-sized, non-immunogenic compounds was demonstrated by an Affimer-based 
competition assay in the QCM-D.  
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4.2 Characterisation of LCAT-OEG-MB SAMs  
 
4.2.1 Materials  
 
LCAT-OEG-MB and LCAT-OEG-NH2 (Figure 4.1b and 4.1c) were synthesised using solid-phase 
synthesis as described in Murray et al. [119] (Figure 4.2 and Appendix B) and stored in ethanol at 
1 mM concentration (-18 
o
C). All chemicals for LCAT-OEG-MB synthesis were purchased from 
Sigma-Aldrich (Gillingham, UK), unless noted otherwise. 29-mercapto-3,6,9,12,15,18-
hexaoxanonacosan-1-ol, referred to here as LCAT-OEG-OH (Figure 4.1d), was purchased from 
Prochimia Surfaces (Gdansk, Poland). Methylene blue chloride was purchased from Acros 
Organics (Geel, Belgium) and 1-dodecanethiol 98% (Figure 4.1e) was purchased from Sigma-
Aldrich (Gillingham, UK). All buffers and solutions were prepared using ultrapure water (18.2 
MΩ·cm, Milli-Q systems, Millipore) and the pH was measured using a pH meter (Mettler-Toledo, 
Switzerland). 
 
 
Figure 4.1: a) methylene blue, b) LCAT-OEG-MB c) LCAT-OEG-NH2, d) LCAT-OEG-OH and e) 1-
dodecanethiol.  
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Figure 4.2: Schematic of the solid phase synthesis of LCAT-OEG-MB adapted from Murray et al. [119]: a) 
preparation of amino-OEG (12), b) Solid phase synthesis of MB-terminated LCAT–OEG on 2-chlorotrityl 
chloride resin, using N-(carboxypropyl)methylene blue (5), (Appendix A). Abbreviations: DCM=dichloromethane; 
DIC=diisopropylcarbodiimide; DIPEA=N,N-diisopropylethylamine; DMAP=4-dimethylaminopyridine; 
DMF=N,N-dimethylformamide; HOBt=1-hydroxybenzotriazole; TES=triethylsilane; TFA=trifluoroacetic acid; 
Ts=4-toluenesulfonyl.  
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4.2.2 Target immobilisation on Au-coated substrates 
 
Planar gold surfaces, fabricated by electron beam evaporation of 25 nm Ti/100 nm Au onto a 
cleaned Si wafer (IDB technologies, Wiltshire, UK), were functionalised with single-species or 
mixed LCAT-OEG monolayers. Prior to functionalisation, the wafers were cleaved to 
approximately 10 by 20 mm and cleaned by immersion in piranha solution (H2SO4:H2O2 70:30) for 
10 min, followed by sonication in water, then ethanol for 10 min each and finally, dried with N2 
gas. (Note: Extreme caution must be taken when handling piranha solution, since it is strongly 
acidic and a strong oxidiser).  
 
Pure LCAT-OEG SAMs were formed by immersion of the gold surfaces in a 0.1 mM ethanolic 
solution of the corresponding compound for 48 hours. The mixed MB:OH SAM was prepared 
using a mixture of 0.1 mM LCAT-OEG-MB and 0.1 mM LCAT-OEG-OH in ethanol at a 1:3 ratio 
(v/v). Pure LCAT-OEG-OH (Figure 4.1d) and 1-dodecanethiol (Figure 4.1e) SAMs were formed 
following the same approach and were used as references in PM-IRRAS (referred to as OH SAM 
and C12 SAM respectively). After incubation, the functionalised substrates were gently rinsed with 
ethanol and dried with N2 gas. 
 
4.2.3 Cyclic voltammetry and electrochemical impedance spectroscopy 
 
The SAM-functionalised, gold-coated substrates were used as the working electrode and mounted 
in a three electrode electrochemical cell that included a Pt counter electrode and a Ag/AgCl 
(saturated KCl) reference electrode. Contact to the working electrode was achieved using a spring 
loaded pin connector. A Viton O-ring defined the surface area exposed to the electrolyte which was 
equal to 9.1 mm
2
. EIS and CV measurements were performed using a Bio Logic SP-300 
potentiostat (Berkshire, UK). All measurements, excluding those for pH dependency studies, were 
performed in 100 mM sodium phosphate buffer pH 7 (PB 7). 
 
For pH dependency studies, McIlvaine buffers ranging from pH 2.2 to 8.0 were prepared by mixing 
different ratios of 0.1 M citric acid and 0.2 M Na2HPO4, as described by McIlvaine [164].  
Moreover, a series of electrolytes covering a pH range from 4 to 12 were prepared, by mixing 
appropriate quantities of 0.04 M CH3COOH, 0.04 M H3PO4, 0.04 M H3BO3, and adjusting with 0.2 
M NaOH, as described in Britton and Robinson [165]. Each buffer was introduced to the SAM-
functionalised gold electrode by pipetting 400 μL of it into the electrochemical cell. Following each 
measurement, the electrode was rinsed with ultrapure water and dried with N2 gas. The order of CV 
measurements began at neutral solutions and moved gradually to higher, and then lower pH values, 
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since highly acidic or alkaline conditions can potentially cause the SAMs to deteriorate. The 
voltage range of the measurements was kept within -0.3V to +0.1V, again to minimise damage to 
the SAM via desorption of the thiol group or damage to the electrode surface. CV measurements 
were performed at different scan rates, ranging from 50 mV/s to 10,000 mV/s.  
 
For EIS measurements, the impedance and phase angle were measured over the frequency range of 
200 kHz to 0.1 Hz at a 10 mV DC potential vs reference electrode Ag/AgCl and an AC potential of 
10 mV.  
 
4.2.4 Polarisation modulated - infrared reflection absorption 
spectroscopy 
 
For PM-IRRAS measurements, Au-coated Si wafers were cleaved to 20 by 30 mm and 
functionalised with SAMs analogously to Section 4.2.2. Infrared spectra of the LCAT-OEG SAMs 
assembled on the gold surfaces were acquired using a Bruker Vertex70 spectrometer (Bruker UK 
Ltd, Coventry, UK) coupled with a PMA50 polarisation modulation unit. The incident angle was 
set at 80
o
 with a 4 cm
-1
 spectral resolution, while the PEM controller operated at 1000 cm
-1
. 
Average measurement time was 15 min, collecting 1000 scans. As reference, 1-dodecanethiol 
SAMs (referred to as C12 SAM) were prepared using the same immobilisation approach as for 
LCAT-OEG SAMs. 
 
4.2.5 Quartz crystal microbalance with dissipation monitoring coupled 
with electrochemicstry (EQCM-D) 
 
Frequency and dissipation were measured in McIlvaine buffers of different pH, initially on a bare 
gold QCM-D sensor surface and then on an MB-LCAT-OEG SAM-functionalised sensor. The 
QCM-D measurements were combined with cyclic voltammetry (EQCM-D), in order to 
demonstrate that the pH dependency was due to the redox activity of the MB SAM rather than 
conformational changes in the monolayer. The pH dependency of the MB SAM redox reaction was 
investigated by comparing the shifts in frequency and dissipation as a function of pH before and 
after functionalisation of the MB SAM.   
 
Gold coated QCM-D sensors (QSX 301, Biolin Scientific, Stockholm, Sweden) were cleaned by 
sonication in a 2% Hellmanex III solution (Hellma Analytics, Müllheim, Germany) and thorough 
rinsing in ultrapure water, followed by UV-ozone treatment (30 min) and immersion in EtOH (30 
min). McIlvaine buffers ranging from pH 5 to pH 8 were prepared as described by McIlvaine [164]. 
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A broader pH range was avoided to ensure the integrity of the SAM and the QCM-D sensors and 
fluidics.  
 
The cleaned sensors were mounted into the QCM-D flow modules (QSense E4, QFM 401, Biolin 
Scientific, Stockholm, Sweden). The surface area exposed to solution was equal to 0.95 cm
2
 as 
defined by a Viton O-ring (inner diameter 1.11 cm). EQCM-D was performed using a QEM 401 
electrochemistry module (Biolin Scientific, Stockholm, Sweden) which includes a stainless steel 
counter electrode, a low leak Ag/AgCl reference electrode and a contact to the working electrode, 
here a gold coated electrochemical QCM-D sensor (QSX-338, Biolin Scientific, Stockholm, 
Sweden). Electrochemical measurements were performed using a Bio Logic SP-200 potentiostat 
(Berkshire, UK).  
 
The resonant frequency (F) and dissipation (D) were monitored while ultrapure water was passed 
over the sensors using a peristaltic pump at a flow rate of 20 μL/min, until a steady baseline was 
achieved (defined by a frequency shift of less than 1 Hz over 10 minutes). Next, the frequency and 
dissipation were monitored over time as the sensors were exposed to the pH buffers using ultrapure 
water for the intermediate washing steps. Then, a 0.02 mM solution of LCAT-OEG-MB in 
ultrapure water was injected at a 20 μL/min flow rate for approximately 45 min until the frequency 
reached a plateau. The sensors were then washed with ultrapure water for approximately 20 mins 
and then exposed to each pH buffer solution in turn for approximately 25 mins. Before switching to 
the next pH buffer, the peristaltic pump was paused for 5 min and cyclic voltammetry was 
performed at a low scan rate of 100 mV/s and over a [-0.3V; +0.1V] voltage range.  
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4.3 Results 
 
4.3.1 Redox activity of MB in LCAT-OEG-MB SAMs on Au surfaces 
 
In Sections 4.3.1 and 4.3.2, the LCAT-OEG-MB SAM on Au surfaces was studied through CV and 
QCM-D in order to characterise the molecular monolayer structure and properties, and investigate 
whether the attachment of a long-chained linker and the subsequent surface immobilisation affects 
the properties and behaviour of the target (here, the redox activity of MB).  
 
 
Figure 4.3: Cyclic voltamogramm of 0.2 mM MB SAM at 100 mV/s scan rate in McIlvaine buffer pH 7. Arrows 
indicate the charging (or capacitive) current, ich.  
 
Figure 4.3 shows a cyclic voltammogram of the MB SAM in McIlvaine buffer pH 7 at 100 mV/s 
scan rate. Both peaks are fairly symmetric, (ipa/ipc = 1.24), and show minimum peak separation, 
ΔEp = 1.90 mV, which is typical of an ideal and reversible redox active monolayer that is well 
tethered to the surface (Section 3.3.1). In addition, the formal potential, E
o
, was found to be -
144.35 mV, (E
0
= Epa+Epc / 2), which is consistent with previous studies of MB electrochemistry 
with alkanethiol-SAMs or DNA monolayers [119] [130] [166]. The full width at half maximum 
(FWHM)
8
 of the oxidation and reduction peaks was found to be 81.36 mV and 76.55 mV 
respectively. Both values are larger than the theoretical ideal (45.3 mV) for a two electron process 
                                                          
8
 The full-width at half of the peak maximum height (Chapter 3, Figure 3.6) 
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(Figure 4.5), but such deviations are often observed in redox active monolayers and are attributed 
to electrostatic interactions between neighbouring charged species [126]. The charging (or 
capacitive) current was extracted from the cyclic voltammogram (Figure 4.3) and used to determine 
the capacitance of the SAM through Equation 3.7. Specifically, the ich of the MB SAM is found to 
be 0.845 × 10
-4
 mA, leading to a capacitance of: 
 
𝐶𝐷𝐿 =
𝑖𝑐ℎ
𝑣
=
0.845 × 10−4 𝑚𝐴
100 𝑚𝑉𝑠−1
= 0.845 ×  10−6 𝐹 
 
The capacitance per unit area is often used for comparison to other SAMs. Here, the surface area of 
the electrode was 0.091 cm
2
., thus, the capacitance per unit area was equal to 9.3 × 10
-6
 F/cm
2
, 
which compares well with previous reports on alkanethiol SAMs, suggesting that the SAM forms a 
dense, well-packed monolayer [132] [167]. The calculated capacitance was used to estimate the 
thickness of the monolayer using Equation 3.8. The relative permittivity of molecular monolayers 
is typically assumed to be in the range 2-20 [168] and a value of 10 was used here.  
 
𝑑 = 𝜀0𝜀𝑟
𝐴
𝐶𝐷𝐿
=  8.85419𝐹/𝑚 × 10−12 ∙ 10
0.091 𝑐𝑚2
0.845 ×  10−6 𝐹
= 0.95 𝑛𝑚 
 
This value is slightly lower than the typical theoretical range of 1-3 nm [120]; however, it should 
be noted that due to the unknown true value of the relative permittivity, an arbitrary value has been 
used. Such deviations are not uncommon for monolayers with very long chains [126], especially 
considering the interference of the hydrophilic OEG layer that affects the ordered and dense 
packing of the monolayers.  
 
The surface coverage of the MB SAM was calculated by plotting the peak anodic and cathodic 
current, ipa and ipc, against the scan rate (Figure 4.4a), and fitting the slope in Equation 3.3 (Section 
3.3.1). The slope  
𝑖𝑝𝑎
𝑣
  was found to be 5.21 × 10-6 sA/V, so by rearranging Equation 3.3, the 
surface coverage, Γ, is:  
 
𝛤 =
𝑖𝑝𝑎
𝑣
4𝑅𝑇
𝑛2𝐹2𝐴
=  5.21 × 10−6𝐴 𝑠/𝑉 ∙
4 ∙ 8.314472 𝐽 /𝐾 𝑚𝑜𝑙 ∙ 293.15 𝐾
22 ∙  (96,485.3365 𝑠𝐴/𝑚𝑜𝑙)2 ∙ 0.0908𝑐𝑚2
 
 
𝛤 = 1.5 × 10−11 𝑚𝑜𝑙𝑒𝑠/𝑐𝑚2  
 
𝛤 = 9.05 × 1012 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠/𝑐𝑚2 
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This value is lower than the predicted theoretical density for an ideal LCAT SAM (4.5×10
14
 
molecules/cm
2
). This difference is attributed to the amorphous structure of the OEG layer and the 
steric hindrance caused by the bulky MB groups that affect packing of the monolayer [121][126]. 
Nonetheless, the peak current exhibits an approximately linear relationship with increasing scan 
rate, which is typical of an ideal, reversible process of a surface-immobilised redox system and 
demonstrates that MB is well-tethered to the gold substrate [126].  
 
 
Figure 4.4: a) Peak current vs scan rate from CVs of 0.2 mM MB SAM in McIlvaine buffer pH 7. The slope of the 
fitted plot is used to determine the surface coverage of the monolayer; b) Laviron plot of the same MB SAM in 
McIlvaine buffer at pH 7. The linear regions at higher scan rates have been fitted to calculate the rate of electron 
transfer,  𝒌𝑬𝑻. 
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As shown in Figure 4.4b, the oxidation and reduction peak potentials, Epa and Epc, have similar 
values at low scan rates. However, as the scan rate increases, diffusion of ions and protons to the 
MB groups affects the rate of the redox reaction so that larger overpotentials are required for 
charge transfer, and as a result, peak separation is observed. The kinetics of the redox reaction can 
be assessed by plotting Epa and Epc against the logarithm of the scan rate and the Laviron method is 
used to determine the rate of electron transfer, 𝑘𝐸𝑇, as described in Section 3.3.1. 
 
The slope and intercept of each branch (corresponding to the oxidation and reduction reactions) 
were determined by fitting the linear regions observed at high scan rates. These values allow 
calculation of the transfer coefficient, α, and the rate of electron transfer, kET. The calculated 
values, summarised in Table 4.1, are consistent with previous studies on redox-coupled long-
chained alkanethiol monolayers on gold surfaces [169]. It should be noted that the accuracy of the 
Laviron method is reduced for densely packed monolayers, such as those studied here. 
Nevertheless these findings demonstrate that MB retains its redox activity when labelled and 
immobilised on a gold surface through an LCAT-OEG SAM. The symmetry and shape of the 
peaks, the very low peak splitting, the linear relationship between peak current and scan rate, as 
well as the thickness and surface coverage demonstrate that the LCAT-OEG-MB SAMs were well 
tethered to the surface, formed a dense and well-packed monolayer and the MB groups exhibited an 
ideal and reversible electrochemical behaviour of a two electron process.  
 
 Epa Epc 
Slope (mV) 90.035 -69.552 
Intercept (mV) -410.074 57.13292 
α  0.323 -0.42 
kET (s
-1
) 10.501 -1.889 
Table 4.1: Fitting data from Laviron plots, the estimated transfer coefficient, a, and the rate of electron transfer, 
 𝒌𝑬𝑻 
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4.3.2 Investigating pH dependency of LCAT-OEG-MB SAM (CV, 
EQCM-D) 
 
The two electron redox reaction of MB is proton dependent (Figure 4.5), therefore pH changes are 
expected to affect this process [34] [170]. To explore whether this pH dependency is retained in the 
surface-immobilised MB, the redox response of LCAT-OEG-MB SAM at different pHs was 
measured through cyclic voltammetry and QCM-D.  
 
 
Figure 4.5: Redox reaction of methylene blue in solution [119] 
 
Cyclic voltammogramms of LCAT-OEG-MB SAMs (on Au-coated silicon wafers) in McIlvaine 
buffers ranging from pH 5 to pH 8 revealed a decreasing shift in potential with increasing pH 
(Figure 4.6a), as expected for a proton-dependent redox reaction. This effect was also examined 
over a broader pH range using Britton-Robinson buffers ranging from pH 4 to pH 12. The rate of 
potential shift with proton concentration was determined by plotting the peak potential as a 
function of pH (Figure 4.6b). Both Epa and Epc were found to shift by around -33 mV/pH, which is 
very close to the predicted value of -29 mV/pH for a 2e
-
, 1H
+
 process [171]. It should be noted that 
highly acidic or alkaline conditions were found to affect the reversibility of the MB redox process 
and had a damaging impact on the SAM.  
 
In near-neutral pH conditions, the peak current exhibited an approximately linear relationship with 
scan rate (Figure 4.7a), as expected for surface-immobilised redox systems (Equation 3.3). This 
linearity is based on the assumption that, since the electroactive species are adsorbed on the 
electrode surface (via SAMs), diffusion is not a limiting parameter of the redox reaction. This is 
true for slow scan rates, where the solution species involved in the redox reaction (here, electrons 
and protons) have enough time to diffuse to the SAM-modified electrode surface [126] [128]. In 
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faster scan rates, however, the potential is swept faster than the solution species can reach the 
electrode surface, thus diffusion becomes a rate-limiting step. This is reflected in the peak potential 
splitting observed with higher scan rates (Figure 4.7b). Diffusion is also dependent on the 
concentration of the solution species, and, therefore, is dependent on the proton concentration of 
the solution. Consequently, at extremes of pH, a deviation from the expected linearity between 
peak current and scan rate is observed.  
 
 
Figure 4.6: a) Cyclic voltamogramms of 0.2 mM MB SAM at 100 mV/s scan rate in different pH values of 
McIlvaine buffer; b) peak potential plotted as a function of pH of 0.2 mM MB SAM using Britton-Robinson 
buffers from pH 4 to pH 12. The slope of the fitted lines are used to determine the rate of potential shifts with pH. 
Insert shows the corresponding cyclic voltammograms for each pH.  
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Figure 4.7: Oxidation and reduction peak current plotted against the scan rate and b) Laviron plots of CVs of 0.2 
mM MB SAM in different pH values of McIlvaine buffer. The linear regions at higher scan rates of the Laviron 
plots have been fitted to calculate the rate of electron transfer, 𝒌𝐄𝐓, for each pH (here shown only for the pH 2.1 
plot).  
 
The rate of electron transfer as a function of pH, calculated using the Laviron method (Figure 
4.7b), was found to decrease at lower pH (Figure 4.8a), indicating that the rate of protonation and 
de-protonation of the redox group affect the kinetics of the reaction. In a proton-coupled electron 
transfer process (PCET), electron transfer occurs separately from proton transfer [171] [172], and 
consequently, intermediate forms exist between the fully oxidised or reduced forms (Figure 4.8b). 
At low pH, however, proton transfer is expected to precede electron transfer. As a result, the 
protonated intermediate will prevail, especially at fast scan rates, and the increased concentration of 
protons will impede the complete re-oxidation of the molecule. This sluggishness of the electron 
transfer rate with decreasing pH was indeed observed here, as seen in (Figure 4.8a). These findings 
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demonstrate that the redox reaction of the MB-terminal groups of the LCAT-OEG SAM follows a 
proton-coupled electron transfer process, thus demonstrating that MB retains its redox behaviour 
following immobilisation.  
 
 
Figure 4. 8: a) Rate of electron transfer as a function of pH for the oxidation and reduction of MB SAM; b) 
schematic of the redox forms of MB for a 2e-/1H+ process, including intermediate forms of the partially oxidised 
molecule [170]. 
 
While the electrochemical studies are indicative of a proton dependent redox-reaction, it is 
important to demonstrate that the observed pH dependency is indeed a result of the change in the 
electron transfer kinetics rather than conformational changes of the monolayer caused by shifts in 
pH. EQCM-D was thus used to study the structural properties of the MB SAM by comparing the 
frequency and dissipation shifts as a function of pH before and after functionalisation of the MB 
SAM, while performing electrochemical measurements.  
 
Figure 4.9a illustrates the changes in frequency and dissipation as a gold-coated QCM-D sensor is 
challenged with different pH buffers (McIlvaine buffers pH 5-8). D3, D5 and D7 represent the 
third, fifth and seventh dissipation overtones respectively, while F3 corresponds to the third 
frequency overtone. The introduction of a pH 5 McIlvaine buffer resulted in a decrease in 
frequency from the ultrapure water baseline and a corresponding increase in dissipation. When the 
sensor was washed with ultrapure water both frequency and dissipation returned to their original 
values. As the buffer pH increased, the frequency shifts became larger, as seen in Figures 4.9a and 
4.9d, where the frequency shifts in each buffer were normalised to that of pH 7. Both D5 and D7 
exhibited a stepwise increase with rising pH, whereas D3 showed a less linear pattern (Figures 
4.9e-g).  
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Figure 4.9: Shifts in frequency, Δf, and dissipation, ΔD, over time as a result of a) injection of 100 mM McIlvaine 
buffers pH 5-8 over the bare gold surface of the QCM-D sensor, b) functionalisation of QCM-D sensor with 0.02 
mM MB SAM in ultrapure water and c) injection of 100 mM McIlvaine buffers pH 5-8 over the SAM-
functionalised sensor; (blue: F3, third frequency overtone); (orange: D3, red: D5, burgundy: D7 third, fifth and 
seventh dissipation overtone, respectively). Shifts in d) F3, e) D3, f) D5 and g) D7 as a function of buffer pH. Each 
shift was normalised to the shift corresponding to McIlvaine buffer pH 7.  
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The characteristics of the solution, such as density, viscosity or conductivity, have a significant 
effect on the oscillating frequency of a quartz crystal in contact with liquid [144] [147]. 
Consequently, the introduction of each pH buffer will induce a frequency shift and a corresponding 
change in the dissipation of the oscillating energy, according to the properties of each solution. 
Here, for instance, the increasing density of the McIlvaine buffers (in order of rising pH), caused a 
corresponding increase in dissipation, as seen in Figures 4.9a and 4.9e-g. 
 
Following exposure to the pH buffers, the sensor was then challenged with a 0.1 M aqueous 
solution of LCAT-OEG-MB. Figure 4.8b shows the gradual decrease in frequency as the MB-SAM 
assembled onto the QCM-D sensor, while dissipation increased over time as the viscoelastic 
properties of the crystal changed due to formation of the monolayer.  
 
The distance above the surface where the energy of the oscillation dissipates is inversely dependent 
on the frequency [148]. Therefore, dissipation shifts for the higher order frequency harmonics, D5 
and D7, are expected to be more sensitive to the viscoelasticity of the near surface region of the 
layer (here, the rigid LCAT region), while the energy of the lower order harmonic, D3, dissipates 
further away from the surface and thus describes the viscoelastic properties of the upper parts of the 
layer (amorphous OEG phase).  
 
Following SAM assembly, each pH buffer was again introduced into the QCM-D flow cell (Figure 
4.9c). Both frequency and dissipation follow a similar trend to that of the sensor before 
functionalisation, as seen in Figures 4.9d-g, which indicates that the conformation of the monolayer 
is not affected significantly by different pH conditions. 
 
Cyclic voltammograms (100 mV/s) of the MB SAM-functionalised EQMC-D sensor are shown as 
a function of buffer pH in Figure 4.10. Similarly to the CVs of the MB SAM on Au-Si substrates 
(Section 4.3.1), the peaks are highly symmetric with minimum peak separation, which correspond 
to the reversibility of the redox system. The peak potential decreased with changing pH and the 
potential shift rates were close to the predicted value of -29 mV/pH for a 2e
-
, 1H
+
 process (insert, 
Figure 4.10).  
 
By linking the findings from QCM-D measurements with CV data of the MB SAM, it can be 
concluded that the pH dependency of the MB SAM redox response is due to the influence of the 
local proton concentration on the redox reaction kinetics, rather than conformational changes of the 
monolayer. Therefore, the redox process of the MB attached to the LCAT-OEG SAM is indeed 
dependent on the pH conditions and follows a 2e
-
, 1H
+
 process. 
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Figure 4.10: Cyclic voltamogramms of 0.02 mM MB SAM at 100 mV/s scan rate in different pH values of 100 mM 
McIlvaine buffer. Insert shows the CV peak potentials plotted as a function of pH. The slopes of the fitted lines 
correspond to the potential shift rates with increasing pH.  
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4.3.3 Mixed and pure MB SAMs: comparison by CV, EIS and PM-
IRRAS 
 
In this section, electrochemical (CV, EIS) and spectroscopic (PM-IRRAS) techniques were used to 
assess the differences between pure and mixed MB SAMs. In the previous sections (4.3.1, 4.3.2), 
CV and QCM-D measurements of the MB SAM showed that MB retains its redox properties after 
immobilisation through a long-chained OEG linker. The observed redox activity showed a pH 
dependency, which demonstrates that the redox reaction is a 2e
-
, 1H
+
 redox process, as expected of 
MB. These findings support the use of LCAT-OEG-MB SAMs for studying biomolecular 
interactions of MB-Affimers with surface-immobilised MB. However, the redox-active and bulky 
MB groups can interfere with the orderly packing of the monolayer and potentially inhibit access of 
the Affimer to the MB. Co-immobilisation with an appropriate SAM dilutant can reduce these 
effects. It is important, however, that the selected SAM dilutant does not exhibit non-specific 
binding with Affimers or other reagents present in a sample. An OH-terminated LCAT-OEG was 
selected for this purpose (Figure 4.1d), due to its excellent protein resistance properties [118] [127] 
[173].  
 
 
Figure 4.11: Real-time QCM-D showing shifts in the resonant frequency (third harmonic, F3) as a function of 
time; here, the sensors were functionalised with OH or NH2 SAM and challenged with 2.3 μg/mL MB−Aff5 in PB 
7. Inset shows bar charts of frequency shifts of OH and NH2 SAM vs MB-Aff5 (four nominally identical QCM-D 
measurements for each SAM).    
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To verify the reduced bio-fouling property of LCAT-OEG-OH SAMs (referred to as OH SAM), its 
QCM-D response to Affimers was compared to that of a NH2-terminated LCAT-OEG SAM 
(referred to as NH2 SAM). Figure 4.11 shows the frequency shifts of OH and NH2 SAM-
functionalised QCM-D sensors challenged with 2.3 μg/mL Affimer solutions in PB 7. The OH 
SAM exhibits considerably lower non-specific binding than the NH2 SAM, thus demonstrating its 
suitability as a dilutant of the MB SAM. 
 
 
Figure 4.12: a) Cyclic voltammograms (250 mV/s) and b) Bode impedance of MB and mixed MB:OH (1:3) SAMs 
in PB 7.  
 
Mixed MB:OH SAMs were formed by co-immobilisation of LCAT-OEG-MB and mixed with 
LCAT-OEG-OH at a 1:3 ratio and CV, EIS and PM-IRRAS were used to compare the resulting 
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monolayers to undiluted MB SAMs . Cyclic voltammograms of MB and mixed MB:OH SAMs at 
250 mV/s scan rate in 100 mM sodium phosphate buffer pH 7 are shown in Figure 4.12a. As 
expected for ideal and reversible surface-immobilised redox systems, both monolayers exhibit 
highly symmetric oxidation and reduction peaks with very little peak splitting. The oxidation and 
reduction peak current of the mixed SAM is lower than that of the pure LCAT-OEG-MB SAM, 
which is attributed to the dilution of redox groups in the mixed monolayer. 
 
When assessed by EIS, both SAMs seem to form well-packed films, as demonstrated by Bode plots 
in Figure 4.12b. Here, the slope of log|Z| vs log(frequency) at low frequencies was close to -1 
(MB:OH: -0.975, R
2
=0.999; DCF: -0.883, R
2
=0.999), thus approaching ideal capacitor behaviour. 
This behaviour is associated with densely-packed monolayers with good insulating properties 
[174]. At 0.1 Hz, the minimum phase angle for the MB SAM was -69.95º. In constrast, the phase 
angle of the mixed MB:OH SAM (-81.93º) approached closer to the phase angle of an ideal 
capacitor (-90°). The lower phase angle of the mixed SAM corresponds to a dense, highly 
insulating monolayer that is almost free of pinholes and defects [126], signifying that dilution of 
the bulky redox centres improved the orderly packing of the monolayer. 
 
Both MB SAM and MB:OH SAM were further characterised using PM-IRRAS which provides 
deeper insight into the conformation differences between the two monolayers. A pure OH SAM 
(100% LCAT-OEG-OH) and a 1-dodecanethiol SAM (referred to as C12 SAM) were also used and 
acted as references. Figure 4.13a shows the IR absorption spectra of the four SAMs. The C12 SAM 
exhibited well-defined IR absorption peaks at 2919 cm
-1
, 2851 cm
-1
, 2963 cm
-1
 and 2877 cm
-1
. 
These are associated with the CH3 and CH2 symmetric (vs) and asymmetric stretch (va) bands and 
are typical for a tightly-packed, highly crystalline alkanethiol SAM with all-trans alkyl chains and 
very little gauche defects (va CH2 2919 cm
-1
 , vs CH2 2851 cm
-1
, va CH3 2963 cm
-1
, vs CH3 2877 cm
-
1
) [127] [175] [176]. The va CH2 stretch in particular, is an indicator of the crystallinity of the 
molecular film [175-178]. This peak (at 2919 cm
-1
) was also present in the data from all the LCAT-
OEG SAMs which shows the existence of a well-packed, all-trans LCAT component under the 
OEG layer. 
 
Absorption peaks associated with the conformation of the OEG component are contained within 
the fingerprint region between 900-1800 cm
-1
 (Figure 4.13b). Specifically, the peaks at 1348, 1244, 
1114 and 964 cm
-1
 which were observed for both the OH and MB:OH SAMs, are distinctive of a 
helical conformation of the OEG component [176]. The band at 1114 cm
-1
 in particular, appeared 
as an intense and sharp peak for the OH SAM and MB:OH SAM. This peak is characteristic of 
asymmetric C-O-C stretching and the high intensity reveals the high degree of crystallinity of the 
OEG layer where the OEG helices are orientated almost parallel to the surface normal [127] [178]. 
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Moreover, the sharp, intense peak at 1348 cm
-1
 is typical of the CH2 wagging mode of a helical 
OEG. It is worth noting that the detection of several short peaks and/or shoulders (such as ~1124 or 
~1080 cm
-1
) indicates the existence of regions with less ordered, amorphous-like OEG domains. 
This suggests that while both the OH and MB:OH SAMs are mostly ordered with a high degree of 
helical OEG conformation, regions of amorphous OEG occur. 
 
 
Figure 4.13: PM-IRRAS spectra of LCAT-OEG and alkanethiol SAMs on gold, showing a) the CH stretch region 
(2750-3100 cm-1) and b) the fingerprint region (900-1800 cm-1). The spectra have been stacked and presented with 
the y-axis expanded, to make it easier to see the relevant peaks. 
 
In contrast, the C-O-C stretch region for the MB SAM appears as a broad band with short peaks in 
the IR spectrum (at 1080, 1100, 1148, and 1137 cm
-1
) corresponding to a mainly amorphous OEG 
conformation that is less ordered than the OH and MB:OH SAMs [127] [177]. Moreover, the CH2 
wagging mode characteristic of helical OEG (at 1348 cm
-1
), appeared as a weak doublet at ~1360 
and 1340 cm
-1
, indicative of a more amorphous conformation. In addition, unlike the MB and 
MB:OH SAMs, the IR absorption peak of the CH2 twisting mode of a helical OEG layer (at 1244 
cm
-1
) was weak for the MB SAM [176] [179]. The reduced ordering of the OEG phase in MB-
terminated SAMs can also be observed in the CH2 stretch region (Figure 4.13a). Here, a 2930 cm
-1
 
shoulder (va CH2 stretch of an amorphous OEG phase) was seen in the IR spectra of MB and 
99 
 
MB:OH SAMs, indicating a higher ratio of amorphous to helical OEG conformation in these MB-
terminated SAMs compared to the pure OH SAM. Moreover, the band associated with the vs CH2 
stretch of helical OEG chains (2891 cm
-1
) was clearly observed for the OH SAM, but was less 
intense for the MB:OH SAM and absent for the MB SAM. The fact that the amorphous phase is 
more dominant in SAMs containing a component of LCAT-OEG-MB is attributed to the steric 
hindrance caused by the bulky MB units that interfere with the ordered packing of the OEG layer. 
The differences in helical to amorphous OEG ratio between the MB SAM and the mixed MB:OH 
SAM accounts for the differences in the EIS spectra of these molecular monolayers shown in 
Figure 4.12b. 
 
These findings suggest that dilution of the MB SAM with LCAT-OEG-OH can improve the order 
and packing of the SAM by reducing the steric hindrance effects of the redox-active MB tail 
groups. Consequently, by forming mixed MB:OH SAMs, the target is immobilised through a well-
ordered monolayer that enables efficient access by the Affimers. Therefore, this immobilisation 
approach was followed for studying biomolecular interactions of MB-Affimers with surface 
immobilised MB.   
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4.4 QCM-D monitoring of MB-Affimer interactions with 
surface-immobilised MB 
 
The previous section showed that a) MB retains its redox activity when immobilised on a surface 
through self-assembled monolayers on gold and b) dilution of the LCAT-OEG-MB with LCAT-
OEG-OH improved the structure of the monolayer. This approach to analyte immobilisation was 
thus employed to study biomolecular interactions of surface-immobilised MB with MB-Affimers. 
LCAT-OEG-OH was used as a control SAM to monitor potential non-specific interaction of 
Affimers with the surface and as a SAM dilutant to separate the bulky redox MB tail groups. Here, 
QCM-D was used to investigate the kinetics, affinity and selectivity of MB-Affimers for their 
target and demonstrate the possibility of operation in a competition assay format.   
  
4.4.1 Methods 
 
Gold coated QCM-D sensors (QSX 301, Biolin Scientific, Stockholm, Sweden) were cleaned by 
sonication in a 2% Hellmanex III solution (Hellma Analytics, Müllheim, Germany) and thorough 
rinsing in ultrapure water, followed by UV-ozone treatment (30 min) and immersion in EtOH (30 
min). Cleaned sensors were functionalised with LCAT-OEG SAMs (mixed MB:OH 1:3 ratio or 
OH SAM) by immersion in 0.1 mM ethanolic solutions for 48 hours.  
 
Following fuctionalisation, the sensors were rinsed in EtOH, dried with N2 gas and loaded into the 
QCM-D flow modules (QSense E4, QFM 401, Biolin Scientific, Stockholm, Sweden). The surface 
area exposed to solution was equal to 0.95 cm
2
 as defined by a Viton O-ring. Resonant frequency 
(F) and dissipation (D) were monitored while ultrapure water was passed over the sensors using a 
peristaltic pump at a flow rate of 20 μL/min, until a steady baseline was achieved (defined by a 
frequency shift of less than 1 Hz over 10 minutes), followed by injection of PB 7 to establish a 
running buffer baseline. Next, MB-Affimer solutions (either MB-Aff1 or MB-Aff5) in PB 7 were 
introduced at 20 μL/min flow rate until the frequency saturated. Affimers raised against green 
fluorescent protein (GFP) were used as controls (referred to as GFP-Aff). Finally, the sensors were 
washed with PB 7. For binding kinetics measurements, the flow rate was set at 10 μL/min.  
 
Affimer binding was also interrogated electrochemically (EQCM-D). Cyclic voltammetry was 
performed at a scan rate of 100 mV/s and over a [-0.3V; +0.1V] voltage range.  
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To study the selectivity of MB-Affimers (that is, the ability to recognise MB among the 
interferences in a complex sample), limnetic water samples were collected (Heslington, York, UK), 
syringe-filtered through a 0.22 μM sterile filter unit (Millex, Millipore, Cork, Ireland) and used as a 
running solvent in QCM-D measurements (measured pH 8.17 ± 0.01). The limnetic samples were 
spiked with MB-Aff5 (or GFP-Aff as control) and injected over a MB SAM-functionalised QCM-
D sensor.  
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4.5 Results 
 
4.5.1 Interactions of MB-Affimer with MB (QCM-D/EQCM-D) 
 
QCM-D and EQCM-D were used to explore molecular interactions between MB-Affimers and MB 
immobilised on the surface via the mixed MB:OH SAM. MB-Aff5 demonstrated significantly 
higher levels of expression than MB-Aff1 (Appendix A) and was thus taken forward for in-depth 
analysis. However, the affinity of MB-Aff1 was also investigated through kinetics and saturation 
binding measurements using QCM-D (Section 4.5.2).  
 
 
Figure 4.14: Real-time QCM-D showing shifts in the resonant frequency (third harmonic, F3) and dissipation (D3) 
as a function of time; here, the sensors were functionalised with MB:OH SAM and challenged with 4.5 μg/mL 
MB−Aff5  in PB 7 
 
Real-time QCM-D data following exposure of a mixed MB:OH SAM (1:3) to a 4.5 μg/mL 
MB−Aff5 solution are shown in Figure 4.14. The interaction of MB−Aff5 with MB lead to a 
significant decrease in the resonant frequency of the quartz sensor as a result of the increase in the 
mass deposited on the surface (the third harmonic (F3) is shown here). The average frequency shift 
due to MB−Aff5 binding was −29.54 ± 2.11 Hz (from six nominally identical measurements). 
These ΔF values indicate a strong interaction between MB-Aff5 and the MB immobilised on the 
sensor surface. In vacuum, the resonant frequency of QCM-D is related to the mass loading of the 
crystal according to the Sauerbrey model, Δm=−CΔf/n, (Section 3.4, Equation 3.15 [61]). This 
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corresponds to an estimated deposited mass of 174.31 ± 12.44 ng/cm
2
 and translates to a surface 
coverage of (8.47 ± 0.6) × 10
12
 molecules/cm
2
 for a 12.4 kDa Affimer. Although, the Sauerbrey 
model does not account for the viscoelasticity of the layer, here the dissipation shift was 
sufficiently low (ΔD < 0.5 × 10−6) to assume a dense, rigid film that couples to the oscillation of the 
quartz crystal. However, it should be noted that, in the liquid phase, the resonant frequency is 
sensitive to a number of solution and interfacial factors, as described by Kanazawa and Gordon 
[147] so the actual mass loading can differ from that estimated by Sauerbrey.  
 
 
Figure 4.15: Real-time QCM-D showing changes in the resonant frequency (third harmonic, F3) and dissipation 
(D3) as a function of time. QCM-D sensors functionalised with (a) mixed MB:OH SAM and challenged with 4 
μg/mL GFP−Aff in PB 7 and  (b) 100% OH SAM and challenged with 4.5 μg/mL MB−Aff5.  
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To account for non-specific interactions of Affimers with the monolayer or the sensor surface, the 
mixed MB:OH SAM was also challenged with to GFP-Aff (control Affimer). As seen in Figure 
4.15a, the frequency shift in the presence of GFP-Aff was insignificant compared to that of MB-
Aff5 (Figure 4.14) and quickly recovered following rinsing in PB 7, thus demonstrating that MB-
Aff5 showed specific binding to MB. The specificity of the interaction between MB and MB-Aff5 
was further investigated by exposure of a 100% OH SAM to MB-Aff5 solution. As shown in 
Figure 4.15b, the resonant frequency remained constant. The absence of interaction between 
MB−Aff5 and the OH SAM is consistent with the demonstrated antifouling properties of the OEG 
region (Section 4.3.3).  
 
Interactions between MB-Aff5 and the surface-immobilised MB were also observed by monitoring 
the redox activity of MB in the monolayer. Figure 4.16 shows cyclic voltammograms of an 
MB:OH SAM-functionalised EQCM-D sensor before and after exposure to MB-Aff5. Here, 
binding of Affimers on the SAM limits the access of ions and/or protons from solution to the 
electrode, resulting in a reduction in the peak oxidation and reduction currents (ipa and ipc). The 
reduction in peak current was found to be dependent on MB-Aff5 concentration, suggesting the 
potential for electrochemical detection and quantification of Affimer binding to redox-active 
targets. 
 
 
Figure 4.16: Cyclic voltammograms (100 mV/s) of a MB:OH SAM-functionalised EQCM-D sensor challenged 
with  0, 1, and 10 μg/mL MB−Aff5 in PB 7.  
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4.5.2 MB-Affimer affinity: saturation binding and binding kinetics 
 
An MB:OH SAM-functionalised QCM-D sensor was exposed to increasing concentrations of MB−
Aff5 or MB-Aff1 and monitored by QCM-D in order to calculate the Affimer binding affinity. 
Figures 4.17a and 4.18a show the third harmonic of the sensor resonant frequency as a function of 
time during exposure to MB-Aff1 or MB-Aff5 respectively from 1 to 10 μg/mL (PB 7 was injected 
between samples to remove non-specifically bound material). As the Affimer concentration 
increased, the frequency shifts became larger, peaking around 4 μg/mL for MB-Aff5 and 6 μg/mL 
for MB-Aff1. The response then saturated at a concentration around 8 μg/mL. The frequency shift 
was plotted as a function of concentration (Figures 4.17b and 4.18b) and fitted to a Hill-Langmuir 
isotherm, (Equation 4.1).  
 
     𝑌 =
𝐵𝑚𝑎𝑥∙𝐶
ℎ
𝐾𝐷
ℎ+ 𝐶ℎ
     (4.1) 
 
Here, Bmax is the maximum response, C is the Affimer concentration (nM), h is the Hill slope, and 
KD is the dissociation constant [180]. The value of the Hill slope reveals information regarding the 
number of binding sites of the receptor, so that a Hill slope of ~1 corresponds to monomeric (one-
site) binding, whereas a slope of ~2 to dimeric binding (cooperative). Here, the Hill slope was 
found to be 1.36 for MB-Aff1 and 2.36 for MB-Aff5 (Table 4.2); the latter implies the possibility 
of two-site binding. It should be noted, however, that the Hill model assumes that the binding 
reaction under investigation has reached equilibrium, which in these QCM-D experiments was not 
attained within the injection time of reagent at each Affimer concentration. Consequently, the Hill 
slope values estimated here cannot provide an accurate determination of the number of sites used in 
Affimer binding.   
 
The saturation binding data were also fitted using a standard Langmuir isotherm (Equation 4.2), but 
due to its poor fitting (Figures 4.17b and 4.18b), the Hill-Langmuir model was preferred for 
estimating the dissociation constant, KD. For MB-Aff5, the KD was found to be 216.4 nM, 
comparable to previously reported values for antibodies of small molecules (10
-10
-10
-7
 M) [48] 
[181] [182]. The KD of MB-Aff1 was 444.4 nM.  
 
     𝑌 =
𝐵𝑚𝑎𝑥∙C
𝐾𝐷+ C
     (4.2) 
 
 
106 
 
 
Figure 4.17: a) MB-Aff1 saturation binding: real-time QCM-D of resonant frequency shifts Δf (third harmonic) of 
MB:OH SAM-functionalised sensors during introduction of increasing concentrations of MB-Aff1 (in PB7); b) 
Frequency shifts plotted against Affimer concentration (red line shows Hill-Langmuir fit, dotted line shows 
Langmuir fit); c) MB-Aff1 binding kinetics: real-time QCM-D of frequency shift of MB:OH SAM-functionalised 
sensors during injection of 4 μg/mL (322 nM) MB−Aff1 at 10 μL/min flow rate. Red line shows association-
dissociation fitting curves.  
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Figure 4.18: a) MB-Aff5 saturation binding: real-time QCM-D of resonant frequency shifts Δf (third harmonic) of 
MB:OH SAM-functionalised sensors during introduction of increasing concentrations of MB-Aff5 (in PB7); b) 
Frequency shifts plotted against Affimer concentration (red line shows Hill-Langmuir fit, dotted line shows 
Langmuir fit); c) MB-Aff5 binding kinetics: real-time QCM-D of frequency shift of MB:OH SAM-functionalised 
sensors during injection of 8 μg/mL (645 nM) MB−Aff5 at 10 μL/min flow rate. Red line shows association-
dissociation fitting curves. 
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Affinity parameter MB-Aff1 MB-Aff5 
KDsat (nM) 444.4 (R
2
=0.993) 216.4 (R2=0.991) 
Bmax-sat (Hz) 59.65 20.20 
h 1.36 2.36 
KDkin (nM) 1.41 (R
2
=0.998) 13.70 (R
2
=0.989) 
kon (M
-1
min
-1
) 7.2×10
4
 4.1×10
4
 
koff (min
-1
) 1.0×10
-4
 5.6×10
-4
 
Bmax-kin (Hz) 52.00 17.50 
Table 4.2: Affinity parameters of MB-Aff1 and MB-Aff5, as estimated by saturation binding (Hill-Langmuir 
model) and binding kinetics measurements using QCM-D (Figures 4.17 and 4.18).  
 
To study the kinetics of the binding reaction, MB-Aff1 or MB-Aff5 were injected over an MB:OH 
SAM-functionalised QCM-D sensor at a flow rate of 10 μL/min and the frequency shift was 
measured as a function of time (Figure 4.17c and 4.18c respectively). The data were fitted using 
Equations 4.3 and 4.4. The rates of association (kon) and dissociation (koff) for MB-Aff5 were found 
to be 4.1 × 10
4
 M−
1
 min−
1
 and 4.6 × 10−
4
 min−
1
, respectively (Table 4.2). Since KD = koff/kon, this 
yielded a dissociation constant of 13.7 nM for MB-Aff5, which is one order of magnitude lower 
than that calculated by saturation binding analysis. This discrepancy between kinetic and saturation 
binding analysis is not uncommon, since, in the latter case, equilibrium is usually not reached 
within the injection time of reagent at each concentration, which leads to overestimates of the KD. 
Thus, the dissociation constant calculated by kinetic analysis is expected to be closer to the true 
affinity of the binder than the dissociation constant estimated by saturation binding measurements 
[180]. The KD of MB-Aff1 was found to be one order of magnitude lower than MB-Aff5 (1.41 
nM). However, considering the significantly higher expression levels of MB-Aff5, the latter was 
selected for the remaining study of MB Affimers. 
  
  Association = (
𝐵𝑚𝑎𝑥∙𝐶
𝐾D+𝐶
)(1 − 𝑒−𝑘𝑜𝑏𝑠∙𝑡)    (4.3)  
 
Where kobs is the observed rate constant of the association reaction: Kobs = kon·C + koff 
      
 Dissociation = 𝑌0 ∙ 𝑒
−𝑘𝑜𝑓𝑓∙(𝑡−𝑡0)    (4.4)  
 
Where Bmax is the maximum binding at equilibrium with maximum concentration of Affimer, C is 
the Affimer concentration, t0 is the time at which dissociation was initiated and Y0 is Y at time=t0 
(Y corresponds to response signal, here ΔF) [180] [183].   
109 
 
4.5.3 Selectivity of MB-Affimers in a complex matrix 
 
 
Figure 4.19: a) Real-time QCM-D and b) bar charts of shifts in the resonant frequency (third harmonic, F3) of 
MB:OH SAM-functionalised sensors during introduction of 300 nM MB-Aff5 in limnetic water samples. Unspiked 
limnetic samples (lake water is graphs) were used as blank, and 300 nM GFP-Aff in the same matrix was used as a 
control. It should be noted that the limnetic water samples were syringe-filtered through a 0.2 μM filter unit.  
 
For environmental monitoring it is necessary that Affimers show high selectivity, that is, the ability 
to recognise their target among the interferences in a complex matrix, such as surface water 
samples. The selectivity of MB−Aff5 was studied using limnetic samples as the running solvent in 
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QCM-D measurements. Here, following filtration through 0.2 μM, the limnetic samples were 
spiked with MB-Aff5 (or GFP-Aff as a control) and injected to MB:OH SAM-functionalised 
sensors. As shown in Figure 4.19, a significant decrease in frequency was observed following 
exposure of the MB:OH SAM-functionalised QCM-D sensor surface to the limnetic sample spiked 
with MB-Aff5. The shift in frequency was 1.5 times greater than that observed following exposure 
of the same SAM to a blank limnetic sample (i.e., unspiked). This difference suggests that, despite 
the potentially interfering components in the sample, the MB−Aff5 binders were still able to 
effectively bind to MB. This was further supported by the QCM-D response of a limnetic sample 
spiked with the GFP-Aff control binders. Here, the frequency shift observed for the GFP-Aff was 
similar to that of the blank sample, indicating that the MB-Aff5 indeed binds to the surface-
immobilised MB rather than to the interfering components of the background.  
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4.5.4 MB-Aff5 competition assay (QCM-D) 
 
Competition assay formats are usually the most appropriate for small-sized targets (Section 2.2.1). 
The potential of MB-Aff5 binders for analyte detection in competition format was thus assessed 
using QCM-D. A mixture of 1:100 MB-Aff5:MB in PB 7 was injected over a mixed MB:OH 
SAM. A second MB:OH SAM-functionalised sensor was treated with a solution containing only 
MB-Aff5 in order to compare the two signals and investigate the degree of competition between 
surface-bound MB and free MB for MB-Aff5 binding sites. As seen in Figure 4.20, the QCM-D 
response from the MB-Aff5:MB mixture was 7 times lower than that of the MB-Aff5 baseline, 
revealing considerable interactions of MB-Aff5 with free MB which competed with that of the 
surface-bound MB. Notably, the injection of a solution of MB at 30 μM in the same buffer yielded 
no response, showing the absence of nonspecific interactions between the monolayer and free MB. 
 
 
 
Figure 4.20: Comparison of QCM-D response (third harmonic, F3) between a MB-Aff5 solution and a 1:100 
mixture of MB-Aff5 and MB injected over MB:OH SAM-functionalised sensors. As a control, the QCM-D 
response to a 30 μM MB solution was measured. 
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Figure 4.21: a) MB-Aff5 competition assay format showing QCM-D response (third harmonic, F3) during 
injection of MB-Aff5 and MB mixture, followed by injection of MB−Aff5 (400 nM) until saturation; b) Calibration 
curve of MB−Aff5 competition QCM-D assay. For each measurement, the first plateau (MB Sample) was 
normalised to the second plateau (Total) so that (sample/total)% was plotted as a function of MB concentration. 
 
For the construction of a calibration curve, the degree of competition at different MB 
concentrations was measured through a two-step QCM-D experiment (Figure 4.21a). First, a pre-
mixed sample of MB and MB-Aff5 was injected over a mixed 1:3 MB:OH SAM-functionalised 
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sensor. The sample was allowed to flow over the surface until the resonant frequency reached a 
plateau, at which point a solution containing only MB-Aff5 at the same concentration as in the 
mixture was introduced until a second plateau was reached, corresponding to a surface fully 
saturated with MB-Aff5. The first plateau (Sample) was then normalised to the second (Total, i.e. 
saturated). The process was repeated for a range of different MB concentrations in order to 
construct a standard curve (Figure 4.21b). Here, (Sample/Total)% was plotted as a function of MB 
concentration and fitted using a four parameter logistic (4PL) curve, typical for concentration-
response data in competition assays (Equation 4.5):  
 
   𝑌 = 𝑏𝑜𝑡𝑡𝑜𝑚 +
(𝑡𝑜𝑝−𝑏𝑜𝑡𝑡𝑜𝑚)
(1+10((log(𝐼𝐶50−𝑋)
𝑠𝑙𝑜𝑝𝑒
)
    (4.5) 
 
where, X is the competitor (MB) concentration, Y is the response, bottom is the response at infinite 
competitor concentration (lower plateau), top is the response in the absence of competitor (upper 
plateau), slope refers to the steepness of the curve (here, assuming one-site specific binding, the 
slope was set to a constant value of -1). IC50 (inhibitory concentration) is the concentration of 
competitor causing 50% inhibition of binding (i.e. 50% inhibition of MB-Aff5 binding to MB 
SAM due to free MB in solution) [48] [184] [185], and was found to be 1.17 μΜ. Finally, the 
detection limit (here, estimated from the lowest point of the linear range of the curve [186] was 
found to be 360 nM. Both the IC50 and the detection limit are higher than those reported in the 
literature regarding competition assays for detection of small molecules [48] [181] [187].  
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4.6 Conclusions 
 
In this chapter, the potential of Affimers for detection of small organic molecules was evaluated 
using MB, a redox-active dye as a target compound. Detection of small-sized targets through 
immunoassays typically requires surface immobilisation. For this purpose, MB-terminated LCAT-
OEGs were synthesised and used to form SAMs on the gold surfaces of sensors. The potential 
effects of labelling and surface immobilisation on the redox properties of MB were elucidated 
using CV and QCM-D, which demonstrated that MB retained its redox activity in the SAM, 
following the expected 2e
-
, 1H
+
 process. The immobilisation protocol was optimised by forming 
mixed SAMs with an appropriate dilutant (LCAT-OEG-OH), so as to reduce non-specific binding, 
increase order and dense packing of the monolayer and improve exposure of MB groups for 
Affimer binding. The mixed MB:OH SAMs were compared with pure MB SAMs using PM-
IRRAS, CV and EIS, which showed that SAM dilution enabled surface immobilisation through a 
dense, well-ordered monolayer where the target was efficiently presented for biomolecular 
interactions with Affimers, and thus this immobilisation approach was selected for binding studies 
with MB Affimers.  
 
The binding affinity of Aff1 and Aff5 was investigated via QCM-D measurements of MB:OH 
SAM-functionalised sensors. The dissociation constant, KD, was estimated through saturation 
binding measurements and was found in the upper nanomolar region for both MB-Aff1 and MB-
Aff5. Additionally, the KD was estimated by studying the kinetics of the binding reaction in the 
QCM-D and was in the lower nanomolar region. These KD values are comparable with those of 
high affinity antibodies [188] [189]. Notably, control QCM-D measurements (using either MB 
Affimers on OH SAMs or GFP-Affimers on MB:OH SAMs) ruled out non-specific binding. 
Critically, for environmental applications it is important to assess the performance of Affimers in 
the complexity of surface water samples; QCM-D measurements using Affimer-spiked limnetic 
samples revealed that MB-Aff5 showed very good selectivity for MB despite the complex matrix.  
 
Competition formats are typically used for detection of small-sized targets in immunoassays. The 
potential for an Affimer-based competition assay was demonstrated using QMC-D. Here, the 
QCM-D response of MB-Affimer and MB mixtures was compared to that of MB-Affimer samples 
only, and considerable competition from solution-MB with surface-MB was observed.  It is worth 
mentioning that the fact that the MB in solution competed with the surface-bound MB reveals that 
although the Affimers were selected using carboxypropyl-MB, the Affimer binding sites 
recognised the target, i.e. MB. 
 
115 
 
Finally, the degree of competition by different MB concentrations was measured in order to 
construct a calibration curve. The limit of detection (360 nM; 128 μg/L) was in the upper 
nanomolar region. While this is higher than the environmentally relevant concentrations (ng/L to 
μg/L) detected by antibody-based ELISAs for small molecules [48] [181] it should be noted that 
sensitivity in the QCM-D is limited at low concentrations [145] and that the presented assay is 
preliminary and unoptimised, aiming to demonstrate the potential of Affimers for competition 
assays. For the development of an Affimer-based assay or biosensor, other techniques and 
transduction methods should be considered, such as ELISA, SPR, reflectometric, impedimetric, 
etc., that are more amenable to miniaturisation. Moreover, further study would be required to 
improve performance, looking, for instance, at altering the length of the LCAT-OEG linkers or 
ratio of the LCAT-OEG-MB and LCAT-OEG-OH dilutant, working out the optimal concentrations 
of Affimer and surface-immobilised target or investigating sample pre-concentration approaches.  
 
Although preliminary and unoptimised, these results from QCM-D measurements clearly 
demonstrate that the in vitro selected, small and robust Affimers can bind to small-sized, non-
immunogenic targets as strongly as antibodies (Section 4.5.2) and with high selectivity (Section 
4.5.3). Using MB as a proof-of-principle target, these findings showcase the high potential of 
Affimer technology to contribute in faster and cost-efficient assay development for applications 
across the breadth of diagnostics and environmental monitoring.  
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Chapter 5  
 
Investigating Affimer Interactions with 
Diclofenac 
 
5.1 Overview 
 
In Chapter 4, the ability of Affimers to bind to small, organic molecules was demonstrated using 
methylene blue as a model target compound. This chapter is focused on Affimers selected against 
an emerging environmental contaminant, diclofenac (DCF), and their potential as bioreceptors in 
Affimer-based assays.  
 
Interactions between DCF and the DCF-Affimers were studied initially using QCM-D. Here,  
immobilisation of the DCF target on gold-coated, QCM-D sensors was achieved via a SAM of 
DCF-terminated LCAT-OEG (LCAT-OEG-DCF), similar to the LCAT-OEG-MB SAMs used in 
Chapter 4. Prior to QCM-D measurements, the LCAT-OEG-DCF monolayers (also referred to as 
DCF SAMs) were characterised by EIS and PM-IRRAS.  
 
Affimer binding was also assessed using an ELISA protocol developed by BSTG. Here, 
biotinylated-DCF (Appendix A) was immobilised on streptavidin-coated surfaces and the binding 
of DCF-Affimers was detected using an anti-His tag antibody conjugated with horseradish 
peroxidase (HRP). This ELISA was used to estimate the affinity constant, KD, of DCF-Affimers 
through saturation binding measurements. Finally, the ELISA protocol was adapted in order to 
evaluate the potential of DCF-Affimers for use in competition assay formats.  
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5.2 Characterisation of LCAT-OEG-DCF SAMs (EIS, PM-
IRRAS) 
 
5.2.1 Materials  
 
LCAT-OEG-DCF was synthesised by PhD student Jacob Hauser, School of Chemistry, University 
of Leeds, by adapting the solid-phase synthesis protocol described in Murray et al. [119]. An 
overview of the synthesis of LCAT-OEG-DCF is provided below (Figure 5.1). The product was 
stored in ethanol at 1 mM concentration (-18 
o
C). Diclofenac sodium and 1-dodecanethiol 98% 
were purchased from Sigma-Aldrich (Gillingham, UK). 29-mercapto-3,6,9,12,15,18-
hexaoxanonacosan-1-ol, referred to here as LCAT-OEG-OH (Figure 4.1d), was purchased from 
Prochimia Surfaces (Gdansk, Poland). All buffers and solutions were prepared using ultrapure 
water (18.2 MΩ·cm, Milli-Q systems, Millipore) and the pH was measured using a pH meter 
(Mettler-Toledo, Switzerland). 
 
 
Figure 5.1: Schematic of the solid-phase synthesis of the LCAT-OEG-DCF SAM (20) used to produce a SAM. The 
synthetic protocol is an adaptation from Murray et al. [119] for LCAT-OEG-MB synthesis (Section 4.2.1 and 
Appendix B).  
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5.2.2 Target immobilisation on Au-coated substrates 
 
Planar gold surfaces, fabricated by electron beam evaporation of 25 nm Ti/100 nm Au onto a 
cleaned Si wafer (IDB technologies, Wiltshire, UK), were functionalised with single-species or 
mixed LCAT-OEG monolayers. Prior to functionalisation, the wafers were cleaved to 
approximately 10 by 20 mm and cleaned by immersion in piranha solution (H2SO4:H2O2 70:30) for 
10 min, followed by sonication in water, then ethanol for 10 min each and finally, dried with N2 
gas. (Note: Extreme caution must be taken when handling piranha solution, since it is strongly 
acidic and a strong oxidiser).  
 
Pure LCAT-OEG SAMs were formed by immersion in a 0.1 mM ethanolic solution of the 
corresponding compound for 48 hours. Mixed DCF:OH SAMs were prepared using a mixture of 
0.1 mM LCAT-OEG-DCF (20) and 0.1 mM LCAT-OEG-OH in ethanol in either a 1:1 or 1:2 ratio 
(v/v). Pure LCAT-OEG-OH (Figure 4.1d) and 1-dodecanethiol (Figure 4.1e) SAMs (referred to as 
OH SAM and C12 SAM respectively) were formed following the same approach and were used as 
reference in PM-IRRAS. After incubation, the functionalised substrates were rinsed gently with 
ethanol and dried with N2 gas. 
 
5.2.3 Electrochemical impedance spectroscopy 
 
The SAM-functionalised, gold-coated substrates were used as the working electrode in a three-
electrode electrochemical cell that included a Pt counter electrode and a Ag/AgCl (saturated KCl) 
reference electrode. Contact to the working electrode was achieved using a spring loaded pin 
connector. A Viton O-ring defined the surface area exposed to the electrolyte which was equal to 
9.1 mm
2
. EIS measurements were performed using a Bio Logic SP-300 potentiostat (Berkshire, 
UK). All measurements were performed in 100 mM sodium phosphate buffer pH 7 (PB 7). The 
impedance and phase angle of each SAM-modified electrode were measured over the frequency 
range of 200 kHz to 0.1 Hz at a 10 mV DC potential vs reference electrode Ag/AgCl and an AC 
potential of 10 mV.  
 
5.2.4 Polarisation modulated - infrared reflection absorption 
spectroscopy 
 
For PM-IRRAS measurements, Au-coated Si wafers were cleaved to 20 by 30 mm and 
functionalised with SAMs analogously to Section 4.2.2. Infrared spectra of the LCAT-OEG SAMs 
assembled on the gold surfaces were acquired using a Bruker Vertex70 spectrometer coupled with 
119 
 
a PMA50 polarisation modulation unit (Bruker UK Ltd, Coventry, UK). The incident angle was set 
at 80
o
 with a 4 cm
-1
 spectral resolution, while the PEM controller operated at 1000 cm
-1
. Average 
measurement time was 15 min, corresponding to a total of 1000 scans. C12 SAMs were prepared 
using the same immobilisation approach as for LCAT-OEG SAMs and were used as a reference 
SAM. 
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5.2.5 Results 
 
The effect of diluting the LCAT-OEG-DCF with LCAT-OEG-OH to form mixed SAMs was 
investigated through EIS, by comparing the impedance and phase angle of a pure DCF SAM and 
that of a mixed DCF:OH SAM (1:2 ratio). As seen in the Bode plots of Figure 5.2, the slope of 
log|Z| vs log(frequency) at low frequencies is close to -1 for each SAM (DCF: -0.905, R
2
=0.999; 
DCF:OH: -0.925, R
2
=0.999), suggesting that both SAMs are well-packed and approach ideal 
capacitor behaviour [174]. At 0.1 Hz, the phase angle of the DCF SAM is -68.5°; however, the 
phase angle of the DCF:OH SAM is considerably lower, at -81.8°, indicating that the mixed SAM 
forms more dense and insulating monolayers [126]. This observation suggests that dilution of the 
functionalised component of the SAM improves the packing of the monolayer.  
 
 
Figure 5.2: Bode impedance of DCF and mixed DCF:OH 1:2 SAMs in PB 7 
 
The effect of diluting the DCF-SAM component on the conformation of the monolayer was also 
investigated by PM-IRRAS. Here, the pure DCF SAM was compared with mixed DCF:OH SAMs 
prepared using 1:1 and 1:2 ratios. A pure OH SAM and a C12 SAM were also measured for 
reference. As seen in Figure 5.3a, the C12 SAM showed sharp and intense IR absorption peaks at 
2919 cm
-1
, 2850 cm
-1
, 2963 cm
-1
 and CH3 2877 cm
-1
. These are attributed to the CH3 and CH2 
symmetric (vs) and asymmetric stretch (va) bands and correspond to a densely-packed, highly 
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crystalline alkanethiol SAM with all-trans alkyl chains and very little gauche defects (va CH2 2917-
2919 cm
-1
 , vs CH2 2851 cm
-1
, va CH3 2963 cm
-1
, vs CH3 2877 cm
-1
) [127] [175] [176]. The va CH2 
stretch in particular, is an indicator of the crystallinity of the molecular film [175-178]. This 
characteristic absorption peak (at 2919 cm
-1
) was also observed for all LCAT-OEG SAMs, 
indicating the formation of a well-packed, all trans LCAT phase under the OEG layer. This is in 
agreement with the high insulating properties of the DCF and DCF:OH SAMs, shown by EIS 
(Figure 6.2).  
 
 
Figure 5.3: PM-IRRAS spectra of LCAT-OEG SAMs (OH SAM, DCF-SAM, DCF:OH 1:1 SAM, DCF:OH 1:2 
SAM) and alkanethiol SAMs (C12 SAM) on gold, showing a) the CH stretch region (2750-3100 cm
-1) and b) the 
fingerprint region (900-1800 cm-1). ). The spectra have been presented with the y-axis expanded, to make it easier 
to see the relevant peaks.  
 
The fingerprint region between 900-1800 cm
-1
 (Figure 5.3b) contains the IR absorption peaks 
associated with the conformational characteristics of the OEG component of the SAM. Absorption 
peaks at 1348, 1244, 1114 and 964 cm
-1
 are distinctive and characteristic of a helical conformation 
of the OEG chains [176], and were observed as sharp, well-defined peaks for the OH SAM. The 
peak at 1114 cm
-1
, characteristic of asymmetric C-O-C stretching of helical OEGs, was particularly 
intense and sharp for the OH SAM, revealing the high degree of crystallinity of the OEG layer, 
indicating that the OEG helices are orientated almost parallel to the surface normal [178] [127]. 
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The smaller shoulder at 1125 cm
-1
 corresponds to the asymmetric C-O-C stretching of a less-
ordered, amorphous-like OEG layer [178] [190].  The helical OEG peak at 1114 cm
-1
 was also 
observed for the DCF and mixed DCF:OH SAMs, but, as the amount of DCF in the SAM 
increased, the intensity of this peak decreased, while the 1125 cm
-1
 peak of amorphous OEG chains 
became increasingly dominant. The contrast between the helical and highly crystalline character of 
the OEG layer of pure OH SAM and the amorphous nature of the DCF-terminated SAMs was 
further supported by the presence of a strong and sharp IR absorption peak at 2893 cm
-1
 for the OH 
SAM (attributed to the CH2 symmetric stretch of helical OEG chains) and its absence in the IR 
spectra of all other SAMs [127]. These observations indicate that, although all DCF-terminated 
LCAT-OEG SAMs (pure or mixed) contain regions of ordered, helical OEG layers, they are 
primarily dominated by disordered, amorphous OEG regions, and that this behaviour increases with 
the amount of DCF terminal groups in the SAM. The amorphousness of the OEG regions is 
attributed to steric hindrance between neighbouring DCF terminal groups which push the adjacent 
chains apart, preventing close packing and disrupting the helical conformation of the OEG chains.  
 
The amorphous conformation of the OEG layer of the DCF-terminated SAMs was further 
evidenced by the reduced intensity of the 1348 cm
-1
 bands corresponding to the CH2 wagging mode 
of a helical OEG, as well as by the absence of the 964 cm
-1
 peak of the helical, CH2 rocking mode 
[127] [176]. In addition, the CH2 scissoring mode of helical OEG at 1465 cm
-1
 [178] was present in 
the OH SAM, but for all SAMs containing a DCF-terminated molecule, the IR absorption peak of 
this vibrational mode appeared at slightly lower frequencies, around 1457 cm
-1
, which corresponds 
to less ordered OEG layers [178] [191].  
 
Finally, it is worth noting the amide II band (C-N-H bending mode) at 1560 cm
-1
, which is present 
in the spectra of all DCF-terminated SAMs, and more intensely in those of the pure DCF SAM, 
whilst is absent in the spectrum of OH SAM. This absorption peak is the combination of the N-H in 
plane bending and the C-N stretching vibrational modes [192]. The presence of this peak in the 
spectra of the DCF-terminated SAMs can be attributed to two sources: (i) the amide bond 
connecting the LCAT with the OEG component (no amide II band is observed for the LCAT-OEG-
OH SAM as here the LCAT is not connected to the OEG component through an amide bond) and 
(ii) the secondary amine of diclofenac. Finally, the amide I mode (C=O stretch at 1650 cm
-1
) 
associated with the carboxylic acid group of DCF is only observed in the DCF-terminated SAMs as 
a short and broad peak [176] [178] [179]. These observations show that the LCAT-OEG-DCF 
molecules successfully form SAMs on the gold surfaces, which is important for studying DCF-
Affimer interactions (here, using QCM-D), and the presence of the amide I and amide II mode 
bands in the IR spectra of the DCF-terminated SAMs demonstrates that the target has been 
successfully immobilised on the surface either as pure DCF SAMs or as mixed DCF:OH SAMs.  
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These findings show that a pure DCF SAM, although consisting of a densely packed LCAT region, 
exhibits a high degree of disorder in the OEG component. Critically, this disorder can be reduced 
by dilution of the LCAT-OEG-DCF in the SAM with LCAT-OEG-OH, which leads to an increase 
in the amount of helical OEG the SAM can accommodate, effectively improving the crystallinity 
and packing of the entire monolayer.  
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5.3 QCM-D Monitoring of DCF-Affimer Interactions with 
Surface-immobilised DCF 
 
5.3.1 Materials and methods 
 
Gold coated QCM-D sensors (QSX 301, Biolin Scientific, Stockholm, Sweden) were cleaned by 
sonication in a 2% Hellmanex III solution (Hellma Analytics, Müllheim, Germany) and thorough 
rinsing in ultrapure water, followed by UV-ozone treatment (30 min) and immersion in EtOH (30 
min). Cleaned sensors were functionalised with LCAT-OEG SAMs (mixed DCF:OH 1:2 ratio or 
OH SAM as control) by immersion in 0.1 mM ethanolic solutions for 48 hours.  
 
Following fuctionalisation, the sensors were rinsed in EtOH, dried with N2 gas and loaded into the 
QCM-D flow modules (QSense E4, QFM 401, Biolin Scientific, Stockholm, Sweden). The surface 
area exposed to solution was equal to 0.95 cm
2
 as defined by a Viton O-ring. Resonant frequency 
(F) and dissipation (D) were monitored while ultrapure water was passed over the sensors using a 
peristaltic pump at a flow rate of 20 μL/min, until a steady baseline was achieved (defined by a 
frequency shift of less than 1 Hz over 10 minutes), followed by injection of PBST to establish a 
running buffer baseline.  Next, DCF-Affimer (DCF-Aff) solutions in PBST were introduced at a 
flow rate of 20 μL/min until the frequency saturated. Affimers raised against green fluorescent 
protein (GFP-Aff) were used as non-specific binding controls. Finally, the sensors were washed 
with PBST. PBST was prepared by adding 0.1% Tween-20 (Sigma-Aldrich, Gillingham, UK) in 
phosphate buffered saline (PBS: 137 mM NaCl; 10 mM phosphate; 2.7 mM KCl; pH 7.4).  
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5.3.2 Results 
 
Figure 5.4 shows real-time QCM-D data during the exposure of a DCF:OH 1:2 SAM-
functionalised sensor to a 5 μg/mL DCF-Aff solution (corresponding to a concentration of 400 nM) 
in PBST. The interaction of DCF-Aff with DCF caused a sharp decrease in the resonant frequency 
of the quartz sensor, owing to the increase in the mass deposited on the surface (the third harmonic 
(F3) is shown here). The frequency shift due to DCF-Aff binding was −11.61 Hz, which, according 
to the Sauerbrey model (Equation 3.14, Section 3.4), corresponds to an estimated deposited mass of 
60.85 ng/cm
2
 (for a 5 MHz crystal with C = -17.7 ng/Hz∙cm2). This corresponds to a surface 
coverage of 3.3 × 10
12
 molecules/cm
2
 for a 12.4 kDa Affimer (Equation 3.16, Section 3.4). 
Notably, as DCF-Aff was introduced to the sensor, a brief increase in dissipation was observed (~ 
0.8 × 10
-6
); however, it gradually returned to baseline values. This initial increase in dissipation 
suggests that in the beginning of the interaction with DCF, the bound Affimers formed a disordered 
and viscoelastic molecular film above the monolayer. Subsequently, as the deposited mass 
continued to increase, the Affimers became more densely packed and formed a rigid layer above 
the DCF:OH SAM; thus the dissipation dropped back to baseline values (~0.0 × 10
-6
).    
 
 
Figure 5.4: Real-time QCM-D showing changes in the resonant frequency (third harmonic, F3, blue) and 
dissipation (D3, red) as a function of time. Here, QCM-D sensors were functionalised with mixed DCF:OH 1:2 
SAM and challenged with 5 μg/mL DCF−Aff (400 nM) in PBST. 
 
As a control, DCF-OH 1:2 SAM-functionalised sensors were challenged with GFP-Aff (5 μg/mL in 
PBST), which would not be expected to bind to DCF. As shown in Figure 5.5a, the shifts in 
frequency and dissipation were insignificant compared to those observed between DCF-Aff and 
DCF (Figure 5.4), consistent with the lack of binding of GFP-Aff to DCF. Non-specific binding 
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was also investigated by challenging a 100% OH SAM-functionalised QCM-D sensor surface (i.e. 
no DCF) with 5 μg/mL DCF−Aff solution (Figure 5.5b). Again, both frequency and dissipation 
shifts were insignificant, indicating an absence of substantial non-specific binding between DCF-
Aff and the LCAT-OEG SAM-functionalised QCM-D sensor surface, when DCF is not present.  
 
 
Figure 5.5: Real-time QCM-D showing changes in the resonant frequency (third harmonic, F3, blue) and 
dissipation (D3, red) as a function of time. QCM-D sensors were functionalised with a) mixed DCF:OH 1:2 SAM 
and challenged with 5 μg/mL control GFP−Aff in PBST or (b) 100% OH SAM and challenged with 5 μg/mL 
DCF−Aff in PBST.  
 
The kinetics of the binding reaction were studied by injecting a DCF-Aff solution (5 μg/mL) over a 
DCF:OH 1:2 SAM at a slower flow rate of 10 μL/min (Figure 5.6). The rates of association (kon) 
and dissociation (koff) were estimated using Equations 4.3 and 4.4 and were found to be 1.04 × 10
5
 
M−
1
 min−
1
 and 7.3 × 10−
3
 min−
1
, respectively, whilst Bmax was 11.78 Hz. The dissociation constant, 
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KD, calculated using the estimated association and dissociation rates (KD = koff/kon) was found to be 
73 nM (R
2
=0.985). This is comparable with typical values for high affinity antibodies against small 
molecules [48] [181] [193].  
 
 
Figure 5.6: DCF-Aff binding kinetics: real-time QCM-D showing frequency shift (black line: third harmonic, F3) 
of DCF:OH 1:2 SAM-functionalised sensors during injection of 5 μg/mL (400 nM) DCF−Aff in PBST at 10 
μL/min flow rate. Red line shows association−dissociation curve fit to the data and t0 indicates time at which 
dissociation was initiated.  
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5.4 DCF-Affimer ELISA 
 
5.4.1 Materials and methods 
 
An ELISA protocol developed by the BSTG  [194] was adapted in order to further characterise the 
binding reaction of DCF-Affimers to DCF and investigate the potential of diclofenac detection by 
an Affimer-based competition ELISA. ELISAs were performed in polystyrene 96-well ELISA 
microtiter plates (Maxisorp Nunc-Immuno Plate, ThermoFisher Scientific, Loughborough, UK) 
coated with streptavidin (Invitrogen, Paisley, UK) in PBS (137 mM NaCl; 10 mM phosphate; 2.7 
mM KCl; pH 7.4). Triplicates were used for each sample and three controls were carried out; a 
negative control (no immobilised target, i.e. no DCF), an Affimer blank (no DCF-Aff) and a 
specificity control (GFP-Aff). PBST (0.1% Tween-20 in PBS) was used as a washing buffer, whilst 
10x casein blocking buffer (Sigma-Aldrich, Gillingham, UK) was diluted to 2x in PBST and used 
as running buffer or blocking reagent. Anti-6x His Tag® antibody
9
 conjugated with horseradish 
peroxidase (HRP) was purchased from antibodies-online (Aachen, Germany) and 3,3’,5,5’-
tetramethylbenzidine (TMB) with hydrogen peroxide (H2O2) was used as the substrate for colour 
development (Sigma-Aldrich). The intensity of the blue coloured product was measured using a 
VersaMax ELISA Microplate Reader spectrophotometer (Molecular Devices, Berkshire, UK).  
 
First, 50 μL of 5 μg/mL of streptavidin were added to each well of the ELISA plate and incubated 
overnight at 4 °C. The following day, 2x blocking buffer was added to the streptavidin-coated wells 
(200 μL per well), incubated overnight at 37 °C and then washed with 300 μL per well of PBST. 
Biotinylated diclofenac (Appendix A) diluted in 2x blocking buffer to 5 (or 10) μg/mL, was next 
aliquoted at 50 μL per well onto the streptavidin-coated plate and incubated for 1 hour at room 
temperature (50 μL per well of 2x blocking buffer were added to the negative control wells). After 
1 hour, the plate wells were washed 3 times with 300 μL per well of PBST. Then, 5 (or 10) μg/mL 
of DCF-Aff in 2x blocking buffer (or GFP-Aff to the specificity control wells) were added to each 
well (50 μL/well), incubated for 1 hour (50 μL/well of 2x blocking buffer were added to the blank 
control wells) and were washed 3 times with 300 μL of PBST per well. Subsequently, HRP-
conjugated anti-6x His tag antibody (1 μg/mL in 2x blocking buffer) was added (50 μL/well) and 
incubated for 1 hour. Following incubation, the plate wells were washed 5 times with 300 μL per 
well of PBST. TMB and H2O2 were mixed in equal volumes and 50 μL added to each well and left 
                                                          
9
 Engineered proteins, including Affimers, are often designed to carry a string of histidine residues to their N- 
or C-terminus (here, a 6xHis string), which is used as a tag for detection of purification purposes [195]. Here, 
an anti-6xHis tag antibody is used to detect 6xHis-tagged Affimers.  
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to react for 5 minutes. Finally, the intensity of absorbance of the blue colour reaction product was 
measured at 620 nm using a microplate reader.   
 
For competition ELISAs, solutions of different concentrations of DCF (not biotinylated) in PBST 
were prepared from a 10 mM stock solution of diclofenac sodium (Sigma-Aldrich, Gillingham, 
UK) in methanol (final concentration of methanol did not exceed 0.4% v/v in all mixtures of DCF 
with DCF-Aff). The DCF solutions were mixed with DCF-Aff (0.5 μg/mL in PBST) and incubated 
for 30 min. Then, 50 μL per well of each Affimer:DCF mixture were added into the plate wells 
(previously coated with biotinylated DCF) and incubated for 1 hour, before addition of HRP-
labelled antibody.  
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5.4.2 Results 
 
The concentrations of DCF and DCF-Aff were varied in order to identify the optimum amount of 
target (biotinylated DCF) and receptor (DCF-Aff) which yielded the strongest absorbance signal. 
Figure 5.7 shows the average absorbance intensity of the TMB reaction product in each sample 
(N=6, i.e. two ELISA experiments of three replicates per sample) 5 min after substrate addition. 
Although no significant differences between the absorbance readings for the different 
concentrations were found, the combination with highest signal intensity and minimum amounts of 
reagents was 5 μg/mL of DCF-Aff with 5 μg/mL biotinylated DCF and so this combination was 
selected for all subsequent ELISA experiments. 
 
Figure 5.7: Results of DCF-Aff ELISA showing the TMB product absorbance measured by a microplate reader at 
620 nm 5 min after substrate addition. The binding of DCF-Aff to surface-immobilised diclofenac was detected 
using an HRP-conjugated anti-His tag antibody. A negative control (‘No DCF’), a blank (‘No Aff’) and a non-DCF 
Affimer (‘GFP-Aff’) were used as controls to investigate the degree of non-specific interactions. Four different 
combinations of concentrations of DCF-Aff and immobilised DCF were investigated in order to identify conditions 
that yielded the strongest signal.  
 
The degree of non-specific binding was assessed using three controls: a negative control (i.e. no 
biotinylated DCF on the surface of the wells), a blank (no addition of DCF-Aff on DCF-coated 
plate wells) and a specificity control (addition of GFP-Aff on DCF-coated plate wells). As seen in 
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Figure 5.7, all controls yielded very weak signals (~0.04 absorbance units) compared to the DCF-
Aff samples (~0.4). These results are consistent with the specificity of DCF-Aff binding to surface-
immobilised DCF using QCM-D. 
 
Next, the affinity of DCF-Aff was estimated through saturation binding measurements using the 
ELISA format described above, by adding increasing concentrations of DCF-Aff onto DCF-coated 
plate wells. As seen in Figure 5.8a, the colour intensity of the TMB reaction product increased with 
increasing DCF-Aff concentration, which ranged from 0.005 to 10 μg/mL (0.4 to 800 nM for a 12.4 
KDa Affimer). The absorbance intensity was plotted as a function of DCF-Aff concentration 
(Figure 5.8b) and the data points were fitted to a Langmuir isotherm.  
 
     𝑌 =
𝐵𝑚𝑎𝑥∙C
𝐾𝐷+ C
     (5.1) 
 
Here, Bmax is the maximum response, C is the Affimer concentration (nM) and KD is the 
dissociation constant [180] [183].  
 
The calculated KD was 37.87 nM (R
2
 = 0.978), while the Bmax was found to be 0.56 absorbance 
units. Here, the fitting of the Langmuir isotherm is very good and the estimated KD reveals very 
high binding affinity. The Langmuir model, however, assumes one-site specific binding. The 
Affimer scaffold holds two randomised peptide loops for target binding, thus, to investigate the 
possibility of dimeric (cooperative) binding, the Hill (or Hill-Langmuir) model (Equation 5.2) was 
also used to determine the number of binding sites, so as to ensure the fitness of the Langmuir 
isotherm for analysing the saturation binding curve of DCF-Aff to DCF. 
  
     𝑌 =
𝐵𝑚𝑎𝑥∙𝐶
ℎ
𝐾𝐷
ℎ+ 𝐶ℎ
     (5.2) 
 
Here, h refers to the Hill slope or Hill coefficient. Provided that the binding reaction has reached 
equilibrium, an estimated Hill slope value of 1 suggests monomeric (one-site) binding (whilst h≈2 
suggests dimeric binding) [180] [183]. Here, as seen in Figure 5.8b, the Hill fit to the DCF-Aff 
ELISA data was very good (R
2
 = 0.982), displaying a smooth, hyperbolic curve, while the Hill 
slope was found to be 1.25. The proximity of the estimated Hill slope to 1 suggests that the DCF-
Affimers exhibit one-site binding to DCF. The KD was found to be 34.56 nM, which is very close 
to that estimated by the Langmuir equation. Consequently, the simpler model of the Langmuir 
isotherm can be indeed used for describing and analysing the saturation binding curve of DCF-Aff 
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to DCF. The estimate KD is in the same range as that for high affinity antibodies [188] [189], which 
once again demonstrates that Affimers can bind very strongly to a small molecule like diclofenac.  
 
 
Figure 5.8: Saturation binding DCF-Aff ELISA: a) ELISA plate showing the TMB product (each triplicate of 
wells corresponds to different concentration of DCF-Aff on DCF-coated wells, including a blank, negative and 
specificity control); b) measured absorbance at 620 nm plotted as a function of DCF-Aff concentration (red line: 
Langmuir fitting, dotted line: Hill fitting).  
 
Having characterised the affinity of DCF Affimers, the ELISA protocol was adapted to a 
competition format. In a competition assay, free-DCF competes with the immobilised DCF 
(surface-DCF) for Affimer binding. The number of Affimers bound to surface-DCF thus decreases 
with increasing concentration of free-DCF. Following washing, only those Affimers bound to 
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surface-DCF remain in the plate wells to be detected by the HRP-conjugated antibody. 
Consequently, the absorbance signal reduces as the concentration of free-DCF is increased.  
 
 
Figure 5.9: Competition DCF-Aff ELISA: a) ELISA plate wells showing the TMB colour product (each triplicate 
of wells corresponds to different concentration of free-DCF, including a blank and negative control); b) measured 
absorbance at 620 nm plotted as a function of the logarithm of DCF concentration (red line shows 4PL curve 
fitting).  
 
The competition ELISA well plate and associated calibration curve is shown in Figure 5.9. The 
DCF-Aff competition ELISA was performed in collaboration with PhD student, Lia De Faveri, at 
the BSTG, University of Leeds. Here, the DCF-Aff concentration was 0.2 μg/mL (equivalent to 
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15.8 nM), while the free-DCF solution concentrations ranged from 16 nM to 16 μM. All materials 
were the same as described above (Section 5.4.1), save the TMB substrate (SeramunBlau® fast, 
Seramun Diagnostica GmbH, Heidesee, Germany). The data were fitted using a four parameter 
logistic (4PL) curve, Equation 5.3, which is used typically for concentration-response data in 
competition assays:  
 
   𝑌 = 𝑏𝑜𝑡𝑡𝑜𝑚 +
(𝑡𝑜𝑝−𝑏𝑜𝑡𝑡𝑜𝑚)
(1+10((log(𝐼𝐶50−𝑋)
𝑠𝑙𝑜𝑝𝑒
)
    (5.3) 
 
Here, X is the competitor (free-DCF) concentration, Y is the response, bottom is the response at 
infinite competitor concentration (lower plateau), top is the response in the absence of competitor 
(upper plateau), slope refers to the steepness of the curve. IC50 (inhibitory concentration) is the 
concentration of competitor causing 50% inhibition of binding (i.e. 50% inhibition of DCF-Aff 
binding to surface-DCF due to free-DCF) [48] [184] [185].  
 
As seen in Figure 5.9a, at high DCF concentrations the measured absorbance signal was evidently 
decreased, showing that the free-DCF exhibited considerable competition with surface-DCF. The 
response was plotted against the logarithm of DCF concentration and the resulting calibration 
curve, shown in Figure 5.9b, showed a clear decreasing trend with increasing concentration, typical 
of a competition ELISA. The 4PL curve (Equation 5.3) was found to be a good model of the 
experimental data (R
2
 = 0.941) and yielded a value of IC50 = 0.36 μM. The IC50 is a measure of the 
binding inhibition potency of the free-DCF in the competition ELISA [184]. The value estimated 
here is higher than those reported from others in studies of antibody-based competition ELISAs for 
diclofenac detection [48] [187]. Finally, the detection limit for this competition assay (estimated as 
the blank signal + three standard deviations [196] was calculated to be 75 nM (106 μg/L), which is 
also higher that the values reported in the literature.   
  
135 
 
5.5 Conclusions 
The work presented in this chapter aimed to evaluate the potential of DCF-Affimers as bioreceptors 
for Affimer-based immunoassays. The DCF-Aff to DCF binding reaction was investigated using 
QCM-D, where DCF was immobilised on the gold coated QCM-D sensors via LCAT-OEG-DCF 
SAMs. Prior to QCM-D, EIS and PM-IRRAS showed that dilution of the LCAT-OEG-DCF 
component of the SAM with LCAT-OEG-OH improved the order and quality of the monolayer 
conformation. A mixed (1:2 ratio) DCF:OH SAM was thus selected for QCM-D experiments. 
DCF-Aff showed considerable interactions with surface-immobilised DCF in the QCM-D, with 
minimum non-specific binding, as demonstrated using control measurements. Analysis of the 
kinetics of the binding reaction revealed a dissociation constant in the nanomolar region (73 nM), 
which compares well with that of high affinity antibodies [188] [189].  
 
DCF-Aff interactions were also investigated using an ELISA. In agreement with QCM-D 
measurements, DCF-Aff exhibited significant affinity for DCF-coated wells, with negligible non-
specific binding observed in control samples. The dissociation constant, KD, estimated by saturation 
binding measurements, was the same order of magnitude as that found through kinetic analysis in 
QCM-D. Although picomolar affinities have been reported for antibodies against diclofenac [48], 
the value of KD found here for DCF-Aff (37.87 nM) compares well with those for many high 
affinity antibodies against small molecules [181] [182] [187] [193].  
 
While direct ELISAs are well suited for basic studies of molecular interactions, competition 
ELISAs are typically used for the detection of small molecules in the field. The potential of DCF-
Affimers to be used in the competition assay format was thus evaluated. Results showed 
considerable competition between free-DCF and surface-DCF and a calibration curve was 
constructed, showing a clear decreasing trend with increasing free-DCF concentration. Although 
the detection limit (75 nM) was not low enough for the environmentally relevant concentrations of 
diclofenac (typically low picomolar range), these results are very promising, encouraging future 
optimisation of the assay to bring it into the necessary range. The competition ELISA data 
presented here are preliminary results reported with the purpose of demonstrating for the first time 
the potential of Affimers for the detection of small molecules in such competition assays, rather 
than to develop and validate an optimised Affimer-based ELISA. While additional research is 
required in order to optimise the ELISA protocol, the findings presented here are sufficiently 
encouraging to stimulate further research into Affimer-based assays for the detection of small-sized 
molecules, such as diclofenac.   
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Chapter 6  
 
Conclusions 
 
 
Current and emerging pollution issues demand increased monitoring of the presence of 
contaminants in the environment, so as to regulate their levels and apply efficient and well-
informed mitigation plans. For example, many emerging contaminants such as pharmaceuticals, 
personal care products, cleaning agents, microplastics and engineered nanoparticles, are currently 
being freely discharged to the environment without regulation. There is an urgent need for 
additional monitoring in order to map the spatial and temporal distribution of these contaminants 
and to understand their impact on human and ecosystem health. Current analytical techniques 
(mainly LC- or GC-MS) provide accurate, robust and highly reliable approaches for detecting 
emerging contaminants in environmental samples, even at very low concentrations. However, these 
approaches are faced with several limitations (Section 1.2) that greatly impede the wide-spread 
adoption of a time- and cost-efficient environmental monitoring scheme. Immunoassays are an 
attractive alternative to standard analytical approaches, enabling high speed and low-cost 
monitoring in a scheme that can be integrated into a biosensor format to enable rapid, real-time, 
field measurements. Conventional immunoassays rely on antibodies to detect a target compound 
with very high affinity, specificity and selectivity and have found widespread application as 
important bioanalytical tools across a vast range of fields (Section 2.2). However, the use of 
antibodies for the detection of small-sized, non-immunogenic targets, such as many environmental 
contaminants, presents a number of challenges (Section 2.6). These challenges can potentially be 
addressed by Affimers (Section 2.8), which are protein engineered binders that mimic the high 
affinity and specificity associated with antibodies, but with reduced batch-to-batch variability, high 
stability, and in vitro selection that ensures rapid discovery of binders against a wide range of 
targets, including small, non-immunogenic targets. In recent years, many reports have showcased 
the remarkable potential of Affimers as antibody alternatives, but have focussed mainly on protein 
targets, which are large-sized molecules with several epitopes. However, the majority of 
environmental contaminants are small-sized targets. Considering the many advantages of Affimers 
over conventional antibodies, as well as the increasing need to optimise pollution monitoring 
approaches, this project aimed to investigate the potential of Affimers as alternative bioreceptors in 
bioassays for the detection of small-sized compounds, focusing on environmental contaminants.  
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Here, Affimers against two targets were selected: MB, which was selected as a proof-of-principle 
target due to its redox properties, and DCF, an important emerging contaminant with well-
established evidence of its ecotoxicological impacts. The aims of this project were to a) 
demonstrate that the developed Affimers can bind to the selected small-molecule targets with very 
high affinity, b) assess their performance in the complexity of environmental water samples 
(selectivity), and c) develop an Affimer-based immunoassay for small molecule detection.  
 
Biosensors for detecting small-sized targets are typically operated in a competition assay format, 
which requires the immobilisation of the target molecule on the sensing surface. It was thus 
necessary to develop and evaluate an appropriate approach to small molecule immobilisation. Here, 
an approach based on a biotin-OEG8 linker on streptavidin coated surfaces or LCAT-OEG-MB and 
LCAT-OEG-DCF SAMs on gold was demonstrated. QCM-D and CV measurements of MB SAMs 
confirmed that MB retained its redox activity when immobilised on a gold sensor surface (Section 
4.3). in addition, through CV, EIS and PM-IRRAS, it was shown that mixed MB:OH SAMs 
exhibited improved packing order over pure MB SAMs (Section 4.3.3). This immobilisation 
approach was subsequently adopted for studying target-Affimer interactions.  
 
QCM-D studies showed that MB-Affimers bind strongly and specifically to surface-immobilised 
MB (Sections 4.5.1 and 4.5.2), and can demonstrate considerable selectivity in complex matrices, 
such as limnetic water samples (Section 4.5.3). The binding affinity estimated by saturation binding 
and kinetic analysis was found to be in the nanomolar region (KD=13.7 nM for MB-Aff5). This is 
comparable with that of high affinity antibodies [188] [189]. In addition, an Affimer-based 
competition assay for MB detection was demonstrated using QCM-D (Section 4.5.4); the detection 
limit was found to be 360 nM (128 μg/L). This is higher than the environmentally relevant 
concentrations (ng/L to μg/L) [10] and the detection limits reported in the literature for antibody-
based ELISAs for small molecules [48] [181] [193]. However, it should be noted that sensitivity of 
QCM-D is limited at low concentrations [145] and that the assay was presented as a proof-of-
principle and was not optimised. Nonetheless, using MB as a proof-of-concept target, these 
findings demonstrated the ability of Affimers to bind strongly to small-sized compounds and the 
potential to use Affimers in bioassays to detect such targets.  
 
Using the knowledge and experimental approaches developed through the MB-Affimer study, the 
performance of DCF-Affimers was evaluated (Chapter 5). Kinetic analysis of DCF-Affimer 
binding to DCF using QCM-D revealed a low dissociation constant (KD=73 nM) that was within 
the same range as that estimated for MB-Affimers and compared well with that of high affinity 
antibodies [188] [189]. DCF-Aff interactions were also investigated using an ELISA. Here, 
saturation binding measurements yielded a dissociation constant of 37.87 nM, which is consistent 
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with the KD estimated using QCM-D. Although picomolar affinities have been reported for 
antibodies against DCF, the KD values found here for DCF-Affimers using QCM-D and ELISA 
compare well with those for many high affinity antibodies against small molecules [48] [181] [182] 
[193]. Finally, an Affimer-based competition ELISA for DCF detection was demonstrated with a 
detection limit of 75 nM. 
 
The competition assays presented in this work are preliminary results with the purpose of 
demonstrating the potential of Affimers as bioreceptors in bioassays for the detection of small 
molecules. This study has confirmed that 1) in vitro selected, small and robust Affimers can bind to 
small-sized, non-immunogenic targets as strongly as antibodies, even in complex matrices and 2) 
Affimers can be successfully incorporated in conventional immunoassay approaches, such as 
competition ELISAs, to detect such targets. The importance of these findings is significant for 
bioanalytical applications, where there is a need for robust and cost-efficient alternatives to 
antibodies, particularly for environmental monitoring where raising antibodies against targets that 
are typically small-sized, non-immunogenic or toxic compounds can be challenging. Furthermore, 
detection of small molecules by Affimers can be important for healthcare applications, such as 
quantifying the concentration of pharmaceuticals in a patient sample.  
 
Although not optimised, the results presented here are encouraging and support further research on 
Affimer-based bioassays for the detection of small-sized targets. Underpinned by the competition 
ELISA demonstrated in Chapter 5, future research may focus on optimising the assay performance 
in terms of increasing sensitivity (i.e. the slope of the calibration curve), reducing the detection and 
quantification limits of the assay and assessing the accuracy and intra-/inter-assay precision. 
Optimisation of each component of the assay will be required, namely; 1) reagent concentrations 
(i.e. Affimers, immobilised targets, buffers, enzyme-labelled detection antibody, substrate); 2) 
Composition of buffers, including blocking and washing buffers; 3) Selection of detection 
antibody, enzymatic label and substrate; 4) immobilisation approach (e.g. ELISA plate, adjustment 
of length of the biotin linker or possible alternatives to the biotin-streptavidin system); 5) 
Incubation times and number of washing steps. Furthermore, sample preconcentration approaches, 
such as affinity chromatographic columns, can be considered.  
 
Besides assay optimisation, sensitivity can be improved through further development of the binding 
element. For instance, the affinity of strong-binding Affimers can be increased through in vitro 
affinity maturation. This can be achieved by site-directed or randomised mutagenesis of the amino 
acid residues within the antigen-binding sequences of the variable peptide loops, followed by 
increased phage display selection rounds to identify high affinity binders [197] [198]. Another 
approach to increase sensitivity would be the combination of Affimer reagents to create a bivalent 
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or polyvalent binder and thus introduce avidity to the target-binder interaction, mimicking the 
multivalent binding of immunoglobulins.  
 
Critically, the matrix effects from environmental, clinical or other type of samples on the 
performance of the assay must be also examined. In addition, it is important to evaluate the cross-
reactivity of the assay, that is the degree to which Affimers may bind to structurally similar 
molecules or compounds of the same class as the target, focusing on those that are expected to be 
in a particular type of sample (e.g. clinical or environmental). For instance, for the detection of 
DCF in surface water samples, potential cross-reactants may be DCF metabolites, structurally 
similar compounds like meclofenamic or tolfenamic acid or other NSAIDs like ibuprofen or 
ketoprofen [48].  
 
Future considerations for the application of Affimers in environmental monitoring can be identified 
in the biosensor design and approaches. An Affimer-based assay can be combined with established 
lateral flow approaches to enable a low-cost, portable assay in a dipstick format. Furthermore, 
several biosensing techniques, such as optical (e.g. SPR, reflectometric, photonic/electrophotonic) 
or electrochemical (e.g. impedimetric, field-effect transistors) can be combined with novel micro- 
and nanofabrication technologies to develop highly sensitive lab-on-chip sensors for rapid target 
detection. In addition, the fact that Affimers can be designed for efficient immobilisation on sensor 
surfaces enables the development of microarrays for multiplexed detection of contaminants.  
 
Preliminary applications of Affimers are increasingly reported by several studies, demonstrating 
the potential of Affimers as versatile bioreceptors in bioassays. The findings of this work contribute 
to this literature and are encouraging for the future development of biosensors for the detection of 
small molecules, thus introducing a novel, alternative technology for rapid, on-site monitoring of 
contaminants in the environment or for point-of-care clinical diagnostics.   
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Appendix A 
  
Affimer selection against MB and DCF 
 
This section presents the in vitro selection of Affimers against MB and DCF. Initially, both targets 
were coupled to a linker derivatised with biotin. This biotin linker enabled immobilisation on 
streptavidin coated surfaces for Affimer screening of a phage display library. Affimer selection, 
phage ELISA and expression was performed at the BSTG group (University of Leeds), by Dr. 
Christian Tiede, Anna Tang and PhD student Lia de Faveri and was supervised by Dr. Darren 
Tomlinson. A brief overview of the synthesis of the biotin labelled targets, Affimer selection 
processes and results are presented in the following sections. 
 
Biotinylation of MB and DCF 
 
 
 
Figure A.1: Schematic overview of the synthetic protocol of N-(carboxypropyl) methylene blue (5), as described in 
Murray et al. [119], 2014.  
 
A biotin linker with an amine moiety was used for NHS/EDC crosslinking with MB and DCF. This 
reaction links two molecules through an amide bond that is formed between an amine group on one 
molecule and a carboxylic acid on the other molecule. DCF has a single carboxylic acid group 
available for the crosslinking reaction. In contrast, MB does not contain a carboxylic acid and a 
modified version of MB was thus synthesised. For this purpose, N-(carboxypropyl) methylene blue 
was synthesised as described in Murray et al. [119], following a procedure adapted from Pheeney 
and Barton [166]. A schematic overview of the chemical synthesis steps and of the structure of N-
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(carboxypropyl) methylene blue (MB-COOH) is shown in Figure A.1. Next, both MB-COOH and 
DCF were coupled to biotin, following a NHS/EDC coupling reaction [199].  
 
2-Amino-5-(dimethylamino)phenylthiosulfonic acid (2) 
 
 
 
Aluminium sulfate octahydrate (45.0 g, 65 mmol), sodium thiosulfate (22.0 g 140 mmol), and 
zinc(II) chloride (8.8 g, 63 mmol) were dissolved separately into 100 mL, 80 mL and 12 mL of 
water, respectively. The solutions were then added to a flask containing N,N-
dimethylphenylenediamine (2) (10.0 g, 73 mmol) and the mixture cooled to 0 °C under 
continuous stirring. A solution of potassium dichromate (5.0 g, 17 mmol) in water (30 mL) was 
added dropwise for 30 min, and the reaction mixture was stirred at 0 °C for 2 h and then was left to 
warm to room temperature. The precipitate was isolated by filtration; the solid was washed with 
water, acetone, then ether to afford the title compound as a lilac solid (8.3 g, 47%).  
 
N-Methyl-N-(carboxypropyl) aniline (4) 
 
 
 
N-Methylaniline (3) (10.1 mL, 93 mmol), 2, 6-lutidine (11.3 mL, 100 mmol) and 4-bromobutyric 
acid ethyl ester (15.0 mL, 100 mmol) were refluxed in MeCN for 16 h. The MeCN was removed in 
vacuo to leave an indigo residue, which was dissolved in EtOAc (50 mL) and washed with water (2 
× 20 mL). The organic layer was dried (Na2SO4) and concentrated to yield an indigo oil which was 
subjected to flash chromatography (SiO2; EtOAc:Petrol 1:20). The effluent was acidified with HCl, 
washed with Et2O, neutralised with solid NaHCO3 and extracted with EtOAc. The extract was then 
hydrolysed with NaOH (2.5 M, 10 mL) at reflux for 2 h. The mixture was allowed to cool, washed 
with Et2O, acidifed to pH 5 (conc. HCl), then extracted with EtOAc (3 × 30 mL) and dried 
(Na2SO4). Concentration in vacuo gave the title compound as a colourless oil (1.255 g) ESI-LC-
MS: Calcd. for C11H16NO2: m/z 194.1181 [M+H]
+
; found 194.0. tR = 0.79 min (Figure A.2) 
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Figure A.2: ESI-LC-MS of N-Methyl-N-(carboxypropyl) aniline (4) (obtained on a Bruker HCT Ulltra mass 
spectrometer, School of Chemistry, University of Leeds) 
 
N-(carboxypropyl) methylene blue (5) 
 
 
 
Compounds 1 (1.2 g, 4.9 mmol) and 2 (0.95 g, 4.9 mmol) were dissolved in a mixture of MeOH– 
H2O (200:80 mL). The mixture was heated to ~50 °C and Fétizon’s reagent (Ag2CO3 on celite; 5.7 
g, 9.5 mmol) was added portion wise over 15 min. The mixture was then heated at reflux for 2 h. 
The Fétizon’s reagent was removed by filtration and the filtrate was concentrated in vacuo to yield 
a dark blue residue, which was purified on a short SiO2 column. The impurities were eluted with 
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EtOAc, after which the target compound was eluted with DCM-MeOH (9:1) to afford the target 
compound as an indigo-violet glassy solid (0.458 g, 26%). ESI-LC-MS: Calcd. for C19H22N3O2S 
m/z 356.1 [M+H]+; found 356.1; tR = 1.50 min (Figure A.3).  
 
 
Figure A.3: ESI-LC-MS of N-(carboxypropyl) methylene blue (5) (obtained on a Bruker HCT Ulltra mass 
spectrometer, School of Chemistry, University of Leeds) 
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Biotinylation of N-(carboxypropyl) methylene blue 
 
 
Figure A.4: Overview of the NHS/EDC coupling of N-(carboxypropyl) methylene (5) to biotin-PEG(8)-NH2 (6) 
 
Unless noted otherwise, all reagents were purchased from Sigma-Aldrich (Gillingham, UK). A 
mixture of N-hydroxysuccinimide (NHS) solution (0.37 mg, 3.22 μmol) in 100 μL DMF and ethyl-
(dimethylaminopropyl)-carbodiimide (EDC) solution (0.68mg, 3.22 μmol) in 100 μL DMF was 
prepared and a solution of N-(carboxypropyl) methylene (5) (1.14 mg, 3.22 μmol) in100 μL DMF 
was added and stirred for 5 min. Next, a solution of biotin-PEG(8)-NH2 (6) (1 mg, 1.46 μmol) in 
100 μL of water was added dropwise and the reaction mixture was left to stir overnight. The purity 
of the product was examined by ESI-LC-MS (HCT Ultra; Bruker, Bremen, Germany) where only a 
small amount of impurities were detected The reaction mixture was diluted with water up to 1 mL 
to afford the product as a ~1 mg/ mL solution in 30% aqueous DMF. ESI-LC-MS: Calcd. for 
C49H78N7O12S2 m/z 1020.508 [M+H]
+
; found 1020.5; Calcd. for C49H79N7O12S2 m/z 510.758 
[M+2H]
2+
; observed 510.8; tR: 1.53 min (Figure A.5). 
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Figure A.5: ESI-LC-MS of biotinylated methylene blue (7) (obtained on a Bruker HCT Ulltra mass spectrometer, 
School of Chemistry, University of Leeds). 
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Biotinylation of DCF 
 
 
Figure A.6: Overview of the NHS/EDC coupling of DCF (8) to biotin-PEG(8)-NH2 (6) 
 
A mixture of N-hydroxysuccinimide (NHS) solution (7.4 mg, 0.0645 mmol) in 0.5 mL DMF and 
ethyl-(dimethylaminopropyl)-carbodiimide (EDC) solution (12.4 mg, 0.0645 mmol) in 1.0 mL 
DMF was prepared and a solution of diclofenac (8) (20.4 mg, 0.0645 mmol) in 1 mL DMF was 
added and stirred for 5 min. Next, a solution of biotin-PEG(8)-amine  (6) (20 mg, 0.0293 mmol) in 
2.0 mL of water was added dropwise and the reaction mixture was left to stir overnight. After 24 h, 
DMF was removed under ultra-high vacuum (assisted by a warm water bath). The product was 
purified by preparative HPLC. The fractions with the purest product were collected, evaporated and 
freeze-dried to yield an off white solid (5.9 mg). Again, the purity of the product was confirmed by 
ESI-LC-MS (Calcd. for C44H68Cl2N5O12S m/z 480.1985 [M+2H]
2+
; observed m/z 480.1; Calcd. for 
C44H66Cl2N5NaO12S m/z 981.281 [M+Na]
+
; found 981.8); tR=1.85 min (Figure A.7).  
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Figure A.7: ESI-LC-MS of biotinylated diclofenac (9) (obtained on a Bruker HCT Ulltra mass spectrometer, 
School of Chemistry, University of Leeds). 
  
148 
 
Affimer selection 
 
Using a large Affimer phage display library, Affimers that bind to methylene blue and diclofenac 
were selected following the procedure described in Tiede et al. [27]. Due to the small size of the 
targets, five panning rounds were required for Affimer selection. In each round, the library of 
Affimer-carrying phages were screened against the immobilised, biotinylated target. The phages 
isolated from the final panning round were then analysed by a phage ELISA to identify those that 
bind to the target. Finally, the phage binders were sequenced in order to identify unique Affimer 
reagents. Selection and phage ELISA were performed by the BSTG, University of Leeds. Below is 
a brief description of the selection process and the phage ELISA performed by Dr. Christian Tiede, 
Anna Tang (MB-Affimers) and Lia De Faveri (DCF-Affimers). The processes were the same for 
MB and DCF Affimer; thus in the following section, unless noted otherwise, MB and DCF will be 
referred to as ‘target’.  
 
Phage display 
 
For the first panning round, the biotinylated target was bound to streptavidin-coated wells (Pierce, 
Loughborough, UK) for 1 hour, then 10
12
 cfu pre-panned phages (phages screened against wells 
containing only the biotin linker, i.e. no target) were added for 2.5 hours with shaking. Panning 
wells were washed 10 times with PBST and eluted with 50 mM glycine for 10 min (pH 2.2, 
neutralised with Tris-HCl pH 9.1), then 100 mM triethylamine for 6 min (neutralised with Tris-HCl 
pH 7). The collected eluates were used to infect ER2738 cells (1 hour at 37 
o
C with shaking),  
followed by plating onto LB agar plates with 100 µg/mL carbenicillin and grown overnight. 
Colonies were scraped, inoculated in 25 ml of 2XYT with carbenicillin and infected with ca. 1 x 
10
9
 M13K07 helper phages. After 16 hours the phage supernatant was incubated with biotinylated 
target bound to streptavidin magnetic beads (Invitrogen, Paisley, UK) and eluted and amplified as 
above, for the second pan. The third panning round was performed on neutravidin high binding 
capacity wells (Pierce, Loughborough, UK) and eluted as above. The fourth and five panning 
rounds were performed on streptavidin and neutravidin coated plates as described above. 
 
Phage ELISA 
 
Individual ER2738 colonies were grown in 100 µL of 2XTY with 100 µg/mL of carbenicillin in a 
96-deep well plate at 37 °C (900 rpm) for 6 hours. A 25 µL aliquot of the culture was added to 200 
µL of 2XYT containing carbenicillin and grown at 37 °C (900 rpm) for 1 hour. Helper phages (10 
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µL of 10
11/mL) were added, followed by kanamycin to 25 μg/mL overnight and incubated at 25 °C 
(450 rpm). Streptavidin-coated plates were blocked with 2X casein blocking buffer (Sigma-
Aldrich, Gillingham, UK) overnight at 37 °C. The plates were incubated with biotinylated target 
for 1 hour, and 45 µL of growth medium containing the phages was added and incubated for 1 
hour. Following washing, phage binding was detected by adding a 1 : 1000 dilution of HRP-
conjugated anti-phage antibody (Seramun, Heideesee, Germany) for 1 hour and visualised with 
3,3′,5,5′-tetramethylbenzidine (TMB) (Seramun, Heidesee, Germany) and measured at 620 nm. 
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MB-Affimers 
 
Following five panning rounds, 24 individual colonies (each carrying one Affimer binder) were 
isolated. Those that bound to MB were identified by a phage ELISA (Figure A.8). 23 out of 24 
reagents showed binding to MB and following sequencing, three unique sequences were identified: 
MB-Affimer 1, MB-Affimer 2 and MB-Affimer 5, referred to as MB-Aff1, MB-Aff2 and MB-
Aff5, respectively (Table A.1). MB-Aff1 and MB-Aff5 were the most commonly occurring 
sequences and showed sequence homology in both loops, thus were taken forward for 
characterisation (Chapter 4). Notably, MB-Aff5 showed higher expression levels than MB-Aff1 
(2.3 mg/mL and 0.6 mg/mL, respectively) and was selected for in-depth analysis of Affimer 
binding and assay development.  
 
Figure A.8: Phage ELISA of Affimers from 24 clones incubated in streptavidin-coated wells previously treated 
with biotinylated MB (blue), showing the TMB product absorbance (620 nm). Controls (grey) are streptavidin-
coated wells with no biotinylated MB (data provided by Christian Tiede and Anna Tang, BSTG).  
 
Affimer Loop sequence 1 Loop sequence 2 
MB-Aff1 WGWVYTMGD FNSTPPWNV 
MB-Aff2 YKHQWGYW WAHDDAGFF 
MB-Aff5 WGYQEKKVY FDESMPWPM 
Table A.1: Peptide sequences of MB-Affimers binding loops (data provided by Dr Christian Tiede, BSTG). The 
entire Affimer sequence (scaffold and binding loops) can be found in Tiede et al. [27].  
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DCF-Affimers 
 
Following five panning rounds, 48 individual colonies (each carrying one Affimer binder) were 
isolated. All binders demonstrated binding to DCF, as shown by phage ELISA (Figure A.9). Out of 
48 binders, one unique sequence was identified (Table A.2), and the expressed DCF-Affimer (1.39 
mg/mL) was taken forward for affinity characterisation and assay development (Chapter 5).  
 
 
Figure A.9: Phage ELISA of Affimers from 48 clones incubated in streptavidin-coated wells previously treated 
with biotinylated DCF (green), showing the TMB product absorbance (620 nm). Controls (grey) are streptavidin-
coated wells with no biotinylated DCF (data provided by Lia De Faveri, BSTG).  
 
Affimer Loop sequence 1 Loop sequence 2 
DCF-Aff TSMAYMQWG QPAHINCFF 
Table A.2: Peptide sequences of DCF-Affimers binding loops (data provided by Lia De Faveri, BSTG). The entire 
Affimer sequence (scaffold and binding loops) can be found in Tiede et al. [27].  
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Appendix B  
 
LCAT-OEG-MB (18) synthesis 
 
Materials 
 
LCAT-OEG-MB was synthesised by adapting the solid phase synthesis procedure described by 
Murray et al. [119] (Figure 4.2).  All chemicals and coupling reagents were purchased from major 
chemical suppliers. 2-Chlorotrityl chloride resin was purchased from VWR International. All non-
aqueous solution phase reactions were carried out under a N2 atmosphere, using solvents from a 
solvent purification system (Innovative Technology Inc. PureSolv®). Solid phase reactions were 
performed in fritted solid phase extraction tubes (Grace
TM
, Fisher Scientific, Loughborough, UK) 
and agitated on a Stuart rotator. Lyophilisation of compounds was performed using a Virtis 
Benchtop K freeze dryer. 
 
17-hydroxy-3,6,9,12,15-pentaoxaheptadecyl 4-methylbenzenesulfonate (11) 
 
 
 
Silver (I) oxide (1.9 g, 8.3 mmol), and potassium iodide (176 mg, 1.06 mmol) were added to a 
stirred solution of hexaethylene glycol (10) (1.57 g, 5.31 mmol) in DCM (40 mL) at 0 °C. A 
solution of 4-toluenesulfonyl chloride (1.11 g, 5.84 mmol) in DCM (10 mL) was then added drop-
wise and the reaction mixture was stirred at 0 °C until all starting material had been consumed 
(monitored using LC-MS). The reaction was quenched by filtering through a silica pad using 
EtOAc:MeOH 95:5 (125 mL) and the solvents were removed (rotary evaporator). The crude 
tosylate product was subjected to flash chromatography (SiO2; EtOAc–MeOH 95:5) to afford the 
title compound as a colourless oil (1.64 g, 56%). ESI-LC-MS: Calcd. for C19H33O9S: m/z 437.1 
[M+H]
+
; found 437.2; tR = 1.68 min (Figure B.1). 
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Figure B.1: ESI-LC-MS of 17-hydroxy-3,6,9,12,15-pentaoxaheptadecyl 4-methylbenzenesulfonate (11) (obtained 
on a Bruker HCT Ulltra mass spectrometer, School of Chemistry, University of Leeds).  
 
17-amino-3,6,9,12,15-pentaoxaheptadecan-1-ol (12) 
 
 
 
A solution of (11) (1.64 g, 3.76 mmol) in anhydrous DMF was added to a flask containing sodium 
azide (0.37 g, 5.7 mmol. The mixture was stirred and heated to 50 °C for 16 h, then left to cool to 
room temperature. The DMF was removed by co-evaporation with toluene at 50 °C, the residue re-
suspended in EtOAc and filtered over a pad of SiO2. The EtOAc was removed under reduced 
pressure to afford the product as a colourless oil (0.56, 47%). Next, the product was dissolved in 
THF (30 mL) and triphenylphosphine (0.54 g, 2.068 mmol) was added while stirring at 0 °C. The 
reaction mixture was stirred at 0 °C for 16 h, diluted into water (5 mL) and washed with toluene (2 
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× 3 mL); the aqueous layer was concentrated in vacuo to yield a colourless oil (0.41 g, 86%); ESI-
LC-MS: Calcd. for C12H28NO6, m/z 282.1 [M+H]
+
: found 282.1; tR = 0.13 min (Figure B.2). 
 
 
Figure B.2: ESI-LC-MS of 17-amino-3,6,9,12,15-pentaoxaheptadecan-1-ol (12) (obtained on a Bruker HCT Ulltra 
mass spectrometer, School of Chemistry, University of Leeds) 
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Reagent cocktails for solid phase chemistry: 
 
Capping cocktail A for inactivation of 2-chlorotrityl chloride residues: MeOH (10% v/v) and 
DIPEA (1% v/v) in DCM. 
Cleavage cocktail B for cleavage of LCAT-OEG-MB derivative (18): TFA (5% v/v) and TES (2% 
v/v) in DCM. 
 
N – 18 – (N’ – (carboxypropyl) methylene blue) – 3, 6, 9, 11, 15 – pentaoxaheptadecyl 
– 11 – mercaptounadecamide (18) 
 
 
 
2-Chlorotrityl chloride resin (100 mg, 0.12 mmol) was placed in an empty solid phase extraction 
(SPE) tube and was swelled in DCM for 15 min; then the solvent was drained. A solution of 11-
mercaptounadecanoic acid (11) (56 mg, 0.24) in DCM (1.5 mL) was added to the resin and 
allowed to stir for 16 h (tube rotator). The resin was washed with DCM (3 × 1.5 mL), after which 
the remaining, unreacted, 2-chlorotrityl chloride groups were inactivated using capping cocktail A 
(1 mL, 2 × 2 min). The resin was washed with DCM (3 x 1.5 mL) and DMF (3 x 1.5 mL).  
 
A solution of (12), (85 mg, 0.36 mmol), HOBt (49 mg, 0.36 mmol), DIC (56 μL, 0.36 mmol) and 
DIPEA (70 μL, 0.36 mmol) was preincubated for five minutes in DMF (1.5 mL), then added to the 
resin and the reaction mixture stirred for 16 h. The resin was then washed with DMF (3 × 1.5 mL) 
and DCM (3 × 1.5 mL). 
 
A solution of 4-toluenesulfonyl chloride (228 mg, 1.2 mmol), DMAP (29 mg, 0.24 mmol) and 
triethylamine (167 μL, 1.2 mmol) in DCM (1.5 mL) was added to the resin, and the reaction 
mixture was left to react overnight. The following day, the resin was drained, washed with DCM (3 
× 1.5 mL) and treated with a freshly prepared tosylation solution and allowed to react overnight 
again. Then, the resin was washed with DCM (3 × 1.5 mL) and thoroughly with DMF (5 × 1.5 mL) 
to remove all traces of DCM.  
 
Next, a suspension of sodium azide (78 mg, 1.2 mmol) in DMF (1.5 mL) was added to the resin 
and the reaction mixture stirred for 72 h. The excess sodium azide was removed by washing with 
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DMF-H2O (5 × 1.5 mL) and the remaining water was washed out with DMF (5 × 1.5 mL). The 
resin was then washed with DCM (3 × 1.5 mL).  
 
The resin bound azide (16) was washed with THF (3 × 1.5 mL), dried under vacuum and 
transferred to a Schlenk vessel. Then, a solution of anhydrous SnCl2 (157 mg, 0.83 mmol) in THF 
(4 mL) was added to the vessel. The vessel was fitted with a charcoal scrubber and thiophenol (246 
μL, 3.32 mmol) was added followed by DIPEA (786 μL, 4.15 mmol). The solution was stirred 
gently for 1 h. The reaction was quenched by filtering the resin, and the filtrate was collected in a 
bleach bath (10% in H2O). The resin was washed with THF-H2O (2:1, 3 × 10 mL), then THF (3 × 
10 mL), and finally with DCM (3 × 10 mL). The resin-bound amine was transferred back to an 
SPE tube, washed with diethyl ether (1 × 1.5 mL), dried under high vacuum for 2 h and was then 
swelled in DMF.  
 
A solution of N-(carboxypropyl) methylene blue (5) (128 mg, 0.36 mmol), DIC (56 μL, 0.36 
mmol), HOBt (49 mg, 0.36 mmol) and collidine (54μL, 0.36 mmol) was dissolved in DMF and 
then added to the resin bound amine (17). The reaction mixture was protected from light (by 
wrapping the SPE tube in aluminium foil) and stirred overnight. The solution was drained and the 
resin was washed with DMF (3 × 1.5 mL) and DCM (3 × 1.5 mL). 
 
Next, the resin was washed with diethyl ether (1 × 1.5 mL), dried under high vacuum for 2 h and 
then treated with washes of cleavage cocktail B (1.5 mL, 3 × 2 min). The combined washes were 
concentrated to approx. 0.5 mL and precipitated into cold diethyl ether (25 mL; 20 °C) and left in 
a freezer overnight (-18 
o
C). The precipitate was collected by centrifugation (2 min, 40,000 rpm) 
and subjected to reverse phase chromatography, starting at 100% H2O (+0.1% TFA) and moving to 
100% MeOH (+0.1% TFA) in 5% increments, collecting each solvent mixture as a separate 10 mL 
fraction. Each fraction was analysed by TLC and the purity of the most intensely blue spots were 
assessed by LC-MS. All fractions containing the pure target compound were combined and the 
solvent removed in vacuo to yield MB-LCAT-OEG as a dark blue solid (11.1 mg). ESI-LC-MS: 
Calcd. for C42H68N5O7S2 m/z 818.4 [M+H]
+
; found 818.5; tR = 1.83 min (Figure B.3). The product 
was dissolved in ethanol and stored at 4
 o
C.  
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Figure B.3: ESI-LC-MS of LCAT-OEG-MB (18) (obtained on a Bruker HCT Ulltra mass spectrometer, School of 
Chemistry, University of Leeds) 
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Abbreviations 
 
Ab  antibody 
AC  alternating current 
Ag  silver 
AgCl  silver chloride 
AM  antibody mimetic 
AR  ankyrin repeat 
Au  gold 
AWACSS automated water analyser computer supported system  
BAW  bulk acoustic wave 
BEWS  biological early warning systems 
BSTG  BioScreening Technology Group 
CDK  Cyclin-dependent kinase 
CDR  complementarity determining region 
cfu  colony-forming unit 
Co  cobalt 
Cr  chromium  
CV  cyclic voltammetry  
DARPins designed ankyrin repeat proteins 
DC  direct current 
DCF  diclofenac 
DCM  dichloromethane 
DIC  diisopropylcarbodiimide 
DIPEA  N,N-Diisopropylethylamine 
TFA  trifluoroacetic acid 
TES  triethylsilane 
DMAP  4-dimethylaminopyridine 
DMF  dimethylformamide 
DNA  deoxyribonucleic acid 
EC  emerging contaminant 
EDC  ethyl-(dimethylaminopropyl)-carbodiimide 
EDCs  endocrine disruptors  
EIS  electrochemical impedance spectroscopy 
ELISA  enzyme-linked immunosorbent assay 
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ENP  engineered nanoparticle 
Et2O  diethyl ether 
EtOAc  ethyl acetate 
FDA  (US) Food and Drug Administration 
Fe  iron 
FR  framework region 
FT  Fourier transform 
FWHM full-width half maximum 
GC  gas chromatography 
GFP  green fluorescent protein 
hCG  human chorionic gonadotropin 
HER2  human epidermal growth factor 
Hg  mercury 
HOBt  hydroxybenzotriazole 
HPLC  high performance liquid chromatography 
HPV16  human papillomavirus 16 
HRGC  high resolution gas chromatography 
HRMS  high resolution mass spectrometry 
HRP  horseradish peroxidase 
IC50  inhibitory concentration (causing 50% inhibition of binding) 
IHP  inner Helmholtz plane 
IPE  ideal polarised electrode 
IR  infrared 
IUPAC  International Union of Pure and Applied Chemistry 
LB  lysogeny broth 
LC  liquid chromatography  
LCAT  long-chained alkanethiols 
LOD  limit of detection 
MB  methylene blue 
MCT  mercury-cadmium-telluride 
EtOH  ethanol 
MeCN  acetonitrile 
MeOH  methanol 
MIP  molecularly imprinted polymer 
MIR  mid-infrared region 
MRM  multiple reaction monitoring 
MS  mass spectrometry 
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MUA  11-mercaptoundecanoic acid 
MZI  Mach-Zehnder interferometry 
NHS  N-hydroxysuccinimide 
NS1  non-structural protein 1  
NSAID  non-steroidal anti-inflammatory drug 
OEG  oligoethylene glycol 
OHP  outer Helmholtz plane 
Os  osmium 
PAH  polycyclic aromatic hydrocarbons 
PB 7  (sodium) phosphate buffer (pH 7) 
PCET  proton-coupled electron transfer 
PCP  personal care product 
PCR  polymerase chain reaction 
Pd  palladium 
PDB  protein data bank 
PEM  photoelastic modulator 
PM-IRRAS Polarisation modulation-infrared reflection-absorption spectroscopy 
POCIS  polar organic chemical integrative sampler 
Pt  platinum 
PZET  piezoelectric transducer 
QCM-D quartz crystal microbalance with dissipation monitoring 
RIANA River ANAlyser 
RIfS  reflectometric interference spectroscopy 
RNA  ribonucleic acid 
Ru  ruthenium 
SAM  self-assembled monolayer 
SAW  surface acoustic wave 
scFv  single chain variable fragments 
SELEX systematic evolution of ligands by exponential enrichment 
SiC  silicon carbide 
SiO2   silicon dioxide 
SPE  solid phase extraction 
SPR  surface plasmon resonance 
SQT  Stefin A quadruple mutant-Tracy 
ssDNA  single-stranded DNA 
SteA  human cystatin Stefin A 
STM  stefin A triple mutant scaffold 
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SUMO  small-ubiquitin-like modifier 
Taq  Thermus aquaticus 
THF  tetrahydrofuran 
Ti  titanium 
TLC  thin-layer chromatography 
TMB  3,3',5,5'-tetramethylbenzidine 
tR  retention time 
TrxA  thioredoxin 
TWA  time-weighted average 
US-EPA US Environmental Protection Agency 
UV  ultraviolet 
v/v  volume/volume 
ZnSe  zinc selenide 
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